id	sid	tid	token	lemma	pos
dpc-3767	1	1	dermatology	dermatology	NOUN
dpc-3767	1	2	:	:	PUNCT
dpc-3767	1	3	practical	practical	ADJ
dpc-3767	1	4	and	and	CCONJ
dpc-3767	1	5	conceptual	conceptual	ADJ
dpc-3767	1	6	review	review	NOUN
dpc-3767	1	7	|	|	ADV
dpc-3767	1	8	dermatol	dermatol	ADJ
dpc-3767	1	9	pract	pract	NOUN
dpc-3767	1	10	concept	concept	NOUN
dpc-3767	1	11	.	.	PUNCT
dpc-3767	2	1	2024;14(2):e2024109	2024;14(2):e2024109	NUM
dpc-3767	2	2	1	1	NUM
dpc-3767	2	3	efficacy	efficacy	NOUN
dpc-3767	2	4	of	of	ADP
dpc-3767	2	5	intralesional	intralesional	ADJ
dpc-3767	2	6	methotrexate	methotrexate	NOUN
dpc-3767	2	7	injection	injection	NOUN
dpc-3767	2	8	versus	versus	ADP
dpc-3767	2	9	triamcinolone	triamcinolone	PROPN
dpc-3767	2	10	acetonide	acetonide	NOUN
dpc-3767	2	11	in	in	ADP
dpc-3767	2	12	nail	nail	NOUN
dpc-3767	2	13	psoriasis	psoriasis	NOUN
dpc-3767	2	14	:	:	PUNCT
dpc-3767	2	15	a	a	DET
dpc-3767	2	16	systematic	systematic	ADJ
dpc-3767	2	17	review	review	NOUN
dpc-3767	2	18	and	and	CCONJ
dpc-3767	2	19	meta	meta	ADJ
dpc-3767	2	20	-	-	PUNCT
dpc-3767	2	21	analysis	analysis	NOUN
dpc-3767	2	22	stephanie	stephanie	NOUN
dpc-3767	2	23	nathania1	nathania1	PROPN
dpc-3767	2	24	,	,	PUNCT
dpc-3767	2	25	diah	diah	PROPN
dpc-3767	2	26	adriani	adriani	PROPN
dpc-3767	2	27	malik1	malik1	PROPN
dpc-3767	2	28	,	,	PUNCT
dpc-3767	2	29	muslimin1	muslimin1	NOUN
dpc-3767	2	30	,	,	PUNCT
dpc-3767	2	31	hardian2	hardian2	NOUN
dpc-3767	2	32	1	1	NUM
dpc-3767	2	33	department	department	NOUN
dpc-3767	2	34	of	of	ADP
dpc-3767	2	35	dermatovenereology	dermatovenereology	NOUN
dpc-3767	2	36	,	,	PUNCT
dpc-3767	2	37	faculty	faculty	NOUN
dpc-3767	2	38	of	of	ADP
dpc-3767	2	39	medicine	medicine	NOUN
dpc-3767	2	40	,	,	PUNCT
dpc-3767	2	41	diponegoro	diponegoro	ADP
dpc-3767	2	42	university	university	PROPN
dpc-3767	2	43	/	/	SYM
dpc-3767	2	44	dr	dr	PROPN
dpc-3767	2	45	.	.	PROPN
dpc-3767	2	46	kariadi	kariadi	PROPN
dpc-3767	2	47	general	general	PROPN
dpc-3767	2	48	hospital	hospital	PROPN
dpc-3767	2	49	medical	medical	ADJ
dpc-3767	2	50	center	center	NOUN
dpc-3767	2	51	,	,	PUNCT
dpc-3767	2	52	semarang	semarang	PROPN
dpc-3767	2	53	,	,	PUNCT
dpc-3767	2	54	indonesia	indonesia	PROPN
dpc-3767	2	55	2	2	NUM
dpc-3767	2	56	department	department	NOUN
dpc-3767	2	57	of	of	ADP
dpc-3767	2	58	physiology	physiology	NOUN
dpc-3767	2	59	,	,	PUNCT
dpc-3767	2	60	faculty	faculty	NOUN
dpc-3767	2	61	of	of	ADP
dpc-3767	2	62	medicine	medicine	NOUN
dpc-3767	2	63	,	,	PUNCT
dpc-3767	2	64	diponegoro	diponegoro	ADP
dpc-3767	2	65	university	university	PROPN
dpc-3767	2	66	/	/	SYM
dpc-3767	2	67	dr	dr	PROPN
dpc-3767	2	68	.	.	PROPN
dpc-3767	2	69	kariadi	kariadi	PROPN
dpc-3767	2	70	general	general	PROPN
dpc-3767	2	71	hospital	hospital	PROPN
dpc-3767	2	72	medical	medical	ADJ
dpc-3767	2	73	center	center	NOUN
dpc-3767	2	74	,	,	PUNCT
dpc-3767	2	75	semarang	semarang	PROPN
dpc-3767	2	76	,	,	PUNCT
dpc-3767	2	77	indonesia	indonesia	PROPN
dpc-3767	2	78	key	key	ADJ
dpc-3767	2	79	words	word	NOUN
dpc-3767	2	80	:	:	PUNCT
dpc-3767	2	81	methotrexate	methotrexate	NOUN
dpc-3767	2	82	,	,	PUNCT
dpc-3767	2	83	triamcinolone	triamcinolone	NOUN
dpc-3767	2	84	acetonide	acetonide	NOUN
dpc-3767	2	85	,	,	PUNCT
dpc-3767	2	86	nail	nail	NOUN
dpc-3767	2	87	psoriasis	psoriasis	NOUN
dpc-3767	2	88	citation	citation	NOUN
dpc-3767	2	89	:	:	PUNCT
dpc-3767	2	90	nathania	nathania	PROPN
dpc-3767	2	91	s	s	PROPN
dpc-3767	2	92	,	,	PUNCT
dpc-3767	2	93	adriani	adriani	PROPN
dpc-3767	2	94	malik	malik	PROPN
dpc-3767	3	1	d	d	PROPN
dpc-3767	3	2	,	,	PUNCT
dpc-3767	3	3	muslimin	muslimin	ADJ
dpc-3767	3	4	,	,	PUNCT
dpc-3767	3	5	hardian	hardian	ADJ
dpc-3767	3	6	.	.	PUNCT
dpc-3767	4	1	efficacy	efficacy	NOUN
dpc-3767	4	2	of	of	ADP
dpc-3767	4	3	intralesional	intralesional	ADJ
dpc-3767	4	4	methotrexate	methotrexate	NOUN
dpc-3767	4	5	injection	injection	NOUN
dpc-3767	4	6	versus	versus	ADP
dpc-3767	4	7	triamcinolone	triamcinolone	PROPN
dpc-3767	4	8	acetonide	acetonide	NOUN
dpc-3767	4	9	in	in	ADP
dpc-3767	4	10	nail	nail	NOUN
dpc-3767	4	11	psoriasis	psoriasis	NOUN
dpc-3767	4	12	:	:	PUNCT
dpc-3767	4	13	a	a	DET
dpc-3767	4	14	-	-	PUNCT
dpc-3767	4	15	systematic	systematic	ADJ
dpc-3767	4	16	review	review	NOUN
dpc-3767	4	17	and	and	CCONJ
dpc-3767	4	18	meta	meta	ADJ
dpc-3767	4	19	-	-	PUNCT
dpc-3767	4	20	analysis	analysis	NOUN
dpc-3767	4	21	.	.	PUNCT
dpc-3767	5	1	dermatol	dermatol	NOUN
dpc-3767	5	2	pract	pract	PROPN
dpc-3767	5	3	concept	concept	NOUN
dpc-3767	5	4	.	.	PUNCT
dpc-3767	6	1	2024;14(2):e2024109	2024;14(2):e2024109	X
dpc-3767	6	2	.	.	PUNCT
dpc-3767	7	1	doi	doi	NOUN
dpc-3767	7	2	:	:	PUNCT
dpc-3767	8	1	https://doi	https://doi	PROPN
dpc-3767	8	2	.	.	PUNCT
dpc-3767	8	3	org/10.5826	org/10.5826	NUM
dpc-3767	8	4	/	/	SYM
dpc-3767	8	5	dpc.1402a109	dpc.1402a109	VERB
dpc-3767	8	6	accepted	accept	VERB
dpc-3767	8	7	:	:	PUNCT
dpc-3767	8	8	december	december	PROPN
dpc-3767	8	9	12	12	NUM
dpc-3767	8	10	,	,	PUNCT
dpc-3767	8	11	2023	2023	NUM
dpc-3767	8	12	;	;	PUNCT
dpc-3767	8	13	published	publish	VERB
dpc-3767	8	14	:	:	PUNCT
dpc-3767	9	1	april	april	PROPN
dpc-3767	9	2	2024	2024	NUM
dpc-3767	9	3	copyright	copyright	NOUN
dpc-3767	9	4	:	:	PUNCT
dpc-3767	9	5	©	©	PROPN
dpc-3767	9	6	2024	2024	NUM
dpc-3767	9	7	nathania	nathania	PROPN
dpc-3767	9	8	et	et	PROPN
dpc-3767	9	9	al	al	PROPN
dpc-3767	9	10	.	.	PUNCT
dpc-3767	10	1	this	this	PRON
dpc-3767	10	2	is	be	AUX
dpc-3767	10	3	an	an	DET
dpc-3767	10	4	open	open	ADJ
dpc-3767	10	5	-	-	PUNCT
dpc-3767	10	6	access	access	NOUN
dpc-3767	10	7	article	article	NOUN
dpc-3767	10	8	distributed	distribute	VERB
dpc-3767	10	9	under	under	ADP
dpc-3767	10	10	the	the	DET
dpc-3767	10	11	terms	term	NOUN
dpc-3767	10	12	of	of	ADP
dpc-3767	10	13	the	the	DET
dpc-3767	10	14	creative	creative	ADJ
dpc-3767	10	15	commons	common	NOUN
dpc-3767	10	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-3767	10	17	license	license	NOUN
dpc-3767	10	18	(	(	PUNCT
dpc-3767	10	19	by	by	ADP
dpc-3767	10	20	-	-	PUNCT
dpc-3767	10	21	nc-4.0	nc-4.0	NOUN
dpc-3767	10	22	)	)	PUNCT
dpc-3767	10	23	,	,	PUNCT
dpc-3767	10	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-3767	10	25	,	,	PUNCT
dpc-3767	10	26	which	which	PRON
dpc-3767	10	27	permits	permit	VERB
dpc-3767	10	28	unrestricted	unrestricted	ADJ
dpc-3767	10	29	noncommercial	noncommercial	ADJ
dpc-3767	10	30	use	use	NOUN
dpc-3767	10	31	,	,	PUNCT
dpc-3767	10	32	distribution	distribution	NOUN
dpc-3767	10	33	,	,	PUNCT
dpc-3767	10	34	and	and	CCONJ
dpc-3767	10	35	reproduction	reproduction	NOUN
dpc-3767	10	36	in	in	ADP
dpc-3767	10	37	any	any	DET
dpc-3767	10	38	medium	medium	NOUN
dpc-3767	10	39	,	,	PUNCT
dpc-3767	10	40	provided	provide	VERB
dpc-3767	10	41	the	the	DET
dpc-3767	10	42	original	original	ADJ
dpc-3767	10	43	authors	author	NOUN
dpc-3767	10	44	and	and	CCONJ
dpc-3767	10	45	source	source	NOUN
dpc-3767	10	46	are	be	AUX
dpc-3767	10	47	credited	credit	VERB
dpc-3767	10	48	.	.	PUNCT
dpc-3767	11	1	funding	funding	NOUN
dpc-3767	11	2	:	:	PUNCT
dpc-3767	11	3	none	none	NOUN
dpc-3767	11	4	.	.	PUNCT
dpc-3767	12	1	competing	compete	VERB
dpc-3767	12	2	interests	interest	NOUN
dpc-3767	12	3	:	:	PUNCT
dpc-3767	12	4	none	none	NOUN
dpc-3767	12	5	.	.	PUNCT
dpc-3767	13	1	authorship	authorship	NOUN
dpc-3767	13	2	:	:	PUNCT
dpc-3767	13	3	all	all	DET
dpc-3767	13	4	authors	author	NOUN
dpc-3767	13	5	have	have	AUX
dpc-3767	13	6	contributed	contribute	VERB
dpc-3767	13	7	significantly	significantly	ADV
dpc-3767	13	8	to	to	ADP
dpc-3767	13	9	this	this	DET
dpc-3767	13	10	publication	publication	NOUN
dpc-3767	13	11	.	.	PUNCT
dpc-3767	14	1	corresponding	correspond	VERB
dpc-3767	14	2	author	author	NOUN
dpc-3767	14	3	:	:	PUNCT
dpc-3767	14	4	stephanie	stephanie	PROPN
dpc-3767	14	5	nathania	nathania	PROPN
dpc-3767	14	6	,	,	PUNCT
dpc-3767	14	7	department	department	NOUN
dpc-3767	14	8	of	of	ADP
dpc-3767	14	9	dermatovenereology	dermatovenereology	NOUN
dpc-3767	14	10	,	,	PUNCT
dpc-3767	14	11	faculty	faculty	NOUN
dpc-3767	14	12	of	of	ADP
dpc-3767	14	13	medicine	medicine	NOUN
dpc-3767	14	14	,	,	PUNCT
dpc-3767	14	15	diponegoro	diponegoro	PROPN
dpc-3767	14	16	university/	university/	NUM
dpc-3767	14	17	dr	dr	PROPN
dpc-3767	14	18	.	.	PROPN
dpc-3767	14	19	kariadi	kariadi	PROPN
dpc-3767	14	20	general	general	PROPN
dpc-3767	14	21	hospital	hospital	PROPN
dpc-3767	14	22	medical	medical	ADJ
dpc-3767	14	23	center	center	NOUN
dpc-3767	14	24	,	,	PUNCT
dpc-3767	14	25	jl	jl	PROPN
dpc-3767	14	26	.	.	PROPN
dpc-3767	14	27	dr	dr	PROPN
dpc-3767	14	28	.	.	PROPN
dpc-3767	14	29	sutomo	sutomo	PROPN
dpc-3767	14	30	no.16	no.16	PROPN
dpc-3767	14	31	,	,	PUNCT
dpc-3767	14	32	50244	50244	NUM
dpc-3767	14	33	,	,	PUNCT
dpc-3767	14	34	semarang	semarang	PROPN
dpc-3767	14	35	,	,	PUNCT
dpc-3767	14	36	indonesia	indonesia	PROPN
dpc-3767	14	37	.	.	PUNCT
dpc-3767	15	1	phone	phone	NOUN
dpc-3767	15	2	:	:	PUNCT
dpc-3767	16	1	+62/81809013509	+62/81809013509	ADJ
dpc-3767	16	2	email	email	NOUN
dpc-3767	16	3	:	:	PUNCT
dpc-3767	16	4	stephanie.dvjuli18@gmail.com	stephanie.dvjuli18@gmail.com	X
dpc-3767	16	5	introduction	introduction	NOUN
dpc-3767	16	6	:	:	PUNCT
dpc-3767	16	7	psoriasis	psoriasis	NOUN
dpc-3767	16	8	is	be	AUX
dpc-3767	16	9	a	a	DET
dpc-3767	16	10	chronic	chronic	ADJ
dpc-3767	16	11	inflammatory	inflammatory	ADJ
dpc-3767	16	12	skin	skin	NOUN
dpc-3767	16	13	disease	disease	NOUN
dpc-3767	16	14	that	that	PRON
dpc-3767	16	15	can	can	AUX
dpc-3767	16	16	affect	affect	VERB
dpc-3767	16	17	many	many	ADJ
dpc-3767	16	18	parts	part	NOUN
dpc-3767	16	19	of	of	ADP
dpc-3767	16	20	the	the	DET
dpc-3767	16	21	body	body	NOUN
dpc-3767	16	22	.	.	PUNCT
dpc-3767	17	1	psoriatic	psoriatic	ADJ
dpc-3767	17	2	involvement	involvement	NOUN
dpc-3767	17	3	of	of	ADP
dpc-3767	17	4	the	the	DET
dpc-3767	17	5	nail	nail	NOUN
dpc-3767	17	6	bed	bed	NOUN
dpc-3767	17	7	or	or	CCONJ
dpc-3767	17	8	nail	nail	NOUN
dpc-3767	17	9	matrix	matrix	NOUN
dpc-3767	17	10	results	result	NOUN
dpc-3767	17	11	in	in	ADP
dpc-3767	17	12	nail	nail	NOUN
dpc-3767	17	13	psoriasis	psoriasis	NOUN
dpc-3767	17	14	,	,	PUNCT
dpc-3767	17	15	which	which	PRON
dpc-3767	17	16	is	be	AUX
dpc-3767	17	17	common	common	ADJ
dpc-3767	17	18	.	.	PUNCT
dpc-3767	18	1	patients	patient	NOUN
dpc-3767	18	2	with	with	ADP
dpc-3767	18	3	psoriatic	psoriatic	ADJ
dpc-3767	18	4	nails	nail	NOUN
dpc-3767	18	5	have	have	AUX
dpc-3767	18	6	impaired	impair	VERB
dpc-3767	18	7	quality	quality	NOUN
dpc-3767	18	8	of	of	ADP
dpc-3767	18	9	life	life	NOUN
dpc-3767	18	10	due	due	ADP
dpc-3767	18	11	to	to	ADP
dpc-3767	18	12	the	the	DET
dpc-3767	18	13	appearance	appearance	NOUN
dpc-3767	18	14	of	of	ADP
dpc-3767	18	15	nails	nail	NOUN
dpc-3767	18	16	,	,	PUNCT
dpc-3767	18	17	and	and	CCONJ
dpc-3767	18	18	significant	significant	ADJ
dpc-3767	18	19	morbidity	morbidity	NOUN
dpc-3767	18	20	and	and	CCONJ
dpc-3767	18	21	functional	functional	ADJ
dpc-3767	18	22	impairments	impairment	NOUN
dpc-3767	18	23	may	may	AUX
dpc-3767	18	24	arise	arise	VERB
dpc-3767	18	25	in	in	ADP
dpc-3767	18	26	large	large	ADJ
dpc-3767	18	27	cases	case	NOUN
dpc-3767	18	28	.	.	PUNCT
dpc-3767	19	1	the	the	DET
dpc-3767	19	2	management	management	NOUN
dpc-3767	19	3	of	of	ADP
dpc-3767	19	4	nail	nail	NOUN
dpc-3767	19	5	psoriasis	psoriasis	NOUN
dpc-3767	19	6	is	be	AUX
dpc-3767	19	7	challenging	challenging	ADJ
dpc-3767	19	8	because	because	SCONJ
dpc-3767	19	9	it	it	PRON
dpc-3767	19	10	is	be	AUX
dpc-3767	19	11	usually	usually	ADV
dpc-3767	19	12	time	time	NOUN
dpc-3767	19	13	-	-	PUNCT
dpc-3767	19	14	consuming	consume	VERB
dpc-3767	19	15	,	,	PUNCT
dpc-3767	19	16	with	with	ADP
dpc-3767	19	17	uncertain	uncertain	ADJ
dpc-3767	19	18	outcomes	outcome	NOUN
dpc-3767	19	19	.	.	PUNCT
dpc-3767	20	1	the	the	DET
dpc-3767	20	2	existing	exist	VERB
dpc-3767	20	3	evidence	evidence	NOUN
dpc-3767	20	4	suggests	suggest	VERB
dpc-3767	20	5	that	that	SCONJ
dpc-3767	20	6	intralesional	intralesional	ADJ
dpc-3767	20	7	injections	injection	NOUN
dpc-3767	20	8	are	be	AUX
dpc-3767	20	9	particularly	particularly	ADV
dpc-3767	20	10	effective	effective	ADJ
dpc-3767	20	11	for	for	ADP
dpc-3767	20	12	nail	nail	NOUN
dpc-3767	20	13	psoriasis	psoriasis	NOUN
dpc-3767	20	14	.	.	PUNCT
dpc-3767	21	1	current	current	ADJ
dpc-3767	21	2	studies	study	NOUN
dpc-3767	21	3	provide	provide	VERB
dpc-3767	21	4	recommendations	recommendation	NOUN
dpc-3767	21	5	on	on	ADP
dpc-3767	21	6	the	the	DET
dpc-3767	21	7	intralesional	intralesional	ADJ
dpc-3767	21	8	injection	injection	NOUN
dpc-3767	21	9	technique	technique	NOUN
dpc-3767	21	10	,	,	PUNCT
dpc-3767	21	11	recommending	recommend	VERB
dpc-3767	21	12	an	an	DET
dpc-3767	21	13	optimal	optimal	ADJ
dpc-3767	21	14	concentration	concentration	NOUN
dpc-3767	21	15	of	of	ADP
dpc-3767	21	16	methotrexate	methotrexate	NOUN
dpc-3767	21	17	(	(	PUNCT
dpc-3767	21	18	mtx	mtx	NOUN
dpc-3767	21	19	)	)	PUNCT
dpc-3767	21	20	,	,	PUNCT
dpc-3767	21	21	triamcinolone	triamcinolone	NOUN
dpc-3767	21	22	acetonide	acetonide	NOUN
dpc-3767	21	23	(	(	PUNCT
dpc-3767	21	24	ta	ta	NOUN
dpc-3767	21	25	)	)	PUNCT
dpc-3767	21	26	,	,	PUNCT
dpc-3767	21	27	and	and	CCONJ
dpc-3767	21	28	cyclosporine	cyclosporine	NOUN
dpc-3767	21	29	,	,	PUNCT
dpc-3767	21	30	but	but	CCONJ
dpc-3767	21	31	the	the	DET
dpc-3767	21	32	comparison	comparison	NOUN
dpc-3767	21	33	of	of	ADP
dpc-3767	21	34	these	these	DET
dpc-3767	21	35	treatment	treatment	NOUN
dpc-3767	21	36	is	be	AUX
dpc-3767	21	37	still	still	ADV
dpc-3767	21	38	limited	limited	ADJ
dpc-3767	21	39	.	.	PUNCT
dpc-3767	22	1	objective	objective	NOUN
dpc-3767	22	2	:	:	PUNCT
dpc-3767	22	3	this	this	DET
dpc-3767	22	4	study	study	NOUN
dpc-3767	22	5	aimed	aim	VERB
dpc-3767	22	6	to	to	PART
dpc-3767	22	7	evaluate	evaluate	VERB
dpc-3767	22	8	the	the	DET
dpc-3767	22	9	efficacy	efficacy	NOUN
dpc-3767	22	10	of	of	ADP
dpc-3767	22	11	intralesional	intralesional	ADJ
dpc-3767	22	12	injections	injection	NOUN
dpc-3767	22	13	of	of	ADP
dpc-3767	22	14	mtx	mtx	NOUN
dpc-3767	22	15	compared	compare	VERB
dpc-3767	22	16	with	with	ADP
dpc-3767	22	17	ta	ta	PROPN
dpc-3767	22	18	in	in	ADP
dpc-3767	22	19	treating	treat	VERB
dpc-3767	22	20	nail	nail	NOUN
dpc-3767	22	21	psoriasis	psoriasis	NOUN
dpc-3767	22	22	using	use	VERB
dpc-3767	22	23	the	the	DET
dpc-3767	22	24	nail	nail	NOUN
dpc-3767	22	25	psoriasis	psoriasis	NOUN
dpc-3767	22	26	severity	severity	NOUN
dpc-3767	22	27	index	index	NOUN
dpc-3767	22	28	(	(	PUNCT
dpc-3767	22	29	napsi	napsi	NOUN
dpc-3767	22	30	)	)	PUNCT
dpc-3767	22	31	score	score	NOUN
dpc-3767	22	32	.	.	PUNCT
dpc-3767	23	1	methods	method	NOUN
dpc-3767	23	2	:	:	PUNCT
dpc-3767	23	3	a	a	DET
dpc-3767	23	4	systematic	systematic	ADJ
dpc-3767	23	5	literature	literature	NOUN
dpc-3767	23	6	search	search	NOUN
dpc-3767	23	7	was	be	AUX
dpc-3767	23	8	performed	perform	VERB
dpc-3767	23	9	on	on	ADP
dpc-3767	23	10	ebscohost	ebscohost	NOUN
dpc-3767	23	11	,	,	PUNCT
dpc-3767	23	12	scopus	scopus	PROPN
dpc-3767	23	13	,	,	PUNCT
dpc-3767	23	14	proquest	proquest	PROPN
dpc-3767	23	15	,	,	PUNCT
dpc-3767	23	16	sciencedirect	sciencedirect	PROPN
dpc-3767	23	17	,	,	PUNCT
dpc-3767	23	18	springerlink	springerlink	NOUN
dpc-3767	23	19	,	,	PUNCT
dpc-3767	23	20	elsevier	elsevier	PROPN
dpc-3767	23	21	clinical	clinical	ADJ
dpc-3767	23	22	key	key	NOUN
dpc-3767	23	23	,	,	PUNCT
dpc-3767	23	24	cochrane	cochrane	NOUN
dpc-3767	23	25	library	library	NOUN
dpc-3767	23	26	,	,	PUNCT
dpc-3767	23	27	and	and	CCONJ
dpc-3767	23	28	clinicaltrials.gov	clinicaltrials.gov	NOUN
dpc-3767	23	29	using	use	VERB
dpc-3767	23	30	subgroups	subgroup	NOUN
dpc-3767	23	31	terms	term	NOUN
dpc-3767	23	32	:	:	PUNCT
dpc-3767	23	33	“	"	PUNCT
dpc-3767	23	34	intralesional	intralesional	ADJ
dpc-3767	23	35	methotrexate	methotrexate	NOUN
dpc-3767	23	36	injections	injection	NOUN
dpc-3767	23	37	for	for	ADP
dpc-3767	23	38	nail	nail	NOUN
dpc-3767	23	39	psoriasis	psoriasis	NOUN
dpc-3767	23	40	,	,	PUNCT
dpc-3767	23	41	”	"	PUNCT
dpc-3767	23	42	“	"	PUNCT
dpc-3767	23	43	intralesional	intralesional	ADJ
dpc-3767	23	44	triamcinolone	triamcinolone	NOUN
dpc-3767	23	45	acetonide	acetonide	ADJ
dpc-3767	23	46	injections	injection	NOUN
dpc-3767	23	47	for	for	ADP
dpc-3767	23	48	nail	nail	NOUN
dpc-3767	23	49	psoriasis	psoriasis	NOUN
dpc-3767	23	50	,	,	PUNCT
dpc-3767	23	51	”	"	PUNCT
dpc-3767	23	52	and	and	CCONJ
dpc-3767	23	53	“	"	PUNCT
dpc-3767	23	54	napsi	napsi	NOUN
dpc-3767	23	55	score	score	NOUN
dpc-3767	23	56	.	.	PUNCT
dpc-3767	23	57	”	"	PUNCT
dpc-3767	24	1	three	three	NUM
dpc-3767	24	2	studies	study	NOUN
dpc-3767	24	3	were	be	AUX
dpc-3767	24	4	included	include	VERB
dpc-3767	24	5	in	in	ADP
dpc-3767	24	6	the	the	DET
dpc-3767	24	7	qualitative	qualitative	ADJ
dpc-3767	24	8	synthesis	synthesis	NOUN
dpc-3767	24	9	and	and	CCONJ
dpc-3767	24	10	meta	meta	ADJ
dpc-3767	24	11	-	-	PUNCT
dpc-3767	24	12	analysis	analysis	NOUN
dpc-3767	24	13	.	.	PUNCT
dpc-3767	25	1	abstract	abstract	ADJ
dpc-3767	25	2	2	2	NUM
dpc-3767	25	3	review	review	NOUN
dpc-3767	25	4	|	|	ADV
dpc-3767	25	5	dermatol	dermatol	ADJ
dpc-3767	25	6	pract	pract	NOUN
dpc-3767	25	7	concept	concept	NOUN
dpc-3767	25	8	.	.	PUNCT
dpc-3767	26	1	2024;14(2):e2024109	2024;14(2):e2024109	NUM
dpc-3767	26	2	introduction	introduction	NOUN
dpc-3767	26	3	psoriasis	psoriasis	NOUN
dpc-3767	26	4	is	be	AUX
dpc-3767	26	5	a	a	DET
dpc-3767	26	6	chronic	chronic	ADJ
dpc-3767	26	7	inflammatory	inflammatory	ADJ
dpc-3767	26	8	skin	skin	NOUN
dpc-3767	26	9	disease	disease	NOUN
dpc-3767	26	10	with	with	ADP
dpc-3767	26	11	predominantly	predominantly	ADV
dpc-3767	26	12	skin	skin	NOUN
dpc-3767	26	13	and	and	CCONJ
dpc-3767	26	14	joint	joint	ADJ
dpc-3767	26	15	involvement	involvement	NOUN
dpc-3767	26	16	.	.	PUNCT
dpc-3767	27	1	psoriatic	psoriatic	ADJ
dpc-3767	27	2	involvement	involvement	NOUN
dpc-3767	27	3	of	of	ADP
dpc-3767	27	4	the	the	DET
dpc-3767	27	5	nail	nail	NOUN
dpc-3767	27	6	bed	bed	NOUN
dpc-3767	27	7	or	or	CCONJ
dpc-3767	27	8	nail	nail	NOUN
dpc-3767	27	9	matrix	matrix	NOUN
dpc-3767	27	10	results	result	NOUN
dpc-3767	27	11	in	in	ADP
dpc-3767	27	12	nail	nail	NOUN
dpc-3767	27	13	psoriasis	psoriasis	NOUN
dpc-3767	27	14	.	.	PUNCT
dpc-3767	28	1	nail	nail	NOUN
dpc-3767	28	2	psoriasis	psoriasis	NOUN
dpc-3767	28	3	is	be	AUX
dpc-3767	28	4	more	more	ADV
dpc-3767	28	5	common	common	ADJ
dpc-3767	28	6	in	in	ADP
dpc-3767	28	7	adults	adult	NOUN
dpc-3767	28	8	,	,	PUNCT
dpc-3767	28	9	with	with	ADP
dpc-3767	28	10	a	a	DET
dpc-3767	28	11	 	 	SPACE
dpc-3767	28	12	prevalence	prevalence	NOUN
dpc-3767	28	13	 	 	SPACE
dpc-3767	28	14	of	of	ADP
dpc-3767	28	15	up	up	ADP
dpc-3767	28	16	to	to	PART
dpc-3767	28	17	10	10	NUM
dpc-3767	28	18	-	-	SYM
dpc-3767	28	19	78	78	NUM
dpc-3767	28	20	%	%	NOUN
dpc-3767	28	21	[	[	X
dpc-3767	28	22	1	1	NUM
dpc-3767	28	23	]	]	PUNCT
dpc-3767	28	24	.	.	PUNCT
dpc-3767	29	1	it	it	PRON
dpc-3767	29	2	can	can	AUX
dpc-3767	29	3	manifest	manifest	VERB
dpc-3767	29	4	clinically	clinically	ADV
dpc-3767	29	5	as	as	ADP
dpc-3767	29	6	a	a	DET
dpc-3767	29	7	wide	wide	ADJ
dpc-3767	29	8	variety	variety	NOUN
dpc-3767	29	9	of	of	ADP
dpc-3767	29	10	nail	nail	NOUN
dpc-3767	29	11	changes	change	NOUN
dpc-3767	29	12	,	,	PUNCT
dpc-3767	29	13	like	like	ADP
dpc-3767	29	14	discoloration	discoloration	NOUN
dpc-3767	29	15	,	,	PUNCT
dpc-3767	29	16	subungual	subungual	ADJ
dpc-3767	29	17	hyperkeratosis	hyperkeratosis	NOUN
dpc-3767	29	18	,	,	PUNCT
dpc-3767	29	19	pitting	pitting	NOUN
dpc-3767	29	20	,	,	PUNCT
dpc-3767	29	21	onycholysis	onycholysis	NOUN
dpc-3767	29	22	,	,	PUNCT
dpc-3767	29	23	and	and	CCONJ
dpc-3767	29	24	splinter	splinter	VERB
dpc-3767	29	25	hemorrhaging	hemorrhaging	NOUN
dpc-3767	29	26	of	of	ADP
dpc-3767	29	27	the	the	DET
dpc-3767	29	28	nail	nail	NOUN
dpc-3767	29	29	bed	bed	NOUN
dpc-3767	29	30	,	,	PUNCT
dpc-3767	29	31	depending	depend	VERB
dpc-3767	29	32	on	on	ADP
dpc-3767	29	33	the	the	DET
dpc-3767	29	34	part	part	NOUN
dpc-3767	29	35	of	of	ADP
dpc-3767	29	36	the	the	DET
dpc-3767	29	37	nail	nail	NOUN
dpc-3767	29	38	unit	unit	NOUN
dpc-3767	29	39	affected	affect	VERB
dpc-3767	29	40	.	.	PUNCT
dpc-3767	30	1	the	the	DET
dpc-3767	30	2	most	most	ADV
dpc-3767	30	3	observed	observed	ADJ
dpc-3767	30	4	forms	form	NOUN
dpc-3767	30	5	are	be	AUX
dpc-3767	30	6	psoriasis	psoriasis	NOUN
dpc-3767	30	7	of	of	ADP
dpc-3767	30	8	the	the	DET
dpc-3767	30	9	nail	nail	NOUN
dpc-3767	30	10	matrix	matrix	NOUN
dpc-3767	30	11	,	,	PUNCT
dpc-3767	30	12	nail	nail	NOUN
dpc-3767	30	13	bed	bed	NOUN
dpc-3767	30	14	,	,	PUNCT
dpc-3767	30	15	and	and	CCONJ
dpc-3767	30	16	nail	nail	NOUN
dpc-3767	30	17	fold	fold	NOUN
dpc-3767	30	18	.	.	PUNCT
dpc-3767	31	1	patients	patient	NOUN
dpc-3767	31	2	with	with	ADP
dpc-3767	31	3	psoriatic	psoriatic	ADJ
dpc-3767	31	4	nails	nail	NOUN
dpc-3767	31	5	have	have	VERB
dpc-3767	31	6	impaired	impair	VERB
dpc-3767	31	7	quality	quality	NOUN
dpc-3767	31	8	of	of	ADP
dpc-3767	31	9	life	life	NOUN
dpc-3767	31	10	due	due	ADP
dpc-3767	31	11	to	to	ADP
dpc-3767	31	12	the	the	DET
dpc-3767	31	13	appearance	appearance	NOUN
dpc-3767	31	14	of	of	ADP
dpc-3767	31	15	nails	nail	NOUN
dpc-3767	31	16	,	,	PUNCT
dpc-3767	31	17	and	and	CCONJ
dpc-3767	31	18	significant	significant	ADJ
dpc-3767	31	19	morbidity	morbidity	NOUN
dpc-3767	31	20	and	and	CCONJ
dpc-3767	31	21	functional	functional	ADJ
dpc-3767	31	22	impairments	impairment	NOUN
dpc-3767	31	23	may	may	AUX
dpc-3767	31	24	arise	arise	VERB
dpc-3767	31	25	in	in	ADP
dpc-3767	31	26	large	large	ADJ
dpc-3767	31	27	cases	case	NOUN
dpc-3767	31	28	[	[	X
dpc-3767	31	29	2	2	NUM
dpc-3767	31	30	,	,	PUNCT
dpc-3767	31	31	3	3	NUM
dpc-3767	31	32	]	]	PUNCT
dpc-3767	31	33	.	.	PUNCT
dpc-3767	32	1	the	the	DET
dpc-3767	32	2	management	management	NOUN
dpc-3767	32	3	of	of	ADP
dpc-3767	32	4	nail	nail	NOUN
dpc-3767	32	5	psoriasis	psoriasis	NOUN
dpc-3767	32	6	is	be	AUX
dpc-3767	32	7	challenging	challenging	ADJ
dpc-3767	32	8	because	because	SCONJ
dpc-3767	32	9	it	it	PRON
dpc-3767	32	10	is	be	AUX
dpc-3767	32	11	usually	usually	ADV
dpc-3767	32	12	time	time	NOUN
dpc-3767	32	13	-	-	PUNCT
dpc-3767	32	14	consuming	consume	VERB
dpc-3767	32	15	,	,	PUNCT
dpc-3767	32	16	with	with	ADP
dpc-3767	32	17	uncertain	uncertain	ADJ
dpc-3767	32	18	outcomes	outcome	NOUN
dpc-3767	32	19	.	.	PUNCT
dpc-3767	33	1	the	the	DET
dpc-3767	33	2	treatment	treatment	NOUN
dpc-3767	33	3	options	option	NOUN
dpc-3767	33	4	mainly	mainly	ADV
dpc-3767	33	5	depend	depend	VERB
dpc-3767	33	6	upon	upon	SCONJ
dpc-3767	33	7	the	the	DET
dpc-3767	33	8	severity	severity	NOUN
dpc-3767	33	9	and	and	CCONJ
dpc-3767	33	10	extent	extent	NOUN
dpc-3767	33	11	of	of	ADP
dpc-3767	33	12	disease	disease	NOUN
dpc-3767	33	13	.	.	PUNCT
dpc-3767	34	1	patients	patient	NOUN
dpc-3767	34	2	with	with	ADP
dpc-3767	34	3	nail	nail	NOUN
dpc-3767	34	4	psoriasis	psoriasis	NOUN
dpc-3767	34	5	are	be	AUX
dpc-3767	34	6	treated	treat	VERB
dpc-3767	34	7	with	with	ADP
dpc-3767	34	8	either	either	CCONJ
dpc-3767	34	9	topical	topical	ADJ
dpc-3767	34	10	,	,	PUNCT
dpc-3767	34	11	intralesional	intralesional	ADJ
dpc-3767	34	12	,	,	PUNCT
dpc-3767	34	13	or	or	CCONJ
dpc-3767	34	14	systemic	systemic	ADJ
dpc-3767	34	15	therapies	therapy	NOUN
dpc-3767	34	16	[	[	X
dpc-3767	34	17	4	4	NUM
dpc-3767	34	18	]	]	PUNCT
dpc-3767	34	19	.	.	PUNCT
dpc-3767	35	1	methotrexate	methotrexate	NOUN
dpc-3767	35	2	(	(	PUNCT
dpc-3767	35	3	mtx	mtx	NOUN
dpc-3767	35	4	)	)	PUNCT
dpc-3767	35	5	,	,	PUNCT
dpc-3767	35	6	acitretin	acitretin	NOUN
dpc-3767	35	7	,	,	PUNCT
dpc-3767	35	8	and	and	CCONJ
dpc-3767	35	9	leflunomide	leflunomide	ADJ
dpc-3767	35	10	are	be	AUX
dpc-3767	35	11	the	the	DET
dpc-3767	35	12	options	option	NOUN
dpc-3767	35	13	for	for	ADP
dpc-3767	35	14	systemic	systemic	ADJ
dpc-3767	35	15	therapy	therapy	NOUN
dpc-3767	35	16	of	of	ADP
dpc-3767	35	17	psoriasis	psoriasis	NOUN
dpc-3767	35	18	but	but	CCONJ
dpc-3767	35	19	,	,	PUNCT
dpc-3767	35	20	as	as	SCONJ
dpc-3767	35	21	they	they	PRON
dpc-3767	35	22	result	result	VERB
dpc-3767	35	23	in	in	ADP
dpc-3767	35	24	mild	mild	ADJ
dpc-3767	35	25	improvement	improvement	NOUN
dpc-3767	35	26	of	of	ADP
dpc-3767	35	27	nail	nail	NOUN
dpc-3767	35	28	psoriasis	psoriasis	NOUN
dpc-3767	35	29	,	,	PUNCT
dpc-3767	35	30	many	many	ADJ
dpc-3767	35	31	experts	expert	NOUN
dpc-3767	35	32	consider	consider	VERB
dpc-3767	35	33	systemic	systemic	ADJ
dpc-3767	35	34	treatment	treatment	NOUN
dpc-3767	35	35	inadequate	inadequate	ADJ
dpc-3767	35	36	for	for	ADP
dpc-3767	35	37	treating	treat	VERB
dpc-3767	35	38	nail	nail	NOUN
dpc-3767	35	39	psoriasis	psoriasis	NOUN
dpc-3767	35	40	.	.	PUNCT
dpc-3767	36	1	topical	topical	ADJ
dpc-3767	36	2	therapy	therapy	NOUN
dpc-3767	36	3	represents	represent	VERB
dpc-3767	36	4	one	one	NUM
dpc-3767	36	5	of	of	ADP
dpc-3767	36	6	the	the	DET
dpc-3767	36	7	oldest	old	ADJ
dpc-3767	36	8	and	and	CCONJ
dpc-3767	36	9	most	most	ADV
dpc-3767	36	10	well	well	ADV
dpc-3767	36	11	-	-	PUNCT
dpc-3767	36	12	studied	study	VERB
dpc-3767	36	13	treatment	treatment	NOUN
dpc-3767	36	14	methods	method	NOUN
dpc-3767	36	15	for	for	ADP
dpc-3767	36	16	nail	nail	NOUN
dpc-3767	36	17	psoriasis	psoriasis	NOUN
dpc-3767	36	18	.	.	PUNCT
dpc-3767	37	1	multiple	multiple	ADJ
dpc-3767	37	2	medications	medication	NOUN
dpc-3767	37	3	have	have	AUX
dpc-3767	37	4	been	be	AUX
dpc-3767	37	5	studied	study	VERB
dpc-3767	37	6	,	,	PUNCT
dpc-3767	37	7	including	include	VERB
dpc-3767	37	8	corticosteroids	corticosteroid	NOUN
dpc-3767	37	9	,	,	PUNCT
dpc-3767	37	10	calcipotriol	calcipotriol	NOUN
dpc-3767	37	11	,	,	PUNCT
dpc-3767	37	12	tazarotene	tazarotene	NOUN
dpc-3767	37	13	,	,	PUNCT
dpc-3767	37	14	5	5	NUM
dpc-3767	37	15	-	-	PUNCT
dpc-3767	37	16	fluorouracil	fluorouracil	NOUN
dpc-3767	37	17	,	,	PUNCT
dpc-3767	37	18	cyclosporin	cyclosporin	NOUN
dpc-3767	37	19	,	,	PUNCT
dpc-3767	37	20	psoralene	psoralene	NOUN
dpc-3767	37	21	,	,	PUNCT
dpc-3767	37	22	and	and	CCONJ
dpc-3767	37	23	topical	topical	ADJ
dpc-3767	37	24	calcineurin	calcineurin	NOUN
dpc-3767	37	25	inhibitors	inhibitor	NOUN
dpc-3767	37	26	.	.	PUNCT
dpc-3767	38	1	however	however	ADV
dpc-3767	38	2	,	,	PUNCT
dpc-3767	38	3	achieving	achieve	VERB
dpc-3767	38	4	optimal	optimal	ADJ
dpc-3767	38	5	therapeutic	therapeutic	ADJ
dpc-3767	38	6	concentrations	concentration	NOUN
dpc-3767	38	7	of	of	ADP
dpc-3767	38	8	topical	topical	ADJ
dpc-3767	38	9	medications	medication	NOUN
dpc-3767	38	10	is	be	AUX
dpc-3767	38	11	challenging	challenge	VERB
dpc-3767	38	12	with	with	ADP
dpc-3767	38	13	nail	nail	NOUN
dpc-3767	38	14	psoriasis	psoriasis	NOUN
dpc-3767	38	15	given	give	VERB
dpc-3767	38	16	the	the	DET
dpc-3767	38	17	presence	presence	NOUN
dpc-3767	38	18	of	of	ADP
dpc-3767	38	19	the	the	DET
dpc-3767	38	20	nail	nail	NOUN
dpc-3767	38	21	plate	plate	NOUN
dpc-3767	38	22	,	,	PUNCT
dpc-3767	38	23	which	which	PRON
dpc-3767	38	24	can	can	AUX
dpc-3767	38	25	serve	serve	VERB
dpc-3767	38	26	as	as	ADP
dpc-3767	38	27	an	an	DET
dpc-3767	38	28	impermeable	impermeable	ADJ
dpc-3767	38	29	physical	physical	ADJ
dpc-3767	38	30	barrier	barrier	NOUN
dpc-3767	38	31	.	.	PUNCT
dpc-3767	39	1	the	the	DET
dpc-3767	39	2	existing	exist	VERB
dpc-3767	39	3	evidence	evidence	NOUN
dpc-3767	39	4	suggests	suggest	VERB
dpc-3767	39	5	that	that	SCONJ
dpc-3767	39	6	intralesional	intralesional	ADJ
dpc-3767	39	7	injections	injection	NOUN
dpc-3767	39	8	into	into	ADP
dpc-3767	39	9	the	the	DET
dpc-3767	39	10	nail	nail	NOUN
dpc-3767	39	11	bed	bed	NOUN
dpc-3767	39	12	and	and	CCONJ
dpc-3767	39	13	matrix	matrix	NOUN
dpc-3767	39	14	are	be	AUX
dpc-3767	39	15	particularly	particularly	ADV
dpc-3767	39	16	effective	effective	ADJ
dpc-3767	39	17	for	for	ADP
dpc-3767	39	18	alleviating	alleviate	VERB
dpc-3767	39	19	lesions	lesion	NOUN
dpc-3767	39	20	caused	cause	VERB
dpc-3767	39	21	by	by	ADP
dpc-3767	39	22	psoriasis	psoriasis	NOUN
dpc-3767	39	23	of	of	ADP
dpc-3767	39	24	the	the	DET
dpc-3767	39	25	nail	nail	NOUN
dpc-3767	39	26	matrix	matrix	NOUN
dpc-3767	39	27	and	and	CCONJ
dpc-3767	39	28	also	also	ADV
dpc-3767	39	29	have	have	VERB
dpc-3767	39	30	moderate	moderate	ADJ
dpc-3767	39	31	effects	effect	NOUN
dpc-3767	39	32	on	on	ADP
dpc-3767	39	33	nail	nail	NOUN
dpc-3767	39	34	bed	bed	NOUN
dpc-3767	39	35	signs	sign	NOUN
dpc-3767	39	36	[	[	X
dpc-3767	39	37	5	5	NUM
dpc-3767	39	38	]	]	PUNCT
dpc-3767	39	39	.	.	PUNCT
dpc-3767	40	1	current	current	ADJ
dpc-3767	40	2	studies	study	NOUN
dpc-3767	40	3	provide	provide	VERB
dpc-3767	40	4	recommendations	recommendation	NOUN
dpc-3767	40	5	on	on	ADP
dpc-3767	40	6	the	the	DET
dpc-3767	40	7	intralesional	intralesional	ADJ
dpc-3767	40	8	injection	injection	NOUN
dpc-3767	40	9	technique	technique	NOUN
dpc-3767	40	10	,	,	PUNCT
dpc-3767	40	11	recommending	recommend	VERB
dpc-3767	40	12	an	an	DET
dpc-3767	40	13	optimal	optimal	ADJ
dpc-3767	40	14	concentration	concentration	NOUN
dpc-3767	40	15	of	of	ADP
dpc-3767	40	16	triamcinolone	triamcinolone	NOUN
dpc-3767	40	17	acetonide	acetonide	NOUN
dpc-3767	40	18	(	(	PUNCT
dpc-3767	40	19	ta	ta	PROPN
dpc-3767	40	20	)	)	PUNCT
dpc-3767	40	21	,	,	PUNCT
dpc-3767	40	22	 	 	SPACE
dpc-3767	40	23	methotrexate	methotrexate	NOUN
dpc-3767	40	24	(	(	PUNCT
dpc-3767	40	25	mtx	mtx	NOUN
dpc-3767	40	26	)	)	PUNCT
dpc-3767	40	27	,	,	PUNCT
dpc-3767	40	28	and	and	CCONJ
dpc-3767	40	29	cyclosporine	cyclosporine	VERB
dpc-3767	41	1	[	[	X
dpc-3767	41	2	6	6	NUM
dpc-3767	41	3	]	]	PUNCT
dpc-3767	41	4	.	.	PUNCT
dpc-3767	42	1	mittal	mittal	PROPN
dpc-3767	42	2	et	et	PROPN
dpc-3767	42	3	al	al	PROPN
dpc-3767	42	4	.	.	PROPN
dpc-3767	43	1	compared	compare	VERB
dpc-3767	43	2	mtx	mtx	NOUN
dpc-3767	43	3	with	with	ADP
dpc-3767	43	4	other	other	ADJ
dpc-3767	43	5	active	active	ADJ
dpc-3767	43	6	treatments	treatment	NOUN
dpc-3767	43	7	such	such	ADJ
dpc-3767	43	8	as	as	ADP
dpc-3767	43	9	ta	ta	PROPN
dpc-3767	43	10	and	and	CCONJ
dpc-3767	43	11	cyclosporine	cyclosporine	PROPN
dpc-3767	43	12	(	(	PUNCT
dpc-3767	43	13	csa	csa	PROPN
dpc-3767	43	14	)	)	PUNCT
dpc-3767	43	15	;	;	PUNCT
dpc-3767	43	16	good	good	ADJ
dpc-3767	43	17	outcomes	outcome	NOUN
dpc-3767	43	18	were	be	AUX
dpc-3767	43	19	reported	report	VERB
dpc-3767	43	20	for	for	ADP
dpc-3767	43	21	ta	ta	PROPN
dpc-3767	43	22	and	and	CCONJ
dpc-3767	43	23	mtx	mtx	PROPN
dpc-3767	43	24	,	,	PUNCT
dpc-3767	43	25	which	which	PRON
dpc-3767	43	26	both	both	PRON
dpc-3767	43	27	appeared	appear	VERB
dpc-3767	43	28	to	to	PART
dpc-3767	43	29	be	be	AUX
dpc-3767	43	30	better	well	ADJ
dpc-3767	43	31	than	than	ADP
dpc-3767	43	32	cyclosporine	cyclosporine	NOUN
dpc-3767	43	33	.	.	PUNCT
dpc-3767	44	1	both	both	PRON
dpc-3767	44	2	ta	ta	PROPN
dpc-3767	44	3	and	and	CCONJ
dpc-3767	44	4	mtx	mtx	PROPN
dpc-3767	44	5	acted	act	VERB
dpc-3767	44	6	as	as	ADP
dpc-3767	44	7	anti	anti	ADJ
dpc-3767	44	8	-	-	ADJ
dpc-3767	44	9	inflammatory	inflammatory	ADJ
dpc-3767	44	10	,	,	PUNCT
dpc-3767	44	11	anti	anti	ADJ
dpc-3767	44	12	-	-	NOUN
dpc-3767	44	13	proliferation	proliferation	NOUN
dpc-3767	44	14	,	,	PUNCT
dpc-3767	44	15	and	and	CCONJ
dpc-3767	44	16	immunosuppressive	immunosuppressive	ADJ
dpc-3767	44	17	agents	agent	NOUN
dpc-3767	44	18	[	[	X
dpc-3767	44	19	7	7	NUM
dpc-3767	44	20	]	]	PUNCT
dpc-3767	44	21	.	.	PUNCT
dpc-3767	45	1	objectives	objective	VERB
dpc-3767	45	2	this	this	DET
dpc-3767	45	3	study	study	NOUN
dpc-3767	45	4	aimed	aim	VERB
dpc-3767	45	5	to	to	PART
dpc-3767	45	6	evaluate	evaluate	VERB
dpc-3767	45	7	the	the	DET
dpc-3767	45	8	efficacy	efficacy	NOUN
dpc-3767	45	9	of	of	ADP
dpc-3767	45	10	intralesional	intralesional	ADJ
dpc-3767	45	11	injections	injection	NOUN
dpc-3767	45	12	of	of	ADP
dpc-3767	45	13	mtx	mtx	NOUN
dpc-3767	45	14	compared	compare	VERB
dpc-3767	45	15	with	with	ADP
dpc-3767	45	16	ta	ta	PROPN
dpc-3767	45	17	in	in	ADP
dpc-3767	45	18	treating	treat	VERB
dpc-3767	45	19	nail	nail	NOUN
dpc-3767	45	20	psoriasis	psoriasis	NOUN
dpc-3767	45	21	using	use	VERB
dpc-3767	45	22	the	the	DET
dpc-3767	45	23	nail	nail	NOUN
dpc-3767	45	24	psoriasis	psoriasis	NOUN
dpc-3767	45	25	severity	severity	NOUN
dpc-3767	45	26	index	index	NOUN
dpc-3767	45	27	(	(	PUNCT
dpc-3767	45	28	napsi	napsi	NOUN
dpc-3767	45	29	)	)	PUNCT
dpc-3767	45	30	score	score	NOUN
dpc-3767	45	31	.	.	PUNCT
dpc-3767	46	1	methods	method	NOUN
dpc-3767	46	2	we	we	PRON
dpc-3767	46	3	conducted	conduct	VERB
dpc-3767	46	4	a	a	DET
dpc-3767	46	5	systematic	systematic	ADJ
dpc-3767	46	6	review	review	NOUN
dpc-3767	46	7	and	and	CCONJ
dpc-3767	46	8	meta	meta	NOUN
dpc-3767	46	9	-	-	PUNCT
dpc-3767	46	10	analysis	analysis	NOUN
dpc-3767	46	11	for	for	ADP
dpc-3767	46	12	the	the	DET
dpc-3767	46	13	evaluation	evaluation	NOUN
dpc-3767	46	14	of	of	ADP
dpc-3767	46	15	treatments	treatment	NOUN
dpc-3767	46	16	for	for	ADP
dpc-3767	46	17	nail	nail	NOUN
dpc-3767	46	18	psoriasis	psoriasis	NOUN
dpc-3767	46	19	.	.	PUNCT
dpc-3767	47	1	this	this	DET
dpc-3767	47	2	study	study	NOUN
dpc-3767	47	3	was	be	AUX
dpc-3767	47	4	conducted	conduct	VERB
dpc-3767	47	5	using	use	VERB
dpc-3767	47	6	the	the	DET
dpc-3767	47	7	preferred	preferred	ADJ
dpc-3767	47	8	reporting	reporting	NOUN
dpc-3767	47	9	items	item	NOUN
dpc-3767	47	10	for	for	ADP
dpc-3767	47	11	systematic	systematic	ADJ
dpc-3767	47	12	reviews	review	NOUN
dpc-3767	47	13	and	and	CCONJ
dpc-3767	47	14	meta	meta	NOUN
dpc-3767	47	15	-	-	PUNCT
dpc-3767	47	16	analyses	analysis	NOUN
dpc-3767	47	17	(	(	PUNCT
dpc-3767	47	18	prisma	prisma	PROPN
dpc-3767	47	19	)	)	PUNCT
dpc-3767	47	20	2009	2009	NUM
dpc-3767	47	21	.	.	PUNCT
dpc-3767	48	1	literature	literature	NOUN
dpc-3767	48	2	search	search	VERB
dpc-3767	48	3	a	a	DET
dpc-3767	48	4	computer	computer	NOUN
dpc-3767	48	5	-	-	PUNCT
dpc-3767	48	6	based	base	VERB
dpc-3767	48	7	literature	literature	NOUN
dpc-3767	48	8	search	search	NOUN
dpc-3767	48	9	was	be	AUX
dpc-3767	48	10	performed	perform	VERB
dpc-3767	48	11	to	to	PART
dpc-3767	48	12	identify	identify	VERB
dpc-3767	48	13	relevant	relevant	ADJ
dpc-3767	48	14	articles	article	NOUN
dpc-3767	48	15	publish	publish	VERB
dpc-3767	48	16	on	on	ADP
dpc-3767	48	17	medline	medline	PROPN
dpc-3767	48	18	pubmed	pubmed	PROPN
dpc-3767	48	19	,	,	PUNCT
dpc-3767	48	20	ebscohost	ebscohost	NOUN
dpc-3767	48	21	,	,	PUNCT
dpc-3767	48	22	scopus	scopus	PROPN
dpc-3767	48	23	,	,	PUNCT
dpc-3767	48	24	proquest	proquest	PROPN
dpc-3767	48	25	,	,	PUNCT
dpc-3767	48	26	sciencedirect	sciencedirect	PROPN
dpc-3767	48	27	,	,	PUNCT
dpc-3767	48	28	springerlink	springerlink	NOUN
dpc-3767	48	29	,	,	PUNCT
dpc-3767	48	30	elsevier	elsevier	PROPN
dpc-3767	48	31	clinical	clinical	ADJ
dpc-3767	48	32	key	key	NOUN
dpc-3767	48	33	,	,	PUNCT
dpc-3767	48	34	cochrane	cochrane	NOUN
dpc-3767	48	35	library	library	NOUN
dpc-3767	48	36	,	,	PUNCT
dpc-3767	48	37	and	and	CCONJ
dpc-3767	48	38	clinicaltrials	clinicaltrial	NOUN
dpc-3767	48	39	.	.	PUNCT
dpc-3767	49	1	gov	gov	NOUN
dpc-3767	49	2	as	as	ADV
dpc-3767	49	3	well	well	ADV
dpc-3767	49	4	as	as	ADP
dpc-3767	49	5	hand	hand	NOUN
dpc-3767	49	6	searching	search	VERB
dpc-3767	49	7	from	from	ADP
dpc-3767	49	8	indonesia	indonesia	PROPN
dpc-3767	49	9	libraries	library	NOUN
dpc-3767	49	10	.	.	PUNCT
dpc-3767	50	1	the	the	DET
dpc-3767	50	2	main	main	ADJ
dpc-3767	50	3	search	search	NOUN
dpc-3767	50	4	terms	term	NOUN
dpc-3767	50	5	using	use	VERB
dpc-3767	50	6	medical	medical	ADJ
dpc-3767	50	7	subject	subject	NOUN
dpc-3767	50	8	headings	heading	NOUN
dpc-3767	50	9	(	(	PUNCT
dpc-3767	50	10	mesh	mesh	NOUN
dpc-3767	50	11	)	)	PUNCT
dpc-3767	50	12	to	to	PART
dpc-3767	50	13	create	create	VERB
dpc-3767	50	14	subgroups	subgroup	NOUN
dpc-3767	50	15	terms	term	NOUN
dpc-3767	50	16	were	be	AUX
dpc-3767	50	17	:	:	PUNCT
dpc-3767	50	18	“	"	PUNCT
dpc-3767	50	19	intralesional	intralesional	ADJ
dpc-3767	50	20	methotrexate	methotrexate	NOUN
dpc-3767	50	21	injections	injection	NOUN
dpc-3767	50	22	for	for	ADP
dpc-3767	50	23	nail	nail	NOUN
dpc-3767	50	24	psoriasis	psoriasis	NOUN
dpc-3767	50	25	,	,	PUNCT
dpc-3767	50	26	”	"	PUNCT
dpc-3767	50	27	“	"	PUNCT
dpc-3767	50	28	intralesional	intralesional	ADJ
dpc-3767	50	29	triamcinolone	triamcinolone	NOUN
dpc-3767	50	30	acetonide	acetonide	ADJ
dpc-3767	50	31	injections	injection	NOUN
dpc-3767	50	32	for	for	ADP
dpc-3767	50	33	nail	nail	NOUN
dpc-3767	50	34	psoriasis	psoriasis	NOUN
dpc-3767	50	35	,	,	PUNCT
dpc-3767	50	36	”	"	PUNCT
dpc-3767	50	37	and	and	CCONJ
dpc-3767	50	38	“	"	PUNCT
dpc-3767	50	39	napsi	napsi	NOUN
dpc-3767	50	40	score	score	NOUN
dpc-3767	50	41	.	.	PUNCT
dpc-3767	50	42	”	"	PUNCT
dpc-3767	51	1	study	study	NOUN
dpc-3767	51	2	selection	selection	NOUN
dpc-3767	51	3	the	the	DET
dpc-3767	51	4	inclusion	inclusion	NOUN
dpc-3767	51	5	and	and	CCONJ
dpc-3767	51	6	exclusion	exclusion	NOUN
dpc-3767	51	7	criteria	criterion	NOUN
dpc-3767	51	8	were	be	AUX
dpc-3767	51	9	determined	determine	VERB
dpc-3767	51	10	before	before	ADP
dpc-3767	51	11	the	the	DET
dpc-3767	51	12	search	search	NOUN
dpc-3767	51	13	.	.	PUNCT
dpc-3767	52	1	the	the	DET
dpc-3767	52	2	included	include	VERB
dpc-3767	52	3	studies	study	NOUN
dpc-3767	52	4	fulfilled	fulfil	VERB
dpc-3767	52	5	the	the	DET
dpc-3767	52	6	following	follow	VERB
dpc-3767	52	7	inclusion	inclusion	NOUN
dpc-3767	52	8	criteria	criterion	NOUN
dpc-3767	52	9	:	:	PUNCT
dpc-3767	52	10	  	  	SPACE
dpc-3767	52	11	(	(	PUNCT
dpc-3767	52	12	1	1	X
dpc-3767	52	13	)	)	PUNCT
dpc-3767	52	14	the	the	DET
dpc-3767	52	15	study	study	NOUN
dpc-3767	52	16	discussed	discuss	VERB
dpc-3767	52	17	intralesional	intralesional	ADJ
dpc-3767	52	18	mtx	mtx	NOUN
dpc-3767	52	19	and	and	CCONJ
dpc-3767	52	20	ta	ta	ADP
dpc-3767	52	21	injections	injection	NOUN
dpc-3767	52	22	from	from	ADP
dpc-3767	52	23	2018	2018	NUM
dpc-3767	52	24	until	until	ADP
dpc-3767	52	25	2022	2022	NUM
dpc-3767	52	26	;	;	PUNCT
dpc-3767	52	27	(	(	PUNCT
dpc-3767	52	28	2	2	X
dpc-3767	52	29	)	)	PUNCT
dpc-3767	52	30	study	study	NOUN
dpc-3767	52	31	design	design	NOUN
dpc-3767	52	32	was	be	AUX
dpc-3767	52	33	clinical	clinical	ADJ
dpc-3767	52	34	trials	trial	NOUN
dpc-3767	52	35	with	with	ADP
dpc-3767	52	36	/	/	SYM
dpc-3767	52	37	without	without	ADP
dpc-3767	52	38	randomization	randomization	NOUN
dpc-3767	52	39	;	;	PUNCT
dpc-3767	52	40	(	(	PUNCT
dpc-3767	52	41	3	3	X
dpc-3767	52	42	)	)	PUNCT
dpc-3767	52	43	the	the	DET
dpc-3767	52	44	study	study	NOUN
dpc-3767	52	45	participants	participant	NOUN
dpc-3767	52	46	should	should	AUX
dpc-3767	52	47	not	not	PART
dpc-3767	52	48	have	have	AUX
dpc-3767	52	49	received	receive	VERB
dpc-3767	52	50	systemic	systemic	ADJ
dpc-3767	52	51	or	or	CCONJ
dpc-3767	52	52	topical	topical	ADJ
dpc-3767	52	53	therapy	therapy	NOUN
dpc-3767	52	54	within	within	ADP
dpc-3767	52	55	3	3	NUM
dpc-3767	52	56	months	month	NOUN
dpc-3767	52	57	;	;	PUNCT
dpc-3767	52	58	(	(	PUNCT
dpc-3767	52	59	4	4	X
dpc-3767	52	60	)	)	PUNCT
dpc-3767	52	61	the	the	DET
dpc-3767	52	62	evaluated	evaluated	ADJ
dpc-3767	52	63	interventions	intervention	NOUN
dpc-3767	52	64	included	include	VERB
dpc-3767	52	65	3–4	3–4	NUM
dpc-3767	52	66	intralesional	intralesional	ADJ
dpc-3767	52	67	mtx	mtx	NOUN
dpc-3767	52	68	injections	injection	NOUN
dpc-3767	52	69	or	or	CCONJ
dpc-3767	52	70	intralesional	intralesional	ADJ
dpc-3767	52	71	mtx	mtx	NOUN
dpc-3767	52	72	injections	injection	NOUN
dpc-3767	52	73	for	for	ADP
dpc-3767	52	74	4	4	NUM
dpc-3767	52	75	-	-	SYM
dpc-3767	52	76	6	6	NUM
dpc-3767	52	77	-	-	PUNCT
dpc-3767	52	78	week	week	NOUN
dpc-3767	52	79	interval	interval	NOUN
dpc-3767	52	80	;	;	PUNCT
dpc-3767	52	81	(	(	PUNCT
dpc-3767	52	82	5	5	X
dpc-3767	52	83	)	)	PUNCT
dpc-3767	52	84	the	the	DET
dpc-3767	52	85	outcome	outcome	NOUN
dpc-3767	52	86	of	of	ADP
dpc-3767	52	87	the	the	DET
dpc-3767	52	88	studies	study	NOUN
dpc-3767	52	89	was	be	AUX
dpc-3767	52	90	reduction	reduction	NOUN
dpc-3767	52	91	in	in	ADP
dpc-3767	52	92	napsi	napsi	NOUN
dpc-3767	52	93	score	score	NOUN
dpc-3767	52	94	.	.	PUNCT
dpc-3767	53	1	data	datum	NOUN
dpc-3767	53	2	abstraction	abstraction	VERB
dpc-3767	53	3	three	three	NUM
dpc-3767	53	4	independent	independent	ADJ
dpc-3767	53	5	reviewers	reviewer	NOUN
dpc-3767	53	6	abstracted	abstract	VERB
dpc-3767	53	7	data	datum	NOUN
dpc-3767	53	8	using	use	VERB
dpc-3767	53	9	a	a	DET
dpc-3767	53	10	predefined	predefine	VERB
dpc-3767	53	11	data	data	NOUN
dpc-3767	53	12	extraction	extraction	NOUN
dpc-3767	53	13	form	form	NOUN
dpc-3767	53	14	.	.	PUNCT
dpc-3767	54	1	the	the	DET
dpc-3767	54	2	following	follow	VERB
dpc-3767	54	3	information	information	NOUN
dpc-3767	54	4	was	be	AUX
dpc-3767	54	5	extracted	extract	VERB
dpc-3767	54	6	from	from	ADP
dpc-3767	54	7	each	each	DET
dpc-3767	54	8	study	study	NOUN
dpc-3767	54	9	:	:	PUNCT
dpc-3767	54	10	author	author	NOUN
dpc-3767	54	11	,	,	PUNCT
dpc-3767	54	12	year	year	NOUN
dpc-3767	54	13	of	of	ADP
dpc-3767	54	14	publication	publication	NOUN
dpc-3767	54	15	,	,	PUNCT
dpc-3767	54	16	results	result	VERB
dpc-3767	54	17	:	:	PUNCT
dpc-3767	54	18	the	the	DET
dpc-3767	54	19	overall	overall	ADJ
dpc-3767	54	20	standardized	standardized	ADJ
dpc-3767	54	21	mean	mean	ADJ
dpc-3767	54	22	difference	difference	NOUN
dpc-3767	54	23	in	in	ADP
dpc-3767	54	24	napsi	napsi	NOUN
dpc-3767	54	25	scores	score	NOUN
dpc-3767	54	26	after	after	ADP
dpc-3767	54	27	administration	administration	NOUN
dpc-3767	54	28	of	of	ADP
dpc-3767	54	29	intralesional	intralesional	ADJ
dpc-3767	54	30	injection	injection	NOUN
dpc-3767	54	31	of	of	ADP
dpc-3767	54	32	mtx	mtx	NOUN
dpc-3767	54	33	and	and	CCONJ
dpc-3767	54	34	ta	ta	PROPN
dpc-3767	54	35	was	be	AUX
dpc-3767	54	36	−0.213±0.232	−0.213±0.232	NOUN
dpc-3767	54	37	(	(	PUNCT
dpc-3767	54	38	95	95	NUM
dpc-3767	54	39	%	%	NOUN
dpc-3767	54	40	ci	ci	NOUN
dpc-3767	54	41	:	:	PUNCT
dpc-3767	54	42	−0.667–0.241	−0.667–0.241	NOUN
dpc-3767	54	43	)	)	PUNCT
dpc-3767	54	44	.	.	PUNCT
dpc-3767	55	1	the	the	DET
dpc-3767	55	2	q	q	PROPN
dpc-3767	55	3	statistic	statistic	ADJ
dpc-3767	55	4	value	value	NOUN
dpc-3767	55	5	was	be	AUX
dpc-3767	55	6	-0.921	-0.921	X
dpc-3767	55	7	(	(	PUNCT
dpc-3767	55	8	p=0.357	p=0.357	NUM
dpc-3767	55	9	)	)	PUNCT
dpc-3767	55	10	,	,	PUNCT
dpc-3767	55	11	indicating	indicate	VERB
dpc-3767	55	12	the	the	DET
dpc-3767	55	13	insignificant	insignificant	ADJ
dpc-3767	55	14	difference	difference	NOUN
dpc-3767	55	15	in	in	ADP
dpc-3767	55	16	the	the	DET
dpc-3767	55	17	effectiveness	effectiveness	NOUN
dpc-3767	55	18	of	of	ADP
dpc-3767	55	19	both	both	DET
dpc-3767	55	20	therapies	therapy	NOUN
dpc-3767	55	21	.	.	PUNCT
dpc-3767	56	1	conclusion	conclusion	NOUN
dpc-3767	56	2	:	:	PUNCT
dpc-3767	56	3	both	both	DET
dpc-3767	56	4	mtx	mtx	NOUN
dpc-3767	56	5	and	and	CCONJ
dpc-3767	56	6	ta	ta	PROPN
dpc-3767	56	7	were	be	AUX
dpc-3767	56	8	effective	effective	ADJ
dpc-3767	56	9	in	in	ADP
dpc-3767	56	10	treating	treat	VERB
dpc-3767	56	11	nail	nail	NOUN
dpc-3767	56	12	psoriasis	psoriasis	NOUN
dpc-3767	56	13	based	base	VERB
dpc-3767	56	14	on	on	ADP
dpc-3767	56	15	the	the	DET
dpc-3767	56	16	reduction	reduction	NOUN
dpc-3767	56	17	of	of	ADP
dpc-3767	56	18	 	 	SPACE
dpc-3767	56	19	napsi	napsi	NOUN
dpc-3767	56	20	score	score	NOUN
dpc-3767	56	21	.	.	PUNCT
dpc-3767	57	1	review	review	VERB
dpc-3767	57	2	|	|	ADV
dpc-3767	57	3	dermatol	dermatol	ADJ
dpc-3767	57	4	pract	pract	NOUN
dpc-3767	57	5	concept	concept	NOUN
dpc-3767	57	6	.	.	PUNCT
dpc-3767	58	1	2024;14(2):e2024109	2024;14(2):e2024109	NUM
dpc-3767	58	2	3	3	NUM
dpc-3767	58	3	design	design	NOUN
dpc-3767	58	4	of	of	ADP
dpc-3767	58	5	study	study	NOUN
dpc-3767	58	6	,	,	PUNCT
dpc-3767	58	7	blind	blind	ADJ
dpc-3767	58	8	time	time	NOUN
dpc-3767	58	9	period	period	NOUN
dpc-3767	58	10	,	,	PUNCT
dpc-3767	58	11	patient	patient	ADJ
dpc-3767	58	12	type	type	NOUN
dpc-3767	58	13	,	,	PUNCT
dpc-3767	58	14	details	detail	NOUN
dpc-3767	58	15	of	of	ADP
dpc-3767	58	16	the	the	DET
dpc-3767	58	17	interventions	intervention	NOUN
dpc-3767	58	18	(	(	PUNCT
dpc-3767	58	19	intralesional	intralesional	ADJ
dpc-3767	58	20	mtx	mtx	NOUN
dpc-3767	58	21	and	and	CCONJ
dpc-3767	58	22	ta	ta	ADP
dpc-3767	58	23	injections	injection	NOUN
dpc-3767	58	24	)	)	PUNCT
dpc-3767	58	25	,	,	PUNCT
dpc-3767	58	26	and	and	CCONJ
dpc-3767	58	27	the	the	DET
dpc-3767	58	28	improvement	improvement	NOUN
dpc-3767	58	29	after	after	SCONJ
dpc-3767	58	30	the	the	DET
dpc-3767	58	31	treatment	treatment	NOUN
dpc-3767	58	32	using	use	VERB
dpc-3767	58	33	napsi	napsi	NOUN
dpc-3767	58	34	score	score	NOUN
dpc-3767	58	35	.	.	PUNCT
dpc-3767	59	1	data	datum	NOUN
dpc-3767	59	2	analysis	analysis	NOUN
dpc-3767	59	3	we	we	PRON
dpc-3767	59	4	performed	perform	VERB
dpc-3767	59	5	statistical	statistical	ADJ
dpc-3767	59	6	analyses	analysis	NOUN
dpc-3767	59	7	using	use	VERB
dpc-3767	59	8	the	the	DET
dpc-3767	59	9	cochrane	cochrane	PROPN
dpc-3767	59	10	systematic	systematic	PROPN
dpc-3767	59	11	review	review	NOUN
dpc-3767	59	12	software	software	NOUN
dpc-3767	59	13	(	(	PUNCT
dpc-3767	59	14	review	review	NOUN
dpc-3767	59	15	manager	manager	NOUN
dpc-3767	59	16	(	(	PUNCT
dpc-3767	59	17	revman	revman	NOUN
dpc-3767	59	18	)	)	PUNCT
dpc-3767	60	1	[	[	X
dpc-3767	60	2	computer	computer	NOUN
dpc-3767	60	3	program	program	NOUN
dpc-3767	60	4	]	]	PUNCT
dpc-3767	60	5	version	version	NOUN
dpc-3767	60	6	5.4.1	5.4.1	NUM
dpc-3767	60	7	.	.	PROPN
dpc-3767	60	8	,	,	PUNCT
dpc-3767	60	9	2020	2020	NUM
dpc-3767	60	10	)	)	PUNCT
dpc-3767	60	11	.	.	PUNCT
dpc-3767	61	1	categorical	categorical	ADJ
dpc-3767	61	2	data	datum	NOUN
dpc-3767	61	3	are	be	AUX
dpc-3767	61	4	displayed	display	VERB
dpc-3767	61	5	as	as	ADP
dpc-3767	61	6	percentages	percentage	NOUN
dpc-3767	61	7	,	,	PUNCT
dpc-3767	61	8	and	and	CCONJ
dpc-3767	61	9	numerical	numerical	ADJ
dpc-3767	61	10	data	datum	NOUN
dpc-3767	61	11	are	be	AUX
dpc-3767	61	12	displayed	display	VERB
dpc-3767	61	13	as	as	ADP
dpc-3767	61	14	mean	mean	ADJ
dpc-3767	61	15	and	and	CCONJ
dpc-3767	61	16	standard	standard	ADJ
dpc-3767	61	17	deviation	deviation	NOUN
dpc-3767	61	18	(	(	PUNCT
dpc-3767	61	19	sd	sd	NOUN
dpc-3767	61	20	)	)	PUNCT
dpc-3767	61	21	.	.	PUNCT
dpc-3767	62	1	the	the	DET
dpc-3767	62	2	meta	meta	ADJ
dpc-3767	62	3	-	-	PUNCT
dpc-3767	62	4	analysis	analysis	NOUN
dpc-3767	62	5	assessed	assess	VERB
dpc-3767	62	6	the	the	DET
dpc-3767	62	7	weighted	weight	VERB
dpc-3767	62	8	mean	mean	NOUN
dpc-3767	62	9	between	between	ADP
dpc-3767	62	10	changes	change	NOUN
dpc-3767	62	11	in	in	ADP
dpc-3767	62	12	the	the	DET
dpc-3767	62	13	mean	mean	NOUN
dpc-3767	62	14	and	and	CCONJ
dpc-3767	62	15	sd	sd	NOUN
dpc-3767	62	16	from	from	ADP
dpc-3767	62	17	baseline	baseline	NOUN
dpc-3767	62	18	of	of	ADP
dpc-3767	62	19	the	the	DET
dpc-3767	62	20	treatment	treatment	NOUN
dpc-3767	62	21	groups	group	NOUN
dpc-3767	62	22	and	and	CCONJ
dpc-3767	62	23	control	control	NOUN
dpc-3767	62	24	groups	group	NOUN
dpc-3767	62	25	.	.	PUNCT
dpc-3767	63	1	results	result	NOUN
dpc-3767	63	2	systematic	systematic	ADJ
dpc-3767	63	3	review	review	NOUN
dpc-3767	63	4	we	we	PRON
dpc-3767	63	5	identified	identify	VERB
dpc-3767	63	6	51	51	NUM
dpc-3767	63	7	articles	article	NOUN
dpc-3767	63	8	matching	match	VERB
dpc-3767	63	9	the	the	DET
dpc-3767	63	10	search	search	NOUN
dpc-3767	63	11	criteria	criterion	NOUN
dpc-3767	63	12	.	.	PUNCT
dpc-3767	64	1	we	we	PRON
dpc-3767	64	2	extracted	extract	VERB
dpc-3767	64	3	42	42	NUM
dpc-3767	64	4	articles	article	NOUN
dpc-3767	64	5	after	after	ADP
dpc-3767	64	6	reading	read	VERB
dpc-3767	64	7	the	the	DET
dpc-3767	64	8	title	title	NOUN
dpc-3767	64	9	and	and	CCONJ
dpc-3767	64	10	removing	remove	VERB
dpc-3767	64	11	duplicate	duplicate	ADJ
dpc-3767	64	12	publications	publication	NOUN
dpc-3767	64	13	.	.	PUNCT
dpc-3767	65	1	after	after	ADP
dpc-3767	65	2	reading	read	VERB
dpc-3767	65	3	the	the	DET
dpc-3767	65	4	abstract	abstract	ADJ
dpc-3767	65	5	,	,	PUNCT
dpc-3767	65	6	18	18	NUM
dpc-3767	65	7	articles	article	NOUN
dpc-3767	65	8	were	be	AUX
dpc-3767	65	9	excluded	exclude	VERB
dpc-3767	65	10	.	.	PUNCT
dpc-3767	66	1	furthermore	furthermore	ADV
dpc-3767	66	2	,	,	PUNCT
dpc-3767	66	3	we	we	PRON
dpc-3767	66	4	retained	retain	VERB
dpc-3767	66	5	33	33	NUM
dpc-3767	66	6	articles	article	NOUN
dpc-3767	66	7	after	after	ADP
dpc-3767	66	8	a	a	DET
dpc-3767	66	9	full	full	ADJ
dpc-3767	66	10	-	-	PUNCT
dpc-3767	66	11	text	text	NOUN
dpc-3767	66	12	review	review	NOUN
dpc-3767	66	13	.	.	PUNCT
dpc-3767	66	14	 	 	SPACE
dpc-3767	67	1	three	three	NUM
dpc-3767	67	2	complete	complete	ADJ
dpc-3767	67	3	articles	article	NOUN
dpc-3767	67	4	were	be	AUX
dpc-3767	67	5	assessed	assess	VERB
dpc-3767	67	6	for	for	ADP
dpc-3767	67	7	eligibility	eligibility	NOUN
dpc-3767	67	8	in	in	ADP
dpc-3767	67	9	order	order	NOUN
dpc-3767	67	10	to	to	PART
dpc-3767	67	11	evaluate	evaluate	VERB
dpc-3767	67	12	the	the	DET
dpc-3767	67	13	efficacy	efficacy	NOUN
dpc-3767	67	14	of	of	ADP
dpc-3767	67	15	mtx	mtx	NOUN
dpc-3767	67	16	intralesional	intralesional	ADJ
dpc-3767	67	17	injection	injection	NOUN
dpc-3767	67	18	as	as	ADP
dpc-3767	67	19	the	the	DET
dpc-3767	67	20	treatment	treatment	NOUN
dpc-3767	67	21	of	of	ADP
dpc-3767	67	22	nail	nail	NOUN
dpc-3767	67	23	psoriasis	psoriasis	NOUN
dpc-3767	67	24	in	in	ADP
dpc-3767	67	25	qualitative	qualitative	ADJ
dpc-3767	67	26	and	and	CCONJ
dpc-3767	67	27	quantitative	quantitative	ADJ
dpc-3767	67	28	synthesis	synthesis	NOUN
dpc-3767	67	29	.	.	PUNCT
dpc-3767	68	1	the	the	DET
dpc-3767	68	2	literature	literature	NOUN
dpc-3767	68	3	search	search	NOUN
dpc-3767	68	4	was	be	AUX
dpc-3767	68	5	conducted	conduct	VERB
dpc-3767	68	6	based	base	VERB
dpc-3767	68	7	on	on	ADP
dpc-3767	68	8	the	the	DET
dpc-3767	68	9	prisma	prisma	PROPN
dpc-3767	68	10	flow	flow	NOUN
dpc-3767	68	11	diagram	diagram	NOUN
dpc-3767	68	12	(	(	PUNCT
dpc-3767	68	13	figure	figure	NOUN
dpc-3767	68	14	1	1	NUM
dpc-3767	68	15	)	)	PUNCT
dpc-3767	69	1	[	[	X
dpc-3767	69	2	7	7	NUM
dpc-3767	69	3	]	]	PUNCT
dpc-3767	69	4	.	.	PUNCT
dpc-3767	70	1	these	these	DET
dpc-3767	70	2	three	three	NUM
dpc-3767	70	3	studies	study	NOUN
dpc-3767	70	4	included	include	VERB
dpc-3767	70	5	38	38	NUM
dpc-3767	70	6	patients	patient	NOUN
dpc-3767	70	7	and	and	CCONJ
dpc-3767	70	8	were	be	AUX
dpc-3767	70	9	conducted	conduct	VERB
dpc-3767	70	10	in	in	ADP
dpc-3767	70	11	india	india	PROPN
dpc-3767	70	12	(	(	PUNCT
dpc-3767	70	13	n=1	n=1	PROPN
dpc-3767	70	14	)	)	PUNCT
dpc-3767	70	15	,	,	PUNCT
dpc-3767	70	16	egypt	egypt	PROPN
dpc-3767	70	17	(	(	PUNCT
dpc-3767	70	18	n=1	n=1	PROPN
dpc-3767	70	19	)	)	PUNCT
dpc-3767	70	20	,	,	PUNCT
dpc-3767	70	21	and	and	CCONJ
dpc-3767	70	22	italy	italy	PROPN
dpc-3767	70	23	(	(	PUNCT
dpc-3767	70	24	n=1	n=1	PROPN
dpc-3767	70	25	)	)	PUNCT
dpc-3767	70	26	.	.	PUNCT
dpc-3767	71	1	all	all	PRON
dpc-3767	71	2	of	of	ADP
dpc-3767	71	3	the	the	DET
dpc-3767	71	4	included	include	VERB
dpc-3767	71	5	trials	trial	NOUN
dpc-3767	71	6	used	use	VERB
dpc-3767	71	7	the	the	DET
dpc-3767	71	8	mtx	mtx	NOUN
dpc-3767	71	9	intralesional	intralesional	ADJ
dpc-3767	71	10	injection	injection	NOUN
dpc-3767	71	11	as	as	ADP
dpc-3767	71	12	the	the	DET
dpc-3767	71	13	intervention	intervention	NOUN
dpc-3767	71	14	and	and	CCONJ
dpc-3767	71	15	ta	ta	ADP
dpc-3767	71	16	intralesional	intralesional	ADJ
dpc-3767	71	17	injection	injection	NOUN
dpc-3767	71	18	for	for	ADP
dpc-3767	71	19	the	the	DET
dpc-3767	71	20	control	control	NOUN
dpc-3767	71	21	group	group	NOUN
dpc-3767	71	22	.	.	PUNCT
dpc-3767	72	1	two	two	NUM
dpc-3767	72	2	of	of	ADP
dpc-3767	72	3	the	the	DET
dpc-3767	72	4	trials	trial	NOUN
dpc-3767	72	5	used	use	VERB
dpc-3767	72	6	de	de	ADP
dpc-3767	72	7	beker	beker	NOUN
dpc-3767	72	8	injection	injection	NOUN
dpc-3767	72	9	technique	technique	NOUN
dpc-3767	72	10	in	in	ADP
dpc-3767	72	11	four	four	NUM
dpc-3767	72	12	injection	injection	NOUN
dpc-3767	72	13	sites	site	NOUN
dpc-3767	72	14	.	.	PUNCT
dpc-3767	73	1	one	one	NUM
dpc-3767	73	2	of	of	ADP
dpc-3767	73	3	the	the	DET
dpc-3767	73	4	trials	trial	NOUN
dpc-3767	73	5	used	use	VERB
dpc-3767	73	6	v	v	ADV
dpc-3767	73	7	-	-	PUNCT
dpc-3767	73	8	shaped	shape	VERB
dpc-3767	73	9	injection	injection	NOUN
dpc-3767	73	10	technique	technique	NOUN
dpc-3767	73	11	in	in	ADP
dpc-3767	73	12	two	two	NUM
dpc-3767	73	13	injection	injection	NOUN
dpc-3767	73	14	sites	site	NOUN
dpc-3767	73	15	.	.	PUNCT
dpc-3767	74	1	the	the	DET
dpc-3767	74	2	duration	duration	NOUN
dpc-3767	74	3	of	of	ADP
dpc-3767	74	4	the	the	DET
dpc-3767	74	5	intervention	intervention	NOUN
dpc-3767	74	6	in	in	ADP
dpc-3767	74	7	all	all	PRON
dpc-3767	74	8	of	of	ADP
dpc-3767	74	9	the	the	DET
dpc-3767	74	10	trials	trial	NOUN
dpc-3767	74	11	was	be	AUX
dpc-3767	74	12	24	24	NUM
dpc-3767	74	13	weeks	week	NOUN
dpc-3767	74	14	.	.	PUNCT
dpc-3767	75	1	results	result	NOUN
dpc-3767	75	2	of	of	ADP
dpc-3767	75	3	qualitative	qualitative	ADJ
dpc-3767	75	4	data	datum	NOUN
dpc-3767	75	5	analysis	analysis	NOUN
dpc-3767	75	6	1	1	NUM
dpc-3767	75	7	.	.	PUNCT
dpc-3767	75	8	starace	starace	NOUN
dpc-3767	75	9	et	et	PROPN
dpc-3767	75	10	al	al	PROPN
dpc-3767	75	11	.	.	PROPN
dpc-3767	75	12	,	,	PUNCT
dpc-3767	75	13	2022	2022	NUM
dpc-3767	75	14	a	a	DET
dpc-3767	75	15	study	study	NOUN
dpc-3767	75	16	by	by	ADP
dpc-3767	75	17	starace	starace	NOUN
dpc-3767	75	18	et	et	PROPN
dpc-3767	75	19	al	al	PROPN
dpc-3767	75	20	(	(	PUNCT
dpc-3767	75	21	2022	2022	NUM
dpc-3767	75	22	)	)	PUNCT
dpc-3767	75	23	assessed	assess	VERB
dpc-3767	75	24	a	a	DET
dpc-3767	75	25	pilot	pilot	NOUN
dpc-3767	75	26	study	study	NOUN
dpc-3767	75	27	that	that	SCONJ
dpc-3767	75	28	compared	compare	VERB
dpc-3767	75	29	intralesional	intralesional	ADJ
dpc-3767	75	30	methotrexate	methotrexate	NOUN
dpc-3767	75	31	injections	injection	NOUN
dpc-3767	75	32	versus	versus	ADP
dpc-3767	75	33	triamcinolone	triamcinolone	PROPN
dpc-3767	75	34	acetonide	acetonide	NOUN
dpc-3767	75	35	in	in	ADP
dpc-3767	75	36	patients	patient	NOUN
dpc-3767	75	37	affected	affect	VERB
dpc-3767	75	38	by	by	ADP
dpc-3767	75	39	nail	nail	NOUN
dpc-3767	75	40	matrix	matrix	NOUN
dpc-3767	75	41	psoriasis	psoriasis	NOUN
dpc-3767	75	42	.	.	PUNCT
dpc-3767	76	1	the	the	DET
dpc-3767	76	2	study	study	NOUN
dpc-3767	76	3	participants	participant	NOUN
dpc-3767	76	4	were	be	AUX
dpc-3767	76	5	enrolled	enrol	VERB
dpc-3767	76	6	in	in	ADP
dpc-3767	76	7	italy	italy	PROPN
dpc-3767	76	8	between	between	ADP
dpc-3767	76	9	january	january	PROPN
dpc-3767	76	10	2019	2019	NUM
dpc-3767	76	11	and	and	CCONJ
dpc-3767	76	12	september	september	PROPN
dpc-3767	76	13	2020	2020	NUM
dpc-3767	76	14	.	.	PUNCT
dpc-3767	77	1	participants	participant	NOUN
dpc-3767	77	2	included	include	VERB
dpc-3767	77	3	a	a	DET
dpc-3767	77	4	total	total	NOUN
dpc-3767	77	5	of	of	ADP
dpc-3767	77	6	12	12	NUM
dpc-3767	77	7	patients	patient	NOUN
dpc-3767	77	8	with	with	ADP
dpc-3767	77	9	20	20	NUM
dpc-3767	77	10	nails	nail	NOUN
dpc-3767	77	11	affected	affect	VERB
dpc-3767	77	12	with	with	ADP
dpc-3767	77	13	psoriasis	psoriasis	NOUN
dpc-3767	77	14	who	who	PRON
dpc-3767	77	15	had	have	AUX
dpc-3767	77	16	not	not	PART
dpc-3767	77	17	received	receive	VERB
dpc-3767	77	18	any	any	DET
dpc-3767	77	19	treatment	treatment	NOUN
dpc-3767	77	20	in	in	ADP
dpc-3767	77	21	three	three	NUM
dpc-3767	77	22	months	month	NOUN
dpc-3767	77	23	.	.	PUNCT
dpc-3767	78	1	patients	patient	NOUN
dpc-3767	78	2	were	be	AUX
dpc-3767	78	3	divided	divide	VERB
dpc-3767	78	4	into	into	ADP
dpc-3767	78	5	two	two	NUM
dpc-3767	78	6	groups	group	NOUN
dpc-3767	78	7	of	of	ADP
dpc-3767	78	8	six	six	NUM
dpc-3767	78	9	patients	patient	NOUN
dpc-3767	78	10	each	each	PRON
dpc-3767	78	11	:	:	PUNCT
dpc-3767	78	12	group	group	NOUN
dpc-3767	78	13	1	1	NUM
dpc-3767	78	14	was	be	AUX
dpc-3767	78	15	treated	treat	VERB
dpc-3767	78	16	with	with	ADP
dpc-3767	78	17	mtx	mtx	NOUN
dpc-3767	78	18	25	25	NUM
dpc-3767	78	19	mg	mg	PROPN
dpc-3767	78	20	/	/	SYM
dpc-3767	78	21	ml	ml	NOUN
dpc-3767	78	22	and	and	CCONJ
dpc-3767	78	23	group	group	NOUN
dpc-3767	78	24	2	2	NUM
dpc-3767	78	25	with	with	ADP
dpc-3767	78	26	ta	ta	PROPN
dpc-3767	78	27	10	10	NUM
dpc-3767	78	28	mg	mg	NUM
dpc-3767	78	29	/	/	SYM
dpc-3767	78	30	ml	ml	NOUN
dpc-3767	78	31	.	.	PUNCT
dpc-3767	79	1	each	each	DET
dpc-3767	79	2	group	group	NOUN
dpc-3767	79	3	had	have	VERB
dpc-3767	79	4	a	a	DET
dpc-3767	79	5	baseline	baseline	ADJ
dpc-3767	79	6	napsi	napsi	ADJ
dpc-3767	79	7	score	score	NOUN
dpc-3767	79	8	of	of	ADP
dpc-3767	79	9	5.3	5.3	NUM
dpc-3767	79	10	.	.	PUNCT
dpc-3767	80	1	depending	depend	VERB
dpc-3767	80	2	on	on	ADP
dpc-3767	80	3	the	the	DET
dpc-3767	80	4	group	group	NOUN
dpc-3767	80	5	,	,	PUNCT
dpc-3767	80	6	either	either	CCONJ
dpc-3767	80	7	mtx	mtx	NOUN
dpc-3767	80	8	or	or	CCONJ
dpc-3767	80	9	ta	ta	PROPN
dpc-3767	80	10	was	be	AUX
dpc-3767	80	11	injected	inject	VERB
dpc-3767	80	12	into	into	ADP
dpc-3767	80	13	each	each	DET
dpc-3767	80	14	affected	affect	VERB
dpc-3767	80	15	nail	nail	NOUN
dpc-3767	80	16	,	,	PUNCT
dpc-3767	80	17	following	follow	VERB
dpc-3767	80	18	the	the	DET
dpc-3767	80	19	de	de	PROPN
dpc-3767	80	20	berker	berker	NOUN
dpc-3767	80	21	technique	technique	NOUN
dpc-3767	80	22	and	and	CCONJ
dpc-3767	80	23	without	without	ADP
dpc-3767	80	24	digital	digital	ADJ
dpc-3767	80	25	anesthesia	anesthesia	NOUN
dpc-3767	80	26	.	.	PUNCT
dpc-3767	81	1	the	the	DET
dpc-3767	81	2	patients	patient	NOUN
dpc-3767	81	3	were	be	AUX
dpc-3767	81	4	asked	ask	VERB
dpc-3767	81	5	to	to	PART
dpc-3767	81	6	take	take	VERB
dpc-3767	81	7	folic	folic	NOUN
dpc-3767	81	8	acid	acid	NOUN
dpc-3767	81	9	5	5	NUM
dpc-3767	81	10	 	 	SPACE
dpc-3767	81	11	mg	mg	NOUN
dpc-3767	81	12	once	once	ADV
dpc-3767	81	13	weekly	weekly	ADV
dpc-3767	81	14	(	(	PUNCT
dpc-3767	81	15	not	not	PART
dpc-3767	81	16	on	on	ADP
dpc-3767	81	17	the	the	DET
dpc-3767	81	18	day	day	NOUN
dpc-3767	81	19	of	of	ADP
dpc-3767	81	20	injection	injection	NOUN
dpc-3767	81	21	)	)	PUNCT
dpc-3767	81	22	to	to	PART
dpc-3767	81	23	reduce	reduce	VERB
dpc-3767	81	24	figure	figure	NOUN
dpc-3767	81	25	1	1	NUM
dpc-3767	81	26	.	.	PUNCT
dpc-3767	81	27	flow	flow	NOUN
dpc-3767	81	28	diagram	diagram	NOUN
dpc-3767	81	29	of	of	ADP
dpc-3767	81	30	search	search	NOUN
dpc-3767	81	31	strategy	strategy	NOUN
dpc-3767	81	32	and	and	CCONJ
dpc-3767	81	33	study	study	NOUN
dpc-3767	81	34	selection	selection	NOUN
dpc-3767	81	35	.	.	PUNCT
dpc-3767	82	1	4	4	NUM
dpc-3767	82	2	review	review	NOUN
dpc-3767	82	3	|	|	ADV
dpc-3767	82	4	dermatol	dermatol	ADJ
dpc-3767	82	5	pract	pract	NOUN
dpc-3767	82	6	concept	concept	NOUN
dpc-3767	82	7	.	.	PUNCT
dpc-3767	83	1	2024;14(2):e2024109	2024;14(2):e2024109	NUM
dpc-3767	83	2	enrolled	enrol	VERB
dpc-3767	83	3	.	.	PUNCT
dpc-3767	83	4	  	  	SPACE
dpc-3767	83	5	ninety	ninety	NUM
dpc-3767	83	6	fingernails	fingernail	NOUN
dpc-3767	83	7	in	in	ADP
dpc-3767	83	8	17	17	NUM
dpc-3767	83	9	patients	patient	NOUN
dpc-3767	83	10	were	be	AUX
dpc-3767	83	11	assigned	assign	VERB
dpc-3767	83	12	to	to	ADP
dpc-3767	83	13	three	three	NUM
dpc-3767	83	14	groups	group	NOUN
dpc-3767	83	15	of	of	ADP
dpc-3767	83	16	thirty	thirty	NUM
dpc-3767	83	17	nails	nail	NOUN
dpc-3767	83	18	each	each	PRON
dpc-3767	83	19	and	and	CCONJ
dpc-3767	83	20	treated	treat	VERB
dpc-3767	83	21	with	with	ADP
dpc-3767	83	22	intramatricial	intramatricial	ADJ
dpc-3767	83	23	injections	injection	NOUN
dpc-3767	83	24	of	of	ADP
dpc-3767	83	25	triamcinolone	triamcinolone	NOUN
dpc-3767	83	26	acetonide	acetonide	NOUN
dpc-3767	83	27	(	(	PUNCT
dpc-3767	83	28	10	10	NUM
dpc-3767	83	29	  	  	SPACE
dpc-3767	83	30	mg	mg	PROPN
dpc-3767	83	31	/	/	SYM
dpc-3767	83	32	ml	ml	NOUN
dpc-3767	83	33	)	)	PUNCT
dpc-3767	83	34	,	,	PUNCT
dpc-3767	83	35	methotrexate	methotrexate	NOUN
dpc-3767	83	36	(	(	PUNCT
dpc-3767	83	37	25	25	NUM
dpc-3767	83	38	mg	mg	NUM
dpc-3767	83	39	/	/	SYM
dpc-3767	83	40	ml	ml	NOUN
dpc-3767	83	41	)	)	PUNCT
dpc-3767	83	42	,	,	PUNCT
dpc-3767	83	43	or	or	CCONJ
dpc-3767	83	44	cyclosporine	cyclosporine	NOUN
dpc-3767	83	45	(	(	PUNCT
dpc-3767	83	46	50	50	NUM
dpc-3767	83	47	mg	mg	NUM
dpc-3767	83	48	/	/	SYM
dpc-3767	83	49	ml	ml	NOUN
dpc-3767	83	50	)	)	PUNCT
dpc-3767	83	51	,	,	PUNCT
dpc-3767	83	52	respectively	respectively	ADV
dpc-3767	83	53	.	.	PUNCT
dpc-3767	84	1	digital	digital	ADJ
dpc-3767	84	2	nerve	nerve	NOUN
dpc-3767	84	3	blocks	block	NOUN
dpc-3767	84	4	with	with	ADP
dpc-3767	84	5	plain	plain	ADJ
dpc-3767	84	6	lignocaine	lignocaine	NOUN
dpc-3767	84	7	(	(	PUNCT
dpc-3767	84	8	2	2	NUM
dpc-3767	84	9	%	%	NOUN
dpc-3767	84	10	)	)	PUNCT
dpc-3767	84	11	were	be	AUX
dpc-3767	84	12	administered	administer	VERB
dpc-3767	84	13	 	 	SPACE
dpc-3767	84	14	before	before	ADP
dpc-3767	84	15	intervention	intervention	NOUN
dpc-3767	84	16	.	.	PUNCT
dpc-3767	85	1	a	a	DET
dpc-3767	85	2	volume	volume	NOUN
dpc-3767	85	3	of	of	ADP
dpc-3767	85	4	0.05	0.05	NUM
dpc-3767	85	5	ml	ml	NOUN
dpc-3767	85	6	was	be	AUX
dpc-3767	85	7	injected	inject	VERB
dpc-3767	85	8	from	from	ADP
dpc-3767	85	9	each	each	DET
dpc-3767	85	10	lateral	lateral	ADJ
dpc-3767	85	11	angle	angle	NOUN
dpc-3767	85	12	,	,	PUNCT
dpc-3767	85	13	forming	form	VERB
dpc-3767	85	14	a	a	DET
dpc-3767	85	15	v.	v.	ADP
dpc-3767	85	16	two	two	NUM
dpc-3767	85	17	injections	injection	NOUN
dpc-3767	85	18	were	be	AUX
dpc-3767	85	19	administered	administer	VERB
dpc-3767	85	20	into	into	ADP
dpc-3767	85	21	each	each	DET
dpc-3767	85	22	treated	treat	VERB
dpc-3767	85	23	nail	nail	NOUN
dpc-3767	85	24	,	,	PUNCT
dpc-3767	85	25	with	with	ADP
dpc-3767	85	26	an	an	DET
dpc-3767	85	27	interval	interval	NOUN
dpc-3767	85	28	of	of	ADP
dpc-3767	85	29	six	six	NUM
dpc-3767	85	30	weeks	week	NOUN
dpc-3767	85	31	.	.	PUNCT
dpc-3767	86	1	the	the	DET
dpc-3767	86	2	severity	severity	NOUN
dpc-3767	86	3	of	of	ADP
dpc-3767	86	4	nail	nail	NOUN
dpc-3767	86	5	psoriasis	psoriasis	NOUN
dpc-3767	86	6	was	be	AUX
dpc-3767	86	7	evaluated	evaluate	VERB
dpc-3767	86	8	using	use	VERB
dpc-3767	86	9	napsi	napsi	NOUN
dpc-3767	86	10	score	score	NOUN
dpc-3767	86	11	after	after	ADP
dpc-3767	86	12	12	12	NUM
dpc-3767	86	13	and	and	CCONJ
dpc-3767	86	14	24	24	NUM
dpc-3767	86	15	weeks	week	NOUN
dpc-3767	86	16	.	.	PUNCT
dpc-3767	87	1	the	the	DET
dpc-3767	87	2	napsi	napsi	NOUN
dpc-3767	87	3	score	score	NOUN
dpc-3767	87	4	was	be	AUX
dpc-3767	87	5	graded	grade	VERB
dpc-3767	87	6	as	as	ADP
dpc-3767	87	7	:	:	PUNCT
dpc-3767	87	8	g0	g0	NOUN
dpc-3767	87	9	=	=	NOUN
dpc-3767	87	10	no	no	DET
dpc-3767	87	11	improvement	improvement	NOUN
dpc-3767	87	12	;	;	PUNCT
dpc-3767	87	13	g1	g1	PROPN
dpc-3767	87	14	=	=	PUNCT
dpc-3767	87	15	25%–50	25%–50	NUM
dpc-3767	87	16	%	%	NOUN
dpc-3767	87	17	improvement	improvement	NOUN
dpc-3767	87	18	;	;	PUNCT
dpc-3767	88	1	g2	g2	PROPN
dpc-3767	88	2	=	=	PUNCT
dpc-3767	88	3	51%–75	51%–75	NUM
dpc-3767	88	4	%	%	NOUN
dpc-3767	88	5	improvement	improvement	NOUN
dpc-3767	88	6	;	;	PUNCT
dpc-3767	88	7	g3	g3	NOUN
dpc-3767	88	8	=	=	NOUN
dpc-3767	88	9	 	 	SPACE
dpc-3767	88	10	76%–99	76%–99	NUM
dpc-3767	88	11	%	%	NOUN
dpc-3767	88	12	improvement	improvement	NOUN
dpc-3767	88	13	;	;	PUNCT
dpc-3767	88	14	g4	g4	NOUN
dpc-3767	88	15	=	=	SYM
dpc-3767	88	16	complete	complete	ADJ
dpc-3767	88	17	recovery	recovery	NOUN
dpc-3767	88	18	.	.	PUNCT
dpc-3767	89	1	at	at	ADP
dpc-3767	89	2	the	the	DET
dpc-3767	89	3	end	end	NOUN
dpc-3767	89	4	of	of	ADP
dpc-3767	89	5	the	the	DET
dpc-3767	89	6	study	study	NOUN
dpc-3767	89	7	,	,	PUNCT
dpc-3767	89	8	15	15	NUM
dpc-3767	89	9	patients	patient	NOUN
dpc-3767	89	10	(	(	PUNCT
dpc-3767	89	11	50	50	NUM
dpc-3767	89	12	%	%	NOUN
dpc-3767	89	13	)	)	PUNCT
dpc-3767	89	14	from	from	ADP
dpc-3767	89	15	the	the	DET
dpc-3767	89	16	ta	ta	PROPN
dpc-3767	89	17	group	group	NOUN
dpc-3767	89	18	,	,	PUNCT
dpc-3767	89	19	17	17	NUM
dpc-3767	89	20	patients	patient	NOUN
dpc-3767	89	21	(	(	PUNCT
dpc-3767	89	22	56.7	56.7	NUM
dpc-3767	89	23	%	%	NOUN
dpc-3767	89	24	)	)	PUNCT
dpc-3767	89	25	from	from	ADP
dpc-3767	89	26	mtx	mtx	NOUN
dpc-3767	89	27	group	group	NOUN
dpc-3767	89	28	,	,	PUNCT
dpc-3767	89	29	and	and	CCONJ
dpc-3767	89	30	10	10	NUM
dpc-3767	89	31	patients	patient	NOUN
dpc-3767	89	32	(	(	PUNCT
dpc-3767	89	33	33.3	33.3	NUM
dpc-3767	89	34	%	%	NOUN
dpc-3767	89	35	)	)	PUNCT
dpc-3767	89	36	from	from	ADP
dpc-3767	89	37	the	the	DET
dpc-3767	89	38	cyclosporine	cyclosporine	ADJ
dpc-3767	89	39	group	group	NOUN
dpc-3767	89	40	showed	show	VERB
dpc-3767	89	41	g3	g3	NOUN
dpc-3767	89	42	and	and	CCONJ
dpc-3767	89	43	g4	g4	NOUN
dpc-3767	89	44	improvement	improvement	NOUN
dpc-3767	89	45	.	.	PUNCT
dpc-3767	90	1	in	in	ADP
dpc-3767	90	2	the	the	DET
dpc-3767	90	3	cyclosporine	cyclosporine	ADJ
dpc-3767	90	4	group	group	NOUN
dpc-3767	90	5	,	,	PUNCT
dpc-3767	90	6	11	11	NUM
dpc-3767	90	7	patients	patient	NOUN
dpc-3767	90	8	(	(	PUNCT
dpc-3767	90	9	36.7	36.7	NUM
dpc-3767	90	10	%	%	NOUN
dpc-3767	90	11	)	)	PUNCT
dpc-3767	90	12	showed	show	VERB
dpc-3767	90	13	only	only	ADV
dpc-3767	90	14	g2	g2	PROPN
dpc-3767	90	15	improvement	improvement	NOUN
dpc-3767	90	16	at	at	ADP
dpc-3767	90	17	24	24	NUM
dpc-3767	90	18	weeks	week	NOUN
dpc-3767	90	19	.	.	PUNCT
dpc-3767	91	1	this	this	DET
dpc-3767	91	2	study	study	NOUN
dpc-3767	91	3	showed	show	VERB
dpc-3767	91	4	that	that	SCONJ
dpc-3767	91	5	intramatricial	intramatricial	ADJ
dpc-3767	91	6	injection	injection	NOUN
dpc-3767	91	7	therapy	therapy	NOUN
dpc-3767	91	8	was	be	AUX
dpc-3767	91	9	a	a	DET
dpc-3767	91	10	safe	safe	ADJ
dpc-3767	91	11	,	,	PUNCT
dpc-3767	91	12	economical	economical	ADJ
dpc-3767	91	13	,	,	PUNCT
dpc-3767	91	14	simple	simple	ADJ
dpc-3767	91	15	,	,	PUNCT
dpc-3767	91	16	and	and	CCONJ
dpc-3767	91	17	effective	effective	ADJ
dpc-3767	91	18	modality	modality	NOUN
dpc-3767	91	19	in	in	ADP
dpc-3767	91	20	the	the	DET
dpc-3767	91	21	management	management	NOUN
dpc-3767	91	22	of	of	ADP
dpc-3767	91	23	nail	nail	NOUN
dpc-3767	91	24	psoriasis	psoriasis	NOUN
dpc-3767	91	25	.	.	PUNCT
dpc-3767	92	1	pain	pain	NOUN
dpc-3767	92	2	,	,	PUNCT
dpc-3767	92	3	the	the	DET
dpc-3767	92	4	most	most	ADV
dpc-3767	92	5	common	common	ADJ
dpc-3767	92	6	side	side	NOUN
dpc-3767	92	7	effect	effect	NOUN
dpc-3767	92	8	,	,	PUNCT
dpc-3767	92	9	was	be	AUX
dpc-3767	92	10	transient	transient	ADJ
dpc-3767	92	11	with	with	ADP
dpc-3767	92	12	injections	injection	NOUN
dpc-3767	92	13	of	of	ADP
dpc-3767	92	14	mtx	mtx	NOUN
dpc-3767	92	15	and	and	CCONJ
dpc-3767	92	16	ta	ta	X
dpc-3767	92	17	in	in	ADP
dpc-3767	92	18	this	this	DET
dpc-3767	92	19	study	study	NOUN
dpc-3767	92	20	,	,	PUNCT
dpc-3767	92	21	but	but	CCONJ
dpc-3767	92	22	with	with	ADP
dpc-3767	92	23	csa	csa	PROPN
dpc-3767	92	24	injections	injection	NOUN
dpc-3767	92	25	,	,	PUNCT
dpc-3767	92	26	pain	pain	NOUN
dpc-3767	92	27	was	be	AUX
dpc-3767	92	28	severe	severe	ADJ
dpc-3767	92	29	and	and	CCONJ
dpc-3767	92	30	lasted	last	VERB
dpc-3767	92	31	for	for	ADP
dpc-3767	92	32	a	a	DET
dpc-3767	92	33	few	few	ADJ
dpc-3767	92	34	hours	hour	NOUN
dpc-3767	92	35	in	in	ADP
dpc-3767	92	36	about	about	ADV
dpc-3767	92	37	50	50	NUM
dpc-3767	92	38	%	%	NOUN
dpc-3767	92	39	of	of	ADP
dpc-3767	92	40	nails	nail	NOUN
dpc-3767	92	41	and	and	CCONJ
dpc-3767	92	42	for	for	ADP
dpc-3767	92	43	2–3	2–3	NUM
dpc-3767	92	44	days	day	NOUN
dpc-3767	92	45	in	in	ADP
dpc-3767	92	46	eight	eight	NUM
dpc-3767	92	47	nails	nail	NOUN
dpc-3767	92	48	injected	inject	VERB
dpc-3767	92	49	with	with	ADP
dpc-3767	92	50	cyclosporine	cyclosporine	NOUN
dpc-3767	92	51	.	.	PUNCT
dpc-3767	93	1	in	in	ADP
dpc-3767	93	2	this	this	DET
dpc-3767	93	3	study	study	NOUN
dpc-3767	93	4	,	,	PUNCT
dpc-3767	93	5	mtx	mtx	NOUN
dpc-3767	93	6	-	-	PUNCT
dpc-3767	93	7	associated	associate	VERB
dpc-3767	93	8	adverse	adverse	ADJ
dpc-3767	93	9	events	event	NOUN
dpc-3767	93	10	(	(	PUNCT
dpc-3767	93	11	aes	aes	NOUN
dpc-3767	93	12	)	)	PUNCT
dpc-3767	93	13	and	and	CCONJ
dpc-3767	93	14	toxicities	toxicity	NOUN
dpc-3767	93	15	.	.	PUNCT
dpc-3767	94	1	patients	patient	NOUN
dpc-3767	94	2	were	be	AUX
dpc-3767	94	3	treated	treat	VERB
dpc-3767	94	4	every	every	DET
dpc-3767	94	5	six	six	NUM
dpc-3767	94	6	weeks	week	NOUN
dpc-3767	94	7	for	for	ADP
dpc-3767	94	8	24	24	NUM
dpc-3767	94	9	weeks	week	NOUN
dpc-3767	94	10	(	(	PUNCT
dpc-3767	94	11	total	total	NOUN
dpc-3767	94	12	of	of	ADP
dpc-3767	94	13	four	four	NUM
dpc-3767	94	14	treatment	treatment	NOUN
dpc-3767	94	15	sessions	session	NOUN
dpc-3767	94	16	)	)	PUNCT
dpc-3767	94	17	and	and	CCONJ
dpc-3767	94	18	followed	follow	VERB
dpc-3767	94	19	up	up	ADP
dpc-3767	94	20	for	for	ADP
dpc-3767	94	21	an	an	DET
dpc-3767	94	22	additional	additional	ADJ
dpc-3767	94	23	six	six	NUM
dpc-3767	94	24	months	month	NOUN
dpc-3767	94	25	.	.	PUNCT
dpc-3767	95	1	assessment	assessment	NOUN
dpc-3767	95	2	by	by	ADP
dpc-3767	95	3	napsi	napsi	NOUN
dpc-3767	95	4	was	be	AUX
dpc-3767	95	5	performed	perform	VERB
dpc-3767	95	6	during	during	ADP
dpc-3767	95	7	each	each	DET
dpc-3767	95	8	treatment	treatment	NOUN
dpc-3767	95	9	session	session	NOUN
dpc-3767	95	10	and	and	CCONJ
dpc-3767	95	11	at	at	ADP
dpc-3767	95	12	each	each	DET
dpc-3767	95	13	follow	follow	VERB
dpc-3767	95	14	-	-	PUNCT
dpc-3767	95	15	up	up	ADP
dpc-3767	95	16	visit	visit	NOUN
dpc-3767	95	17	.	.	PUNCT
dpc-3767	96	1	at	at	ADP
dpc-3767	96	2	the	the	DET
dpc-3767	96	3	end	end	NOUN
dpc-3767	96	4	of	of	ADP
dpc-3767	96	5	the	the	DET
dpc-3767	96	6	four	four	NUM
dpc-3767	96	7	sessions	session	NOUN
dpc-3767	96	8	,	,	PUNCT
dpc-3767	96	9	all	all	DET
dpc-3767	96	10	patients	patient	NOUN
dpc-3767	96	11	showed	show	VERB
dpc-3767	96	12	improvement	improvement	NOUN
dpc-3767	96	13	in	in	ADP
dpc-3767	96	14	their	their	PRON
dpc-3767	96	15	nail	nail	NOUN
dpc-3767	96	16	psoriasis	psoriasis	NOUN
dpc-3767	96	17	,	,	PUNCT
dpc-3767	96	18	and	and	CCONJ
dpc-3767	96	19	no	no	DET
dpc-3767	96	20	new	new	ADJ
dpc-3767	96	21	nail	nail	NOUN
dpc-3767	96	22	disease	disease	NOUN
dpc-3767	96	23	was	be	AUX
dpc-3767	96	24	noted	note	VERB
dpc-3767	96	25	:	:	PUNCT
dpc-3767	96	26	mean	mean	VERB
dpc-3767	96	27	napsi	napsi	NOUN
dpc-3767	96	28	at	at	ADP
dpc-3767	96	29	one	one	NUM
dpc-3767	96	30	month	month	NOUN
dpc-3767	96	31	after	after	SCONJ
dpc-3767	96	32	the	the	DET
dpc-3767	96	33	last	last	ADJ
dpc-3767	96	34	treatment	treatment	NOUN
dpc-3767	96	35	session	session	NOUN
dpc-3767	96	36	had	have	VERB
dpc-3767	96	37	a	a	DET
dpc-3767	96	38	mean	mean	ADJ
dpc-3767	96	39	value	value	NOUN
dpc-3767	96	40	of	of	ADP
dpc-3767	96	41	0.3	0.3	NUM
dpc-3767	96	42	for	for	ADP
dpc-3767	96	43	the	the	DET
dpc-3767	96	44	mtx	mtx	NOUN
dpc-3767	96	45	group	group	NOUN
dpc-3767	96	46	and	and	CCONJ
dpc-3767	96	47	1.8	1.8	NUM
dpc-3767	96	48	for	for	ADP
dpc-3767	96	49	the	the	DET
dpc-3767	96	50	ta	ta	PROPN
dpc-3767	96	51	group	group	NOUN
dpc-3767	96	52	.	.	PUNCT
dpc-3767	97	1	these	these	DET
dpc-3767	97	2	data	datum	NOUN
dpc-3767	97	3	were	be	AUX
dpc-3767	97	4	confirmed	confirm	VERB
dpc-3767	97	5	at	at	ADP
dpc-3767	97	6	the	the	DET
dpc-3767	97	7	6	6	NUM
dpc-3767	97	8	-	-	PUNCT
dpc-3767	97	9	month	month	NOUN
dpc-3767	97	10	follow	follow	NOUN
dpc-3767	97	11	-	-	PUNCT
dpc-3767	97	12	up	up	NOUN
dpc-3767	97	13	for	for	ADP
dpc-3767	97	14	mtx	mtx	NOUN
dpc-3767	97	15	.	.	PUNCT
dpc-3767	98	1	all	all	DET
dpc-3767	98	2	patients	patient	NOUN
dpc-3767	98	3	were	be	AUX
dpc-3767	98	4	satisfied	satisfied	ADJ
dpc-3767	98	5	with	with	ADP
dpc-3767	98	6	the	the	DET
dpc-3767	98	7	procedure	procedure	NOUN
dpc-3767	98	8	.	.	PUNCT
dpc-3767	99	1	side	side	NOUN
dpc-3767	99	2	effects	effect	NOUN
dpc-3767	99	3	included	include	VERB
dpc-3767	99	4	procedural	procedural	ADJ
dpc-3767	99	5	pain	pain	NOUN
dpc-3767	99	6	,	,	PUNCT
dpc-3767	99	7	which	which	PRON
dpc-3767	99	8	was	be	AUX
dpc-3767	99	9	tolerable	tolerable	ADJ
dpc-3767	99	10	.	.	PUNCT
dpc-3767	100	1	subungual	subungual	ADJ
dpc-3767	100	2	hematoma	hematoma	NOUN
dpc-3767	100	3	occurred	occur	VERB
dpc-3767	100	4	in	in	ADP
dpc-3767	100	5	one	one	NUM
dpc-3767	100	6	patient	patient	NOUN
dpc-3767	100	7	treated	treat	VERB
dpc-3767	100	8	with	with	ADP
dpc-3767	100	9	mtx	mtx	NOUN
dpc-3767	100	10	and	and	CCONJ
dpc-3767	100	11	in	in	ADP
dpc-3767	100	12	one	one	NUM
dpc-3767	100	13	patient	patient	NOUN
dpc-3767	100	14	treated	treat	VERB
dpc-3767	100	15	with	with	ADP
dpc-3767	100	16	ta	ta	PROPN
dpc-3767	101	1	.	.	PUNCT
dpc-3767	101	2	hypopigmentation	hypopigmentation	NOUN
dpc-3767	101	3	of	of	ADP
dpc-3767	101	4	the	the	DET
dpc-3767	101	5	proximal	proximal	ADJ
dpc-3767	101	6	nail	nail	NOUN
dpc-3767	101	7	fold	fold	NOUN
dpc-3767	101	8	was	be	AUX
dpc-3767	101	9	instead	instead	ADV
dpc-3767	101	10	reported	report	VERB
dpc-3767	101	11	in	in	ADP
dpc-3767	101	12	two	two	NUM
dpc-3767	101	13	of	of	ADP
dpc-3767	101	14	the	the	DET
dpc-3767	101	15	six	six	NUM
dpc-3767	101	16	patients	patient	NOUN
dpc-3767	101	17	treated	treat	VERB
dpc-3767	101	18	with	with	ADP
dpc-3767	101	19	ta	ta	PROPN
dpc-3767	101	20	.	.	PUNCT
dpc-3767	102	1	no	no	DET
dpc-3767	102	2	major	major	ADJ
dpc-3767	102	3	ae	ae	PROPN
dpc-3767	102	4	was	be	AUX
dpc-3767	102	5	reported	report	VERB
dpc-3767	102	6	in	in	ADP
dpc-3767	102	7	this	this	DET
dpc-3767	102	8	study	study	NOUN
dpc-3767	102	9	.	.	PUNCT
dpc-3767	103	1	2	2	X
dpc-3767	103	2	.	.	X
dpc-3767	103	3	mittal	mittal	PROPN
dpc-3767	103	4	et	et	PROPN
dpc-3767	103	5	al	al	PROPN
dpc-3767	103	6	.	.	PROPN
dpc-3767	103	7	,	,	PUNCT
dpc-3767	103	8	2018	2018	NUM
dpc-3767	103	9	the	the	DET
dpc-3767	103	10	study	study	NOUN
dpc-3767	103	11	by	by	ADP
dpc-3767	103	12	mittal	mittal	PROPN
dpc-3767	103	13	et	et	PROPN
dpc-3767	103	14	al	al	PROPN
dpc-3767	103	15	.	.	PROPN
dpc-3767	104	1	(	(	PUNCT
dpc-3767	104	2	2018	2018	NUM
dpc-3767	104	3	)	)	PUNCT
dpc-3767	104	4	assessed	assess	VERB
dpc-3767	104	5	an	an	DET
dpc-3767	104	6	open	open	ADJ
dpc-3767	104	7	-	-	PUNCT
dpc-3767	104	8	label	label	NOUN
dpc-3767	104	9	comparative	comparative	ADJ
dpc-3767	104	10	study	study	NOUN
dpc-3767	104	11	of	of	ADP
dpc-3767	104	12	triamcinolone	triamcinolone	NOUN
dpc-3767	104	13	,	,	PUNCT
dpc-3767	104	14	methotrexate	methotrexate	NOUN
dpc-3767	104	15	,	,	PUNCT
dpc-3767	104	16	and	and	CCONJ
dpc-3767	104	17	cyclosporine	cyclosporine	NOUN
dpc-3767	104	18	.	.	PUNCT
dpc-3767	105	1	the	the	DET
dpc-3767	105	2	study	study	NOUN
dpc-3767	105	3	participants	participant	NOUN
dpc-3767	105	4	were	be	AUX
dpc-3767	105	5	enrolled	enrol	VERB
dpc-3767	105	6	in	in	ADP
dpc-3767	105	7	india	india	PROPN
dpc-3767	105	8	in	in	ADP
dpc-3767	105	9	2018	2018	NUM
dpc-3767	105	10	.	.	PUNCT
dpc-3767	106	1	patients	patient	NOUN
dpc-3767	106	2	having	have	VERB
dpc-3767	106	3	at	at	ADV
dpc-3767	106	4	least	least	ADV
dpc-3767	106	5	three	three	NUM
dpc-3767	106	6	affected	affected	ADJ
dpc-3767	106	7	fingernails	fingernail	NOUN
dpc-3767	106	8	with	with	ADP
dpc-3767	106	9	or	or	CCONJ
dpc-3767	106	10	without	without	ADP
dpc-3767	106	11	concomitant	concomitant	ADJ
dpc-3767	106	12	skin	skin	NOUN
dpc-3767	106	13	lesions	lesion	NOUN
dpc-3767	106	14	who	who	PRON
dpc-3767	106	15	had	have	AUX
dpc-3767	106	16	not	not	PART
dpc-3767	106	17	been	be	AUX
dpc-3767	106	18	on	on	ADP
dpc-3767	106	19	any	any	DET
dpc-3767	106	20	systemic	systemic	ADJ
dpc-3767	106	21	and	and	CCONJ
dpc-3767	106	22	topical	topical	ADJ
dpc-3767	106	23	antipsoriatic	antipsoriatic	ADJ
dpc-3767	106	24	medications	medication	NOUN
dpc-3767	106	25	for	for	ADP
dpc-3767	106	26	at	at	ADV
dpc-3767	106	27	least	least	ADJ
dpc-3767	106	28	the	the	DET
dpc-3767	106	29	previous	previous	ADJ
dpc-3767	106	30	three	three	NUM
dpc-3767	106	31	months	month	NOUN
dpc-3767	106	32	were	be	AUX
dpc-3767	106	33	table	table	NOUN
dpc-3767	106	34	1	1	NUM
dpc-3767	106	35	.	.	PUNCT
dpc-3767	107	1	characteristics	characteristic	NOUN
dpc-3767	107	2	of	of	ADP
dpc-3767	107	3	included	include	VERB
dpc-3767	107	4	studies	study	NOUN
dpc-3767	107	5	.	.	PUNCT
dpc-3767	108	1	no	no	DET
dpc-3767	108	2	researcher	researcher	NOUN
dpc-3767	108	3	and	and	CCONJ
dpc-3767	108	4	year	year	NOUN
dpc-3767	108	5	location	location	NOUN
dpc-3767	108	6	final	final	ADJ
dpc-3767	108	7	sample	sample	NOUN
dpc-3767	108	8	size	size	NOUN
dpc-3767	108	9	treatment	treatment	NOUN
dpc-3767	108	10	protocol	protocol	NOUN
dpc-3767	108	11	study	study	NOUN
dpc-3767	108	12	outcome	outcome	NOUN
dpc-3767	108	13	duration	duration	NOUN
dpc-3767	108	14	study	study	NOUN
dpc-3767	108	15	designtreatment	designtreatment	PROPN
dpc-3767	108	16	group	group	PROPN
dpc-3767	108	17	control	control	PROPN
dpc-3767	108	18	group	group	PROPN
dpc-3767	108	19	1	1	NUM
dpc-3767	108	20	.	.	PUNCT
dpc-3767	108	21	mittal	mittal	PROPN
dpc-3767	108	22	et	et	PROPN
dpc-3767	108	23	al	al	PROPN
dpc-3767	108	24	.	.	PROPN
dpc-3767	108	25	,	,	PUNCT
dpc-3767	108	26	2018	2018	NUM
dpc-3767	108	27	[	[	X
dpc-3767	108	28	7	7	NUM
dpc-3767	108	29	]	]	PUNCT
dpc-3767	108	30	india	india	PROPN
dpc-3767	108	31	17	17	NUM
dpc-3767	108	32	mtx	mtx	NOUN
dpc-3767	108	33	intralesional	intralesional	ADJ
dpc-3767	108	34	injection	injection	NOUN
dpc-3767	108	35	2.5	2.5	NUM
dpc-3767	108	36	mg/	mg/	NOUN
dpc-3767	108	37	nail	nail	NOUN
dpc-3767	108	38	in	in	ADP
dpc-3767	108	39	the	the	DET
dpc-3767	108	40	nail	nail	NOUN
dpc-3767	108	41	matrix	matrix	NOUN
dpc-3767	108	42	,	,	PUNCT
dpc-3767	108	43	given	give	VERB
dpc-3767	108	44	in	in	ADP
dpc-3767	108	45	6	6	NUM
dpc-3767	108	46	-	-	PUNCT
dpc-3767	108	47	week	week	NOUN
dpc-3767	108	48	intervals	interval	NOUN
dpc-3767	108	49	ta	ta	ADP
dpc-3767	108	50	intralesional	intralesional	ADJ
dpc-3767	108	51	injection	injection	NOUN
dpc-3767	108	52	2.5	2.5	NUM
dpc-3767	108	53	mg	mg	NOUN
dpc-3767	108	54	/	/	SYM
dpc-3767	108	55	nail	nail	NOUN
dpc-3767	108	56	in	in	ADP
dpc-3767	108	57	the	the	DET
dpc-3767	108	58	nail	nail	NOUN
dpc-3767	108	59	matrix	matrix	NOUN
dpc-3767	108	60	,	,	PUNCT
dpc-3767	108	61	given	give	VERB
dpc-3767	108	62	in	in	ADP
dpc-3767	108	63	6	6	NUM
dpc-3767	108	64	-	-	PUNCT
dpc-3767	108	65	week	week	NOUN
dpc-3767	108	66	intervals	interval	NOUN
dpc-3767	108	67	napsi	napsi	NOUN
dpc-3767	108	68	score	score	VERB
dpc-3767	108	69	24	24	NUM
dpc-3767	108	70	weeks	week	NOUN
dpc-3767	108	71	open	open	ADJ
dpc-3767	108	72	-	-	PUNCT
dpc-3767	108	73	label	label	NOUN
dpc-3767	108	74	comparative	comparative	ADJ
dpc-3767	108	75	study	study	NOUN
dpc-3767	108	76	2	2	NUM
dpc-3767	108	77	.	.	PUNCT
dpc-3767	109	1	abdelmeniem	abdelmeniem	INTJ
dpc-3767	109	2	et	et	PROPN
dpc-3767	109	3	al	al	PROPN
dpc-3767	109	4	.	.	PROPN
dpc-3767	109	5	,	,	PUNCT
dpc-3767	109	6	2022	2022	NUM
dpc-3767	110	1	[	[	X
dpc-3767	110	2	9	9	NUM
dpc-3767	110	3	]	]	SYM
dpc-3767	110	4	egypt	egypt	PROPN
dpc-3767	110	5	15	15	NUM
dpc-3767	110	6	mtx	mtx	NOUN
dpc-3767	110	7	intralesional	intralesional	ADJ
dpc-3767	110	8	injection	injection	NOUN
dpc-3767	110	9	10	10	NUM
dpc-3767	110	10	mg/	mg/	NOUN
dpc-3767	110	11	nail	nail	NOUN
dpc-3767	110	12	in	in	ADP
dpc-3767	110	13	the	the	DET
dpc-3767	110	14	nail	nail	NOUN
dpc-3767	110	15	matrix	matrix	NOUN
dpc-3767	110	16	and	and	CCONJ
dpc-3767	110	17	nail	nail	NOUN
dpc-3767	110	18	bed	bed	NOUN
dpc-3767	110	19	,	,	PUNCT
dpc-3767	110	20	given	give	VERB
dpc-3767	110	21	in	in	ADP
dpc-3767	110	22	4	4	NUM
dpc-3767	110	23	-	-	PUNCT
dpc-3767	110	24	week	week	NOUN
dpc-3767	110	25	intervals	interval	NOUN
dpc-3767	110	26	ta	ta	ADP
dpc-3767	110	27	intralesional	intralesional	ADJ
dpc-3767	110	28	injection	injection	NOUN
dpc-3767	110	29	4	4	NUM
dpc-3767	110	30	mg/	mg/	NOUN
dpc-3767	110	31	nail	nail	NOUN
dpc-3767	110	32	in	in	ADP
dpc-3767	110	33	the	the	DET
dpc-3767	110	34	nail	nail	NOUN
dpc-3767	110	35	matrix	matrix	NOUN
dpc-3767	110	36	and	and	CCONJ
dpc-3767	110	37	nail	nail	NOUN
dpc-3767	110	38	bed	bed	NOUN
dpc-3767	110	39	,	,	PUNCT
dpc-3767	110	40	given	give	VERB
dpc-3767	110	41	in	in	ADP
dpc-3767	110	42	4	4	NUM
dpc-3767	110	43	-	-	PUNCT
dpc-3767	110	44	week	week	NOUN
dpc-3767	110	45	intervals	interval	NOUN
dpc-3767	110	46	napsi	napsi	NOUN
dpc-3767	110	47	score	score	VERB
dpc-3767	110	48	24	24	NUM
dpc-3767	110	49	weeks	week	NOUN
dpc-3767	110	50	pilot	pilot	NOUN
dpc-3767	110	51	study	study	NOUN
dpc-3767	110	52	3	3	NUM
dpc-3767	110	53	.	.	PUNCT
dpc-3767	110	54	starace	starace	NOUN
dpc-3767	110	55	et	et	PROPN
dpc-3767	110	56	al	al	PROPN
dpc-3767	110	57	.	.	PROPN
dpc-3767	110	58	,	,	PUNCT
dpc-3767	110	59	2022	2022	NUM
dpc-3767	110	60	.	.	PUNCT
dpc-3767	111	1	[	[	X
dpc-3767	111	2	10	10	NUM
dpc-3767	111	3	]	]	X
dpc-3767	111	4	italy	italy	PROPN
dpc-3767	111	5	6	6	NUM
dpc-3767	111	6	mtx	mtx	NOUN
dpc-3767	111	7	intralesional	intralesional	ADJ
dpc-3767	111	8	injection	injection	NOUN
dpc-3767	111	9	10	10	NUM
dpc-3767	111	10	mg/	mg/	NOUN
dpc-3767	111	11	nail	nail	NOUN
dpc-3767	111	12	in	in	ADP
dpc-3767	111	13	the	the	DET
dpc-3767	111	14	nail	nail	NOUN
dpc-3767	111	15	matrix	matrix	NOUN
dpc-3767	111	16	and	and	CCONJ
dpc-3767	111	17	nail	nail	NOUN
dpc-3767	111	18	bed	bed	NOUN
dpc-3767	111	19	,	,	PUNCT
dpc-3767	111	20	given	give	VERB
dpc-3767	111	21	in	in	ADP
dpc-3767	111	22	6	6	NUM
dpc-3767	111	23	-	-	PUNCT
dpc-3767	111	24	week	week	NOUN
dpc-3767	111	25	intervals	interval	NOUN
dpc-3767	111	26	ta	ta	ADP
dpc-3767	111	27	intralesional	intralesional	ADJ
dpc-3767	111	28	injection	injection	NOUN
dpc-3767	111	29	4	4	NUM
dpc-3767	111	30	mg/	mg/	NOUN
dpc-3767	111	31	nail	nail	NOUN
dpc-3767	111	32	in	in	ADP
dpc-3767	111	33	the	the	DET
dpc-3767	111	34	nail	nail	NOUN
dpc-3767	111	35	matrix	matrix	NOUN
dpc-3767	111	36	,	,	PUNCT
dpc-3767	111	37	given	give	VERB
dpc-3767	111	38	in	in	ADP
dpc-3767	111	39	6	6	NUM
dpc-3767	111	40	-	-	PUNCT
dpc-3767	111	41	week	week	NOUN
dpc-3767	111	42	interval	interval	NOUN
dpc-3767	111	43	napsi	napsi	NOUN
dpc-3767	111	44	score	score	VERB
dpc-3767	111	45	24	24	NUM
dpc-3767	111	46	weeks	week	NOUN
dpc-3767	111	47	a	a	DET
dpc-3767	111	48	comparative	comparative	ADJ
dpc-3767	111	49	study	study	NOUN
dpc-3767	111	50	review	review	NOUN
dpc-3767	111	51	|	|	ADV
dpc-3767	111	52	dermatol	dermatol	ADJ
dpc-3767	111	53	pract	pract	NOUN
dpc-3767	111	54	concept	concept	NOUN
dpc-3767	111	55	.	.	PUNCT
dpc-3767	112	1	2024;14(2):e2024109	2024;14(2):e2024109	NUM
dpc-3767	112	2	5	5	NUM
dpc-3767	112	3	urea	urea	NOUN
dpc-3767	112	4	combination	combination	NOUN
dpc-3767	112	5	(	(	PUNCT
dpc-3767	112	6	57.1	57.1	NUM
dpc-3767	112	7	±	±	NUM
dpc-3767	112	8	26.4	26.4	NUM
dpc-3767	112	9	)	)	PUNCT
dpc-3767	112	10	than	than	ADP
dpc-3767	112	11	intralesional	intralesional	ADJ
dpc-3767	112	12	ta	ta	PROPN
dpc-3767	112	13	(	(	PUNCT
dpc-3767	112	14	44.2	44.2	NUM
dpc-3767	112	15	±	±	NUM
dpc-3767	112	16	32.7	32.7	NUM
dpc-3767	112	17	)	)	PUNCT
dpc-3767	112	18	,	,	PUNCT
dpc-3767	112	19	intralesional	intralesional	ADJ
dpc-3767	112	20	mtx	mtx	NOUN
dpc-3767	112	21	(	(	PUNCT
dpc-3767	112	22	37.7	37.7	NUM
dpc-3767	112	23	±	±	NUM
dpc-3767	112	24	14.2	14.2	NUM
dpc-3767	112	25	)	)	PUNCT
dpc-3767	112	26	,	,	PUNCT
dpc-3767	112	27	and	and	CCONJ
dpc-3767	112	28	intralesional	intralesional	ADJ
dpc-3767	112	29	5	5	NUM
dpc-3767	112	30	-	-	PUNCT
dpc-3767	112	31	fu	fu	NOUN
dpc-3767	112	32	(	(	PUNCT
dpc-3767	112	33	29.6	29.6	NUM
dpc-3767	112	34	±	±	NUM
dpc-3767	112	35	14	14	NUM
dpc-3767	112	36	)	)	PUNCT
dpc-3767	112	37	.	.	PUNCT
dpc-3767	113	1	adverse	adverse	ADJ
dpc-3767	113	2	effects	effect	NOUN
dpc-3767	113	3	were	be	AUX
dpc-3767	113	4	mild	mild	ADJ
dpc-3767	113	5	and	and	CCONJ
dpc-3767	113	6	insignificant	insignificant	ADJ
dpc-3767	113	7	in	in	ADP
dpc-3767	113	8	the	the	DET
dpc-3767	113	9	studied	study	VERB
dpc-3767	113	10	groups	group	NOUN
dpc-3767	113	11	.	.	PUNCT
dpc-3767	114	1	in	in	ADP
dpc-3767	114	2	this	this	DET
dpc-3767	114	3	study	study	NOUN
dpc-3767	114	4	,	,	PUNCT
dpc-3767	114	5	topical	topical	ADJ
dpc-3767	114	6	calcipotriol	calcipotriol	NOUN
dpc-3767	114	7	/	/	SYM
dpc-3767	114	8	urea	urea	NOUN
dpc-3767	114	9	combination	combination	NOUN
dpc-3767	114	10	seemed	seem	VERB
dpc-3767	114	11	to	to	PART
dpc-3767	114	12	be	be	AUX
dpc-3767	114	13	more	more	ADV
dpc-3767	114	14	effective	effective	ADJ
dpc-3767	114	15	and	and	CCONJ
dpc-3767	114	16	safer	safe	ADJ
dpc-3767	114	17	than	than	ADP
dpc-3767	114	18	intralesional	intralesional	ADJ
dpc-3767	114	19	injections	injection	NOUN
dpc-3767	114	20	of	of	ADP
dpc-3767	114	21	5	5	NUM
dpc-3767	114	22	-	-	PUNCT
dpc-3767	114	23	fu	fu	ADJ
dpc-3767	114	24	,	,	PUNCT
dpc-3767	114	25	mtx	mtx	NOUN
dpc-3767	114	26	,	,	PUNCT
dpc-3767	114	27	and	and	CCONJ
dpc-3767	114	28	ta	ta	PROPN
dpc-3767	114	29	.	.	PUNCT
dpc-3767	114	30	results	result	NOUN
dpc-3767	114	31	of	of	ADP
dpc-3767	114	32	quantitative	quantitative	ADJ
dpc-3767	114	33	data	datum	NOUN
dpc-3767	114	34	analysis	analysis	NOUN
dpc-3767	114	35	(	(	PUNCT
dpc-3767	114	36	meta	meta	NOUN
dpc-3767	114	37	-	-	PUNCT
dpc-3767	114	38	analysis	analysis	NOUN
dpc-3767	114	39	)	)	PUNCT
dpc-3767	114	40	the	the	DET
dpc-3767	114	41	difference	difference	NOUN
dpc-3767	114	42	in	in	ADP
dpc-3767	114	43	mean	mean	PROPN
dpc-3767	114	44	napsi	napsi	NOUN
dpc-3767	114	45	scores	score	NOUN
dpc-3767	114	46	after	after	ADP
dpc-3767	114	47	mtx	mtx	NOUN
dpc-3767	114	48	and	and	CCONJ
dpc-3767	114	49	ta	ta	ADP
dpc-3767	114	50	intralesional	intralesional	ADJ
dpc-3767	114	51	injections	injection	NOUN
dpc-3767	114	52	is	be	AUX
dpc-3767	114	53	shown	show	VERB
dpc-3767	114	54	in	in	ADP
dpc-3767	114	55	table	table	NOUN
dpc-3767	114	56	2	2	NUM
dpc-3767	114	57	.	.	PUNCT
dpc-3767	114	58	all	all	PRON
dpc-3767	114	59	of	of	ADP
dpc-3767	114	60	the	the	DET
dpc-3767	114	61	studies	study	NOUN
dpc-3767	114	62	reported	report	VERB
dpc-3767	114	63	a	a	DET
dpc-3767	114	64	reduction	reduction	NOUN
dpc-3767	114	65	in	in	ADP
dpc-3767	114	66	napsi	napsi	ADJ
dpc-3767	114	67	score	score	NOUN
dpc-3767	114	68	in	in	ADP
dpc-3767	114	69	both	both	CCONJ
dpc-3767	114	70	the	the	DET
dpc-3767	114	71	mtx	mtx	NOUN
dpc-3767	114	72	group	group	NOUN
dpc-3767	114	73	and	and	CCONJ
dpc-3767	114	74	the	the	DET
dpc-3767	114	75	ta	ta	PROPN
dpc-3767	114	76	group	group	NOUN
dpc-3767	114	77	.	.	PUNCT
dpc-3767	115	1	the	the	DET
dpc-3767	115	2	results	result	NOUN
dpc-3767	115	3	of	of	ADP
dpc-3767	115	4	the	the	DET
dpc-3767	115	5	meta	meta	NOUN
dpc-3767	115	6	-	-	PUNCT
dpc-3767	115	7	analysis	analysis	NOUN
dpc-3767	115	8	of	of	ADP
dpc-3767	115	9	the	the	DET
dpc-3767	115	10	effect	effect	NOUN
dpc-3767	115	11	of	of	ADP
dpc-3767	115	12	mtx	mtx	NOUN
dpc-3767	115	13	intralesional	intralesional	ADJ
dpc-3767	115	14	injection	injection	NOUN
dpc-3767	115	15	therapy	therapy	NOUN
dpc-3767	115	16	compared	compare	VERB
dpc-3767	115	17	to	to	ADP
dpc-3767	115	18	ta	ta	ADP
dpc-3767	115	19	intralesional	intralesional	ADJ
dpc-3767	115	20	injection	injection	NOUN
dpc-3767	115	21	therapy	therapy	NOUN
dpc-3767	115	22	are	be	AUX
dpc-3767	115	23	shown	show	VERB
dpc-3767	115	24	in	in	ADP
dpc-3767	115	25	figure	figure	NOUN
dpc-3767	115	26	2	2	NUM
dpc-3767	115	27	.	.	PUNCT
dpc-3767	116	1	the	the	DET
dpc-3767	116	2	heterogeneity	heterogeneity	PROPN
dpc-3767	116	3	test	test	NOUN
dpc-3767	116	4	obtained	obtain	VERB
dpc-3767	116	5	q	q	NOUN
dpc-3767	116	6	value	value	NOUN
dpc-3767	116	7	=	=	NOUN
dpc-3767	116	8	2.066	2.066	NUM
dpc-3767	116	9	;	;	PUNCT
dpc-3767	116	10	df=2	df=2	NOUN
dpc-3767	116	11	;	;	PUNCT
dpc-3767	116	12	p<0.356	p<0.356	NOUN
dpc-3767	116	13	,	,	PUNCT
dpc-3767	116	14	i2=3.201	i2=3.201	NUM
dpc-3767	116	15	.	.	PUNCT
dpc-3767	117	1	this	this	PRON
dpc-3767	117	2	indicated	indicate	VERB
dpc-3767	117	3	that	that	SCONJ
dpc-3767	117	4	the	the	DET
dpc-3767	117	5	data	datum	NOUN
dpc-3767	117	6	were	be	AUX
dpc-3767	117	7	homogenous	homogenous	ADJ
dpc-3767	117	8	,	,	PUNCT
dpc-3767	117	9	and	and	CCONJ
dpc-3767	117	10	the	the	DET
dpc-3767	117	11	analysis	analysis	NOUN
dpc-3767	117	12	was	be	AUX
dpc-3767	117	13	assessed	assess	VERB
dpc-3767	117	14	in	in	ADP
dpc-3767	117	15	fixed	fix	VERB
dpc-3767	117	16	effects	effect	NOUN
dpc-3767	117	17	model	model	NOUN
dpc-3767	117	18	.	.	PUNCT
dpc-3767	118	1	the	the	DET
dpc-3767	118	2	results	result	NOUN
dpc-3767	118	3	of	of	ADP
dpc-3767	118	4	the	the	DET
dpc-3767	118	5	meta	meta	ADJ
dpc-3767	118	6	-	-	PUNCT
dpc-3767	118	7	analysis	analysis	NOUN
dpc-3767	118	8	showed	show	VERB
dpc-3767	118	9	an	an	DET
dpc-3767	118	10	overall	overall	ADJ
dpc-3767	118	11	difference	difference	NOUN
dpc-3767	118	12	in	in	ADP
dpc-3767	118	13	napsi	napsi	NOUN
dpc-3767	118	14	scores	score	NOUN
dpc-3767	118	15	after	after	ADP
dpc-3767	118	16	administration	administration	NOUN
dpc-3767	118	17	of	of	ADP
dpc-3767	118	18	intralesional	intralesional	ADJ
dpc-3767	118	19	injection	injection	NOUN
dpc-3767	118	20	of	of	ADP
dpc-3767	118	21	mtx	mtx	NOUN
dpc-3767	118	22	and	and	CCONJ
dpc-3767	118	23	ta	ta	PROPN
dpc-3767	118	24	that	that	PRON
dpc-3767	118	25	was	be	AUX
dpc-3767	118	26	−0.213±0.232	−0.213±0.232	NOUN
dpc-3767	118	27	(	(	PUNCT
dpc-3767	118	28	95	95	NUM
dpc-3767	118	29	%	%	NOUN
dpc-3767	118	30	ci	ci	NOUN
dpc-3767	118	31	:	:	PUNCT
dpc-3767	118	32	−0.667–0.241	−0.667–0.241	NOUN
dpc-3767	118	33	)	)	PUNCT
dpc-3767	118	34	.	.	PUNCT
dpc-3767	119	1	this	this	PRON
dpc-3767	119	2	showed	show	VERB
dpc-3767	119	3	that	that	SCONJ
dpc-3767	119	4	the	the	DET
dpc-3767	119	5	reduction	reduction	NOUN
dpc-3767	119	6	in	in	ADP
dpc-3767	119	7	napsi	napsi	ADJ
dpc-3767	119	8	score	score	NOUN
dpc-3767	119	9	after	after	SCONJ
dpc-3767	119	10	mtx	mtx	NOUN
dpc-3767	119	11	intralesional	intralesional	ADJ
dpc-3767	119	12	injection	injection	NOUN
dpc-3767	119	13	was	be	AUX
dpc-3767	119	14	greater	great	ADJ
dpc-3767	119	15	than	than	ADP
dpc-3767	119	16	that	that	PRON
dpc-3767	119	17	after	after	ADP
dpc-3767	119	18	ta	ta	X
dpc-3767	119	19	intralesional	intralesional	ADJ
dpc-3767	119	20	injection	injection	NOUN
dpc-3767	119	21	.	.	PUNCT
dpc-3767	120	1	the	the	DET
dpc-3767	120	2	q	q	PROPN
dpc-3767	120	3	statistic	statistic	ADJ
dpc-3767	120	4	value	value	NOUN
dpc-3767	120	5	was	be	AUX
dpc-3767	120	6	z	z	PROPN
dpc-3767	120	7	value=	value=	NUM
dpc-3767	120	8	−0.921	−0.921	PROPN
dpc-3767	120	9	(	(	PUNCT
dpc-3767	120	10	p=0.357	p=0.357	NUM
dpc-3767	120	11	)	)	PUNCT
dpc-3767	120	12	,	,	PUNCT
dpc-3767	120	13	showing	show	VERB
dpc-3767	120	14	an	an	DET
dpc-3767	120	15	insignificant	insignificant	ADJ
dpc-3767	120	16	difference	difference	NOUN
dpc-3767	120	17	though	though	SCONJ
dpc-3767	120	18	the	the	DET
dpc-3767	120	19	differences	difference	NOUN
dpc-3767	120	20	in	in	ADP
dpc-3767	120	21	the	the	DET
dpc-3767	120	22	efficacies	efficacy	NOUN
dpc-3767	120	23	of	of	ADP
dpc-3767	120	24	intramatricial	intramatricial	ADJ
dpc-3767	120	25	ta	ta	PROPN
dpc-3767	120	26	,	,	PUNCT
dpc-3767	120	27	mtx	mtx	PROPN
dpc-3767	120	28	,	,	PUNCT
dpc-3767	120	29	and	and	CCONJ
dpc-3767	120	30	csa	csa	PROPN
dpc-3767	120	31	were	be	AUX
dpc-3767	120	32	not	not	PART
dpc-3767	120	33	statistically	statistically	ADV
dpc-3767	120	34	significant	significant	ADJ
dpc-3767	120	35	,	,	PUNCT
dpc-3767	120	36	mtx	mtx	NOUN
dpc-3767	120	37	yielded	yield	VERB
dpc-3767	120	38	the	the	DET
dpc-3767	120	39	best	good	ADJ
dpc-3767	120	40	results	result	NOUN
dpc-3767	120	41	,	,	PUNCT
dpc-3767	120	42	with	with	ADP
dpc-3767	120	43	the	the	DET
dpc-3767	120	44	maximum	maximum	ADJ
dpc-3767	120	45	number	number	NOUN
dpc-3767	120	46	of	of	ADP
dpc-3767	120	47	nails	nail	NOUN
dpc-3767	120	48	showing	show	VERB
dpc-3767	120	49	complete	complete	ADJ
dpc-3767	120	50	recovery	recovery	NOUN
dpc-3767	120	51	(	(	PUNCT
dpc-3767	120	52	g4	g4	NOUN
dpc-3767	120	53	improvement	improvement	NOUN
dpc-3767	120	54	)	)	PUNCT
dpc-3767	120	55	.	.	PUNCT
dpc-3767	121	1	3	3	X
dpc-3767	121	2	.	.	X
dpc-3767	121	3	abdelmeniem	abdelmeniem	INTJ
dpc-3767	121	4	et	et	PROPN
dpc-3767	121	5	al	al	PROPN
dpc-3767	121	6	.	.	PROPN
dpc-3767	121	7	,	,	PUNCT
dpc-3767	121	8	2022	2022	NUM
dpc-3767	121	9	a	a	DET
dpc-3767	121	10	comparative	comparative	ADJ
dpc-3767	121	11	study	study	NOUN
dpc-3767	121	12	by	by	ADP
dpc-3767	121	13	abdelmeniem	abdelmeniem	PROPN
dpc-3767	121	14	et	et	PROPN
dpc-3767	121	15	al	al	PROPN
dpc-3767	121	16	.	.	PROPN
dpc-3767	121	17	(	(	PUNCT
dpc-3767	121	18	2022	2022	NUM
dpc-3767	121	19	)	)	PUNCT
dpc-3767	121	20	evaluated	evaluate	VERB
dpc-3767	121	21	the	the	DET
dpc-3767	121	22	efficacy	efficacy	NOUN
dpc-3767	121	23	of	of	ADP
dpc-3767	121	24	topical	topical	ADJ
dpc-3767	121	25	calcipotriol	calcipotriol	NOUN
dpc-3767	121	26	combined	combine	VERB
dpc-3767	121	27	with	with	ADP
dpc-3767	121	28	urea	urea	NOUN
dpc-3767	121	29	20	20	NUM
dpc-3767	121	30	%	%	NOUN
dpc-3767	121	31	versus	versus	ADP
dpc-3767	121	32	intralesional	intralesional	ADJ
dpc-3767	121	33	injection	injection	NOUN
dpc-3767	121	34	of	of	ADP
dpc-3767	121	35	triamcinolone	triamcinolone	NOUN
dpc-3767	121	36	acetonide	acetonide	NOUN
dpc-3767	121	37	,	,	PUNCT
dpc-3767	121	38	5	5	NUM
dpc-3767	121	39	-	-	PUNCT
dpc-3767	121	40	fluorouracil	fluorouracil	NOUN
dpc-3767	121	41	,	,	PUNCT
dpc-3767	121	42	and	and	CCONJ
dpc-3767	121	43	methotrexate	methotrexate	VERB
dpc-3767	121	44	in	in	ADP
dpc-3767	121	45	the	the	DET
dpc-3767	121	46	treatment	treatment	NOUN
dpc-3767	121	47	of	of	ADP
dpc-3767	121	48	nail	nail	NOUN
dpc-3767	121	49	psoriasis	psoriasis	NOUN
dpc-3767	121	50	.	.	PUNCT
dpc-3767	122	1	the	the	DET
dpc-3767	122	2	study	study	NOUN
dpc-3767	122	3	participants	participant	NOUN
dpc-3767	122	4	were	be	AUX
dpc-3767	122	5	enrolled	enrol	VERB
dpc-3767	122	6	in	in	ADP
dpc-3767	122	7	egypt	egypt	PROPN
dpc-3767	122	8	in	in	ADP
dpc-3767	122	9	2022	2022	NUM
dpc-3767	122	10	.	.	PUNCT
dpc-3767	123	1	this	this	DET
dpc-3767	123	2	study	study	NOUN
dpc-3767	123	3	included	include	VERB
dpc-3767	123	4	60	60	NUM
dpc-3767	123	5	patients	patient	NOUN
dpc-3767	123	6	with	with	ADP
dpc-3767	123	7	nail	nail	NOUN
dpc-3767	123	8	psoriasis	psoriasis	NOUN
dpc-3767	123	9	who	who	PRON
dpc-3767	123	10	were	be	AUX
dpc-3767	123	11	randomly	randomly	ADV
dpc-3767	123	12	assigned	assign	VERB
dpc-3767	123	13	to	to	ADP
dpc-3767	123	14	four	four	NUM
dpc-3767	123	15	groups	group	NOUN
dpc-3767	123	16	,	,	PUNCT
dpc-3767	123	17	each	each	PRON
dpc-3767	123	18	containing	contain	VERB
dpc-3767	123	19	15	15	NUM
dpc-3767	123	20	patients	patient	NOUN
dpc-3767	123	21	.	.	PUNCT
dpc-3767	124	1	the	the	DET
dpc-3767	124	2	first	first	ADJ
dpc-3767	124	3	three	three	NUM
dpc-3767	124	4	groups	group	NOUN
dpc-3767	124	5	received	receive	VERB
dpc-3767	124	6	intralesional	intralesional	ADJ
dpc-3767	124	7	injection	injection	NOUN
dpc-3767	124	8	of	of	ADP
dpc-3767	124	9	0.1	0.1	NUM
dpc-3767	124	10	ml	ml	NOUN
dpc-3767	124	11	of	of	ADP
dpc-3767	124	12	5	5	NUM
dpc-3767	124	13	-	-	PUNCT
dpc-3767	124	14	fu	fu	NOUN
dpc-3767	124	15	(	(	PUNCT
dpc-3767	124	16	group	group	NOUN
dpc-3767	124	17	a	a	NOUN
dpc-3767	124	18	)	)	PUNCT
dpc-3767	124	19	,	,	PUNCT
dpc-3767	124	20	mtx	mtx	NOUN
dpc-3767	124	21	(	(	PUNCT
dpc-3767	124	22	group	group	NOUN
dpc-3767	124	23	b	b	PROPN
dpc-3767	124	24	)	)	PUNCT
dpc-3767	124	25	,	,	PUNCT
dpc-3767	124	26	and	and	CCONJ
dpc-3767	124	27	ta	ta	X
dpc-3767	124	28	(	(	PUNCT
dpc-3767	124	29	group	group	NOUN
dpc-3767	124	30	c	c	NOUN
dpc-3767	124	31	)	)	PUNCT
dpc-3767	124	32	into	into	ADP
dpc-3767	124	33	the	the	DET
dpc-3767	124	34	nail	nail	NOUN
dpc-3767	124	35	matrix	matrix	NOUN
dpc-3767	124	36	and	and	CCONJ
dpc-3767	124	37	bed	bed	NOUN
dpc-3767	124	38	monthly	monthly	ADV
dpc-3767	124	39	for	for	ADP
dpc-3767	124	40	three	three	NUM
dpc-3767	124	41	months	month	NOUN
dpc-3767	124	42	.	.	PUNCT
dpc-3767	125	1	group	group	NOUN
dpc-3767	125	2	d	d	PROPN
dpc-3767	125	3	received	receive	VERB
dpc-3767	125	4	a	a	DET
dpc-3767	125	5	topical	topical	ADJ
dpc-3767	125	6	combination	combination	NOUN
dpc-3767	125	7	of	of	ADP
dpc-3767	125	8	calcipotriol	calcipotriol	PROPN
dpc-3767	125	9	/	/	SYM
dpc-3767	125	10	urea	urea	NOUN
dpc-3767	125	11	20	20	NUM
dpc-3767	125	12	%	%	NOUN
dpc-3767	125	13	twice	twice	ADV
dpc-3767	125	14	daily	daily	ADV
dpc-3767	125	15	for	for	ADP
dpc-3767	125	16	three	three	NUM
dpc-3767	125	17	months	month	NOUN
dpc-3767	125	18	.	.	PUNCT
dpc-3767	126	1	patients	patient	NOUN
dpc-3767	126	2	that	that	PRON
dpc-3767	126	3	received	receive	VERB
dpc-3767	126	4	intralesional	intralesional	ADJ
dpc-3767	126	5	injections	injection	NOUN
dpc-3767	126	6	were	be	AUX
dpc-3767	126	7	anesthetized	anesthetize	VERB
dpc-3767	126	8	with	with	ADP
dpc-3767	126	9	a	a	DET
dpc-3767	126	10	combination	combination	NOUN
dpc-3767	126	11	of	of	ADP
dpc-3767	126	12	topical	topical	ADJ
dpc-3767	126	13	lidocaine	lidocaine	NOUN
dpc-3767	126	14	and	and	CCONJ
dpc-3767	126	15	prilocaine	prilocaine	NOUN
dpc-3767	126	16	cream	cream	NOUN
dpc-3767	126	17	30	30	NUM
dpc-3767	126	18	minutes	minute	NOUN
dpc-3767	126	19	before	before	ADP
dpc-3767	126	20	injection	injection	NOUN
dpc-3767	126	21	.	.	PUNCT
dpc-3767	127	1	four	four	NUM
dpc-3767	127	2	injections	injection	NOUN
dpc-3767	127	3	were	be	AUX
dpc-3767	127	4	administered	administer	VERB
dpc-3767	127	5	:	:	PUNCT
dpc-3767	127	6	two	two	NUM
dpc-3767	127	7	injections	injection	NOUN
dpc-3767	127	8	at	at	ADP
dpc-3767	127	9	the	the	DET
dpc-3767	127	10	nail	nail	NOUN
dpc-3767	127	11	matrix	matrix	NOUN
dpc-3767	127	12	and	and	CCONJ
dpc-3767	127	13	two	two	NUM
dpc-3767	127	14	injections	injection	NOUN
dpc-3767	127	15	in	in	ADP
dpc-3767	127	16	the	the	DET
dpc-3767	127	17	nail	nail	NOUN
dpc-3767	127	18	bed	bed	NOUN
dpc-3767	127	19	.	.	PUNCT
dpc-3767	128	1	the	the	DET
dpc-3767	128	2	injections	injection	NOUN
dpc-3767	128	3	were	be	AUX
dpc-3767	128	4	administered	administer	VERB
dpc-3767	128	5	twice	twice	DET
dpc-3767	128	6	a	a	DET
dpc-3767	128	7	day	day	NOUN
dpc-3767	128	8	for	for	ADP
dpc-3767	128	9	three	three	NUM
dpc-3767	128	10	months	month	NOUN
dpc-3767	128	11	and	and	CCONJ
dpc-3767	128	12	followed	follow	VERB
dpc-3767	128	13	up	up	ADP
dpc-3767	128	14	after	after	ADP
dpc-3767	128	15	six	six	NUM
dpc-3767	128	16	months	month	NOUN
dpc-3767	128	17	.	.	PUNCT
dpc-3767	129	1	therapeutic	therapeutic	ADJ
dpc-3767	129	2	response	response	NOUN
dpc-3767	129	3	was	be	AUX
dpc-3767	129	4	assessed	assess	VERB
dpc-3767	129	5	every	every	DET
dpc-3767	129	6	month	month	NOUN
dpc-3767	129	7	for	for	ADP
dpc-3767	129	8	three	three	NUM
dpc-3767	129	9	months	month	NOUN
dpc-3767	129	10	using	use	VERB
dpc-3767	129	11	the	the	DET
dpc-3767	129	12	napsi	napsi	NOUN
dpc-3767	129	13	score	score	NOUN
dpc-3767	129	14	.	.	PUNCT
dpc-3767	130	1	at	at	ADP
dpc-3767	130	2	the	the	DET
dpc-3767	130	3	end	end	NOUN
dpc-3767	130	4	of	of	ADP
dpc-3767	130	5	the	the	DET
dpc-3767	130	6	study	study	NOUN
dpc-3767	130	7	,	,	PUNCT
dpc-3767	130	8	the	the	DET
dpc-3767	130	9	mean	mean	ADJ
dpc-3767	130	10	percentage	percentage	NOUN
dpc-3767	130	11	of	of	ADP
dpc-3767	130	12	improvement	improvement	NOUN
dpc-3767	130	13	was	be	AUX
dpc-3767	130	14	significantly	significantly	ADV
dpc-3767	130	15	higher	high	ADJ
dpc-3767	130	16	in	in	ADP
dpc-3767	130	17	topical	topical	ADJ
dpc-3767	130	18	calcipotriol/	calcipotriol/	NUM
dpc-3767	130	19	table	table	NOUN
dpc-3767	130	20	2	2	NUM
dpc-3767	130	21	.	.	PUNCT
dpc-3767	131	1	the	the	DET
dpc-3767	131	2	difference	difference	NOUN
dpc-3767	131	3	in	in	ADP
dpc-3767	131	4	mean	mean	ADJ
dpc-3767	131	5	napsi	napsi	NOUN
dpc-3767	131	6	score	score	NOUN
dpc-3767	131	7	after	after	ADP
dpc-3767	131	8	mtx	mtx	NOUN
dpc-3767	131	9	intralesional	intralesional	ADJ
dpc-3767	131	10	injections	injection	NOUN
dpc-3767	131	11	(	(	PUNCT
dpc-3767	131	12	n=38	n=38	ADJ
dpc-3767	131	13	)	)	PUNCT
dpc-3767	131	14	and	and	CCONJ
dpc-3767	131	15	ta	ta	ADP
dpc-3767	131	16	intralesional	intralesional	ADJ
dpc-3767	131	17	injections	injection	NOUN
dpc-3767	131	18	(	(	PUNCT
dpc-3767	131	19	n=38	n=38	ADJ
dpc-3767	131	20	)	)	PUNCT
dpc-3767	131	21	.	.	PUNCT
dpc-3767	132	1	study	study	NOUN
dpc-3767	132	2	methotrexate	methotrexate	NOUN
dpc-3767	132	3	n	n	X
dpc-3767	132	4	control	control	NOUN
dpc-3767	132	5	n	n	PROPN
dpc-3767	132	6	mean±sd	mean±sd	PROPN
dpc-3767	132	7	mean±sd	mean±sd	ADP
dpc-3767	132	8	pre	pre	ADJ
dpc-3767	132	9	post	post	X
dpc-3767	132	10	pre	pre	X
dpc-3767	132	11	post	post	X
dpc-3767	132	12	starace	starace	NOUN
dpc-3767	132	13	(	(	PUNCT
dpc-3767	132	14	2022	2022	NUM
dpc-3767	132	15	)	)	PUNCT
dpc-3767	133	1	5.33±1.80	5.33±1.80	NUM
dpc-3767	133	2	0.33±0.47	0.33±0.47	NOUN
dpc-3767	133	3	6	6	NUM
dpc-3767	133	4	5.33±1.70	5.33±1.70	NUM
dpc-3767	133	5	1.83±0.69	1.83±0.69	NOUN
dpc-3767	133	6	6	6	NUM
dpc-3767	133	7	mittal	mittal	ADJ
dpc-3767	133	8	(	(	PUNCT
dpc-3767	133	9	2018	2018	NUM
dpc-3767	133	10	)	)	PUNCT
dpc-3767	133	11	4.33±1.37	4.33±1.37	NOUN
dpc-3767	133	12	1.29±0.75	1.29±0.75	NUM
dpc-3767	133	13	17	17	NUM
dpc-3767	133	14	4.06±1.55	4.06±1.55	NOUN
dpc-3767	133	15	1.29±0.89	1.29±0.89	NUM
dpc-3767	133	16	17	17	NUM
dpc-3767	133	17	abdelmeniem	abdelmeniem	NOUN
dpc-3767	133	18	(	(	PUNCT
dpc-3767	133	19	2022	2022	NUM
dpc-3767	133	20	)	)	PUNCT
dpc-3767	133	21	6.70±1.10	6.70±1.10	VERB
dpc-3767	133	22	4.3±1.4	4.3±1.4	NUM
dpc-3767	133	23	15	15	NUM
dpc-3767	134	1	6.5±1.70	6.5±1.70	NUM
dpc-3767	134	2	4.00±2.50	4.00±2.50	NUM
dpc-3767	134	3	15	15	NUM
dpc-3767	134	4	figure	figure	NOUN
dpc-3767	134	5	2	2	NUM
dpc-3767	134	6	.	.	PUNCT
dpc-3767	134	7	forest	forest	NOUN
dpc-3767	134	8	plot	plot	NOUN
dpc-3767	134	9	showing	show	VERB
dpc-3767	134	10	the	the	DET
dpc-3767	134	11	efficacy	efficacy	NOUN
dpc-3767	134	12	of	of	ADP
dpc-3767	134	13	mtx	mtx	NOUN
dpc-3767	134	14	intralesional	intralesional	ADJ
dpc-3767	134	15	injection	injection	NOUN
dpc-3767	134	16	compared	compare	VERB
dpc-3767	134	17	with	with	ADP
dpc-3767	134	18	placebo	placebo	NOUN
dpc-3767	134	19	from	from	ADP
dpc-3767	134	20	all	all	DET
dpc-3767	134	21	studies	study	NOUN
dpc-3767	134	22	that	that	PRON
dpc-3767	134	23	were	be	AUX
dpc-3767	134	24	evaluated	evaluate	VERB
dpc-3767	134	25	in	in	ADP
dpc-3767	134	26	the	the	DET
dpc-3767	134	27	meta	meta	ADJ
dpc-3767	134	28	-	-	PUNCT
dpc-3767	134	29	analysis	analysis	NOUN
dpc-3767	134	30	.	.	PUNCT
dpc-3767	135	1	95	95	NUM
dpc-3767	135	2	%	%	NOUN
dpc-3767	135	3	ci	ci	NOUN
dpc-3767	135	4	=	=	SYM
dpc-3767	135	5	95	95	NUM
dpc-3767	135	6	%	%	NOUN
dpc-3767	135	7	confidence	confidence	NOUN
dpc-3767	135	8	interval	interval	NOUN
dpc-3767	135	9	;	;	PUNCT
dpc-3767	135	10	6	6	NUM
dpc-3767	135	11	review	review	NOUN
dpc-3767	135	12	|	|	ADV
dpc-3767	135	13	dermatol	dermatol	ADJ
dpc-3767	135	14	pract	pract	NOUN
dpc-3767	135	15	concept	concept	NOUN
dpc-3767	135	16	.	.	PUNCT
dpc-3767	136	1	2024;14(2):e2024109	2024;14(2):e2024109	NUM
dpc-3767	136	2	subcutis	subcutis	PROPN
dpc-3767	136	3	hematoma	hematoma	NOUN
dpc-3767	136	4	,	,	PUNCT
dpc-3767	136	5	pigmentation	pigmentation	NOUN
dpc-3767	136	6	change	change	NOUN
dpc-3767	136	7	,	,	PUNCT
dpc-3767	136	8	necrosis	necrosis	NOUN
dpc-3767	136	9	,	,	PUNCT
dpc-3767	136	10	and	and	CCONJ
dpc-3767	136	11	ulceration	ulceration	NOUN
dpc-3767	136	12	of	of	ADP
dpc-3767	136	13	the	the	DET
dpc-3767	136	14	skin	skin	NOUN
dpc-3767	136	15	.	.	PUNCT
dpc-3767	137	1	systemic	systemic	ADJ
dpc-3767	137	2	side	side	NOUN
dpc-3767	137	3	effect	effect	NOUN
dpc-3767	137	4	includes	include	VERB
dpc-3767	137	5	cushing	cushe	VERB
dpc-3767	137	6	syndrome	syndrome	NOUN
dpc-3767	137	7	[	[	X
dpc-3767	137	8	12	12	NUM
dpc-3767	137	9	,	,	PUNCT
dpc-3767	137	10	13	13	NUM
dpc-3767	137	11	]	]	PUNCT
dpc-3767	137	12	.	.	PUNCT
dpc-3767	138	1	patients	patient	NOUN
dpc-3767	138	2	in	in	ADP
dpc-3767	138	3	the	the	DET
dpc-3767	138	4	mtx	mtx	NOUN
dpc-3767	138	5	group	group	NOUN
dpc-3767	138	6	were	be	AUX
dpc-3767	138	7	expected	expect	VERB
dpc-3767	138	8	to	to	PART
dpc-3767	138	9	have	have	VERB
dpc-3767	138	10	lower	low	ADJ
dpc-3767	138	11	napsi	napsi	NOUN
dpc-3767	138	12	scores	score	NOUN
dpc-3767	138	13	after	after	ADP
dpc-3767	138	14	the	the	DET
dpc-3767	138	15	intralesional	intralesional	ADJ
dpc-3767	138	16	injection	injection	NOUN
dpc-3767	138	17	of	of	ADP
dpc-3767	138	18	mtx	mtx	NOUN
dpc-3767	138	19	.	.	PUNCT
dpc-3767	139	1	all	all	PRON
dpc-3767	139	2	of	of	ADP
dpc-3767	139	3	the	the	DET
dpc-3767	139	4	studies	study	NOUN
dpc-3767	139	5	showed	show	VERB
dpc-3767	139	6	a	a	DET
dpc-3767	139	7	reduction	reduction	NOUN
dpc-3767	139	8	in	in	ADP
dpc-3767	139	9	napsi	napsi	NOUN
dpc-3767	139	10	scores	score	NOUN
dpc-3767	139	11	after	after	SCONJ
dpc-3767	139	12	the	the	DET
dpc-3767	139	13	injection	injection	NOUN
dpc-3767	139	14	of	of	ADP
dpc-3767	139	15	mtx	mtx	NOUN
dpc-3767	139	16	.	.	PROPN
dpc-3767	139	17	starace	starace	PROPN
dpc-3767	139	18	et	et	PROPN
dpc-3767	139	19	al	al	PROPN
dpc-3767	139	20	.	.	PROPN
dpc-3767	139	21	reported	report	VERB
dpc-3767	139	22	reduction	reduction	NOUN
dpc-3767	139	23	in	in	ADP
dpc-3767	139	24	napsi	napsi	ADJ
dpc-3767	139	25	score	score	NOUN
dpc-3767	139	26	in	in	ADP
dpc-3767	139	27	mtx	mtx	NOUN
dpc-3767	139	28	group	group	NOUN
dpc-3767	139	29	(	(	PUNCT
dpc-3767	139	30	−5±1.62	−5±1.62	NOUN
dpc-3767	139	31	)	)	PUNCT
dpc-3767	139	32	,	,	PUNCT
dpc-3767	139	33	and	and	CCONJ
dpc-3767	139	34	there	there	PRON
dpc-3767	139	35	was	be	VERB
dpc-3767	139	36	no	no	DET
dpc-3767	139	37	recurrence	recurrence	NOUN
dpc-3767	139	38	during	during	ADP
dpc-3767	139	39	the	the	DET
dpc-3767	139	40	six	six	NUM
dpc-3767	139	41	months	month	NOUN
dpc-3767	139	42	of	of	ADP
dpc-3767	139	43	follow	follow	NOUN
dpc-3767	139	44	-	-	PUNCT
dpc-3767	139	45	up	up	NOUN
dpc-3767	139	46	[	[	X
dpc-3767	139	47	10	10	NUM
dpc-3767	139	48	]	]	PUNCT
dpc-3767	139	49	.	.	PUNCT
dpc-3767	140	1	mittal	mittal	PROPN
dpc-3767	140	2	et	et	PROPN
dpc-3767	140	3	al	al	PROPN
dpc-3767	140	4	.	.	PROPN
dpc-3767	140	5	also	also	ADV
dpc-3767	140	6	reported	report	VERB
dpc-3767	140	7	a	a	DET
dpc-3767	140	8	reduction	reduction	NOUN
dpc-3767	140	9	in	in	ADP
dpc-3767	140	10	napsi	napsi	ADJ
dpc-3767	140	11	score	score	NOUN
dpc-3767	140	12	in	in	ADP
dpc-3767	140	13	mtx	mtx	NOUN
dpc-3767	140	14	group	group	NOUN
dpc-3767	140	15	after	after	ADP
dpc-3767	140	16	four	four	NUM
dpc-3767	140	17	weeks	week	NOUN
dpc-3767	140	18	of	of	ADP
dpc-3767	140	19	follow	follow	NOUN
dpc-3767	140	20	-	-	PUNCT
dpc-3767	140	21	up	up	NOUN
dpc-3767	140	22	.	.	PUNCT
dpc-3767	141	1	the	the	DET
dpc-3767	141	2	reduction	reduction	NOUN
dpc-3767	141	3	in	in	ADP
dpc-3767	141	4	napsi	napsi	ADJ
dpc-3767	141	5	score	score	NOUN
dpc-3767	141	6	was	be	AUX
dpc-3767	141	7	3.04±1.19	3.04±1.19	NUM
dpc-3767	141	8	and	and	CCONJ
dpc-3767	141	9	was	be	AUX
dpc-3767	141	10	statistically	statistically	ADV
dpc-3767	141	11	significant	significant	ADJ
dpc-3767	141	12	[	[	X
dpc-3767	141	13	7	7	NUM
dpc-3767	141	14	]	]	PUNCT
dpc-3767	141	15	.	.	PUNCT
dpc-3767	142	1	lastly	lastly	ADV
dpc-3767	142	2	,	,	PUNCT
dpc-3767	142	3	abdelmeniem	abdelmeniem	INTJ
dpc-3767	142	4	et	et	PROPN
dpc-3767	142	5	al	al	PROPN
dpc-3767	142	6	.	.	PROPN
dpc-3767	142	7	also	also	ADV
dpc-3767	142	8	reported	report	VERB
dpc-3767	142	9	a	a	DET
dpc-3767	142	10	reduction	reduction	NOUN
dpc-3767	142	11	in	in	ADP
dpc-3767	142	12	napsi	napsi	ADJ
dpc-3767	142	13	score	score	NOUN
dpc-3767	142	14	in	in	ADP
dpc-3767	142	15	mtx	mtx	NOUN
dpc-3767	142	16	group	group	NOUN
dpc-3767	142	17	(	(	PUNCT
dpc-3767	142	18	−2.4±1.28	−2.4±1.28	NUM
dpc-3767	142	19	)	)	PUNCT
dpc-3767	143	1	[	[	X
dpc-3767	143	2	9	9	NUM
dpc-3767	143	3	]	]	PUNCT
dpc-3767	143	4	.	.	PUNCT
dpc-3767	144	1	these	these	DET
dpc-3767	144	2	findings	finding	NOUN
dpc-3767	144	3	were	be	AUX
dpc-3767	144	4	consistent	consistent	ADJ
dpc-3767	144	5	with	with	ADP
dpc-3767	144	6	previous	previous	ADJ
dpc-3767	144	7	studies	study	NOUN
dpc-3767	144	8	,	,	PUNCT
dpc-3767	144	9	which	which	PRON
dpc-3767	144	10	reported	report	VERB
dpc-3767	144	11	significant	significant	ADJ
dpc-3767	144	12	improvement	improvement	NOUN
dpc-3767	144	13	in	in	ADP
dpc-3767	144	14	nail	nail	NOUN
dpc-3767	144	15	psoriasis	psoriasis	NOUN
dpc-3767	144	16	receiving	receive	VERB
dpc-3767	144	17	mtx	mtx	NOUN
dpc-3767	144	18	intralesional	intralesional	ADJ
dpc-3767	144	19	injections	injection	NOUN
dpc-3767	144	20	[	[	X
dpc-3767	144	21	11	11	NUM
dpc-3767	144	22	-	-	SYM
dpc-3767	144	23	15	15	NUM
dpc-3767	144	24	]	]	PUNCT
dpc-3767	144	25	.	.	PUNCT
dpc-3767	145	1	patients	patient	NOUN
dpc-3767	145	2	in	in	ADP
dpc-3767	145	3	the	the	DET
dpc-3767	145	4	ta	ta	PROPN
dpc-3767	145	5	group	group	NOUN
dpc-3767	145	6	were	be	AUX
dpc-3767	145	7	also	also	ADV
dpc-3767	145	8	expected	expect	VERB
dpc-3767	145	9	to	to	PART
dpc-3767	145	10	have	have	VERB
dpc-3767	145	11	lower	low	ADJ
dpc-3767	145	12	napsi	napsi	NOUN
dpc-3767	145	13	scores	score	NOUN
dpc-3767	145	14	after	after	ADP
dpc-3767	145	15	intralesional	intralesional	ADJ
dpc-3767	145	16	injections	injection	NOUN
dpc-3767	145	17	of	of	ADP
dpc-3767	145	18	ta	ta	PROPN
dpc-3767	145	19	.	.	PUNCT
dpc-3767	146	1	all	all	DET
dpc-3767	146	2	the	the	DET
dpc-3767	146	3	studies	study	NOUN
dpc-3767	146	4	showed	show	VERB
dpc-3767	146	5	a	a	DET
dpc-3767	146	6	reduction	reduction	NOUN
dpc-3767	146	7	in	in	ADP
dpc-3767	146	8	napsi	napsi	NOUN
dpc-3767	146	9	scores	score	NOUN
dpc-3767	146	10	after	after	SCONJ
dpc-3767	146	11	the	the	DET
dpc-3767	146	12	injection	injection	NOUN
dpc-3767	146	13	of	of	ADP
dpc-3767	146	14	ta	ta	PROPN
dpc-3767	146	15	.	.	PROPN
dpc-3767	146	16	starace	starace	PROPN
dpc-3767	146	17	et	et	PROPN
dpc-3767	146	18	al	al	PROPN
dpc-3767	146	19	.	.	PROPN
dpc-3767	146	20	reported	report	VERB
dpc-3767	146	21	a	a	DET
dpc-3767	146	22	reduction	reduction	NOUN
dpc-3767	146	23	in	in	ADP
dpc-3767	146	24	napsi	napsi	ADJ
dpc-3767	146	25	score	score	NOUN
dpc-3767	146	26	in	in	ADP
dpc-3767	146	27	the	the	DET
dpc-3767	146	28	ta	ta	PROPN
dpc-3767	146	29	group	group	PROPN
dpc-3767	146	30	(	(	PUNCT
dpc-3767	146	31	-3.5±1.48	-3.5±1.48	PROPN
dpc-3767	146	32	)	)	PUNCT
dpc-3767	146	33	during	during	ADP
dpc-3767	146	34	the	the	DET
dpc-3767	146	35	six	six	NUM
dpc-3767	146	36	months	month	NOUN
dpc-3767	146	37	of	of	ADP
dpc-3767	146	38	follow	follow	NOUN
dpc-3767	146	39	-	-	PUNCT
dpc-3767	146	40	up	up	NOUN
dpc-3767	146	41	[	[	X
dpc-3767	146	42	10	10	NUM
dpc-3767	146	43	]	]	PUNCT
dpc-3767	146	44	.	.	PUNCT
dpc-3767	147	1	mittal	mittal	PROPN
dpc-3767	147	2	et	et	PROPN
dpc-3767	147	3	al	al	PROPN
dpc-3767	147	4	.	.	PROPN
dpc-3767	147	5	also	also	ADV
dpc-3767	147	6	reported	report	VERB
dpc-3767	147	7	a	a	DET
dpc-3767	147	8	reduction	reduction	NOUN
dpc-3767	147	9	in	in	ADP
dpc-3767	147	10	napsi	napsi	ADJ
dpc-3767	147	11	score	score	NOUN
dpc-3767	147	12	in	in	ADP
dpc-3767	147	13	the	the	DET
dpc-3767	147	14	ta	ta	PROPN
dpc-3767	147	15	group	group	NOUN
dpc-3767	147	16	after	after	ADP
dpc-3767	147	17	24	24	NUM
dpc-3767	147	18	weeks	week	NOUN
dpc-3767	147	19	of	of	ADP
dpc-3767	147	20	follow	follow	NOUN
dpc-3767	147	21	-	-	PUNCT
dpc-3767	147	22	up	up	NOUN
dpc-3767	147	23	(	(	PUNCT
dpc-3767	147	24	−2.77±1.35	−2.77±1.35	NOUN
dpc-3767	147	25	)	)	PUNCT
dpc-3767	148	1	[	[	X
dpc-3767	148	2	7	7	NUM
dpc-3767	148	3	]	]	PUNCT
dpc-3767	148	4	.	.	PUNCT
dpc-3767	149	1	lastly	lastly	ADV
dpc-3767	149	2	,	,	PUNCT
dpc-3767	149	3	abdelmeniem	abdelmeniem	INTJ
dpc-3767	149	4	et	et	PROPN
dpc-3767	149	5	al	al	PROPN
dpc-3767	149	6	.	.	PROPN
dpc-3767	149	7	also	also	ADV
dpc-3767	149	8	reported	report	VERB
dpc-3767	149	9	a	a	DET
dpc-3767	149	10	reduction	reduction	NOUN
dpc-3767	149	11	in	in	ADP
dpc-3767	149	12	napsi	napsi	ADJ
dpc-3767	149	13	score	score	NOUN
dpc-3767	149	14	in	in	ADP
dpc-3767	149	15	the	the	DET
dpc-3767	149	16	ta	ta	PROPN
dpc-3767	149	17	group	group	NOUN
dpc-3767	149	18	(	(	PUNCT
dpc-3767	149	19	−2.5	−2.5	PROPN
dpc-3767	149	20	±	±	NUM
dpc-3767	149	21	2.21	2.21	NUM
dpc-3767	149	22	)	)	PUNCT
dpc-3767	150	1	[	[	X
dpc-3767	150	2	9	9	NUM
dpc-3767	150	3	]	]	PUNCT
dpc-3767	150	4	.	.	PUNCT
dpc-3767	151	1	these	these	DET
dpc-3767	151	2	findings	finding	NOUN
dpc-3767	151	3	were	be	AUX
dpc-3767	151	4	consistent	consistent	ADJ
dpc-3767	151	5	with	with	ADP
dpc-3767	151	6	previous	previous	ADJ
dpc-3767	151	7	studies	study	NOUN
dpc-3767	151	8	,	,	PUNCT
dpc-3767	151	9	which	which	PRON
dpc-3767	151	10	reported	report	VERB
dpc-3767	151	11	significant	significant	ADJ
dpc-3767	151	12	improvement	improvement	NOUN
dpc-3767	151	13	in	in	ADP
dpc-3767	151	14	nail	nail	NOUN
dpc-3767	151	15	psoriasis	psoriasis	NOUN
dpc-3767	151	16	receiving	receive	VERB
dpc-3767	151	17	ta	ta	ADP
dpc-3767	151	18	intralesional	intralesional	ADJ
dpc-3767	151	19	injections	injection	NOUN
dpc-3767	151	20	[	[	X
dpc-3767	151	21	11–15	11–15	NUM
dpc-3767	151	22	]	]	X
dpc-3767	151	23	.	.	PUNCT
dpc-3767	152	1	various	various	ADJ
dpc-3767	152	2	side	side	NOUN
dpc-3767	152	3	effects	effect	NOUN
dpc-3767	152	4	of	of	ADP
dpc-3767	152	5	intralesional	intralesional	ADJ
dpc-3767	152	6	injection	injection	NOUN
dpc-3767	152	7	of	of	ADP
dpc-3767	152	8	steroids	steroid	NOUN
dpc-3767	152	9	lead	lead	VERB
dpc-3767	152	10	us	we	PRON
dpc-3767	152	11	to	to	PART
dpc-3767	152	12	suggest	suggest	VERB
dpc-3767	152	13	that	that	SCONJ
dpc-3767	152	14	mtx	mtx	NOUN
dpc-3767	152	15	intralesional	intralesional	ADJ
dpc-3767	152	16	injection	injection	NOUN
dpc-3767	152	17	is	be	AUX
dpc-3767	152	18	currently	currently	ADV
dpc-3767	152	19	preferable	preferable	ADJ
dpc-3767	152	20	in	in	ADP
dpc-3767	152	21	the	the	DET
dpc-3767	152	22	treatment	treatment	NOUN
dpc-3767	152	23	of	of	ADP
dpc-3767	152	24	nail	nail	NOUN
dpc-3767	152	25	psoriasis	psoriasis	NOUN
dpc-3767	152	26	.	.	PUNCT
dpc-3767	153	1	we	we	PRON
dpc-3767	153	2	initially	initially	ADV
dpc-3767	153	3	suggested	suggest	VERB
dpc-3767	153	4	that	that	SCONJ
dpc-3767	153	5	the	the	DET
dpc-3767	153	6	reduction	reduction	NOUN
dpc-3767	153	7	in	in	ADP
dpc-3767	153	8	napsi	napsi	ADJ
dpc-3767	153	9	score	score	NOUN
dpc-3767	153	10	in	in	ADP
dpc-3767	153	11	the	the	DET
dpc-3767	153	12	mtx	mtx	NOUN
dpc-3767	153	13	group	group	NOUN
dpc-3767	153	14	was	be	AUX
dpc-3767	153	15	greater	great	ADJ
dpc-3767	153	16	than	than	ADP
dpc-3767	153	17	ta	ta	PROPN
dpc-3767	153	18	group	group	NOUN
dpc-3767	153	19	.	.	PUNCT
dpc-3767	154	1	starace	starace	PROPN
dpc-3767	154	2	et	et	PROPN
dpc-3767	154	3	al	al	PROPN
dpc-3767	154	4	.	.	PROPN
dpc-3767	154	5	and	and	CCONJ
dpc-3767	154	6	mittal	mittal	PROPN
dpc-3767	154	7	et	et	PROPN
dpc-3767	154	8	al	al	PROPN
dpc-3767	154	9	.	.	PROPN
dpc-3767	154	10	reported	report	VERB
dpc-3767	154	11	significantly	significantly	ADV
dpc-3767	154	12	greater	great	ADJ
dpc-3767	154	13	reduction	reduction	NOUN
dpc-3767	154	14	in	in	ADP
dpc-3767	154	15	napsi	napsi	ADJ
dpc-3767	154	16	score	score	NOUN
dpc-3767	154	17	after	after	ADP
dpc-3767	154	18	intralesional	intralesional	ADJ
dpc-3767	154	19	injection	injection	NOUN
dpc-3767	154	20	of	of	ADP
dpc-3767	154	21	mtx	mtx	NOUN
dpc-3767	154	22	(	(	PUNCT
dpc-3767	154	23	starace	starace	NOUN
dpc-3767	154	24	et	et	PROPN
dpc-3767	154	25	al	al	PROPN
dpc-3767	154	26	.	.	PROPN
dpc-3767	154	27	:	:	PUNCT
dpc-3767	155	1	−5±1.62	−5±1.62	NOUN
dpc-3767	155	2	;	;	PUNCT
dpc-3767	155	3	mittal	mittal	PROPN
dpc-3767	155	4	et	et	PROPN
dpc-3767	155	5	al	al	PROPN
dpc-3767	155	6	.	.	PROPN
dpc-3767	155	7	:	:	PUNCT
dpc-3767	156	1	−3.5±1.48	−3.5±1.48	PROPN
dpc-3767	156	2	)	)	PUNCT
dpc-3767	157	1	[	[	X
dpc-3767	157	2	7	7	NUM
dpc-3767	157	3	,	,	PUNCT
dpc-3767	157	4	10	10	NUM
dpc-3767	157	5	]	]	PUNCT
dpc-3767	157	6	.	.	PUNCT
dpc-3767	158	1	different	different	ADJ
dpc-3767	158	2	outcomes	outcome	NOUN
dpc-3767	158	3	were	be	AUX
dpc-3767	158	4	reported	report	VERB
dpc-3767	158	5	by	by	ADP
dpc-3767	158	6	abdelmeniem	abdelmeniem	PROPN
dpc-3767	158	7	et	et	PROPN
dpc-3767	158	8	al	al	PROPN
dpc-3767	158	9	.	.	PROPN
dpc-3767	158	10	:	:	PUNCT
dpc-3767	159	1	the	the	DET
dpc-3767	159	2	reduction	reduction	NOUN
dpc-3767	159	3	in	in	ADP
dpc-3767	159	4	ta	ta	PROPN
dpc-3767	159	5	group	group	NOUN
dpc-3767	159	6	(	(	PUNCT
dpc-3767	159	7	−2.5±2.21	−2.5±2.21	PROPN
dpc-3767	159	8	)	)	PUNCT
dpc-3767	159	9	was	be	AUX
dpc-3767	159	10	greater	great	ADJ
dpc-3767	159	11	than	than	ADP
dpc-3767	159	12	in	in	ADP
dpc-3767	159	13	the	the	DET
dpc-3767	159	14	mtx	mtx	NOUN
dpc-3767	159	15	group	group	NOUN
dpc-3767	159	16	(	(	PUNCT
dpc-3767	159	17	−2.4±1.28	−2.4±1.28	PROPN
dpc-3767	159	18	)	)	PUNCT
dpc-3767	159	19	.	.	PUNCT
dpc-3767	160	1	however	however	ADV
dpc-3767	160	2	,	,	PUNCT
dpc-3767	160	3	abdelmeniem	abdelmeniem	INTJ
dpc-3767	160	4	et	et	PROPN
dpc-3767	160	5	al	al	PROPN
dpc-3767	160	6	.	.	PROPN
dpc-3767	160	7	reported	report	VERB
dpc-3767	160	8	no	no	DET
dpc-3767	160	9	significance	significance	NOUN
dpc-3767	160	10	in	in	ADP
dpc-3767	160	11	their	their	PRON
dpc-3767	160	12	findings	finding	NOUN
dpc-3767	160	13	[	[	X
dpc-3767	160	14	9	9	NUM
dpc-3767	160	15	]	]	PUNCT
dpc-3767	160	16	.	.	PUNCT
dpc-3767	161	1	the	the	DET
dpc-3767	161	2	meta	meta	ADJ
dpc-3767	161	3	-	-	PUNCT
dpc-3767	161	4	analysis	analysis	NOUN
dpc-3767	161	5	of	of	ADP
dpc-3767	161	6	the	the	DET
dpc-3767	161	7	effect	effect	NOUN
dpc-3767	161	8	of	of	ADP
dpc-3767	161	9	mtx	mtx	NOUN
dpc-3767	161	10	intralesional	intralesional	ADJ
dpc-3767	161	11	injection	injection	NOUN
dpc-3767	161	12	therapy	therapy	NOUN
dpc-3767	161	13	on	on	ADP
dpc-3767	161	14	nail	nail	NOUN
dpc-3767	161	15	psoriasis	psoriasis	NOUN
dpc-3767	161	16	treatment	treatment	NOUN
dpc-3767	161	17	was	be	AUX
dpc-3767	161	18	statistically	statistically	ADV
dpc-3767	161	19	insignificant	insignificant	ADJ
dpc-3767	161	20	compared	compare	VERB
dpc-3767	161	21	to	to	ADP
dpc-3767	161	22	ta	ta	ADP
dpc-3767	161	23	intralesional	intralesional	ADJ
dpc-3767	161	24	injection	injection	NOUN
dpc-3767	161	25	.	.	PUNCT
dpc-3767	162	1	(	(	PUNCT
dpc-3767	162	2	p=0.357	p=0.357	NUM
dpc-3767	162	3	)	)	PUNCT
dpc-3767	162	4	.	.	PUNCT
dpc-3767	163	1	the	the	DET
dpc-3767	163	2	statistical	statistical	ADJ
dpc-3767	163	3	analysis	analysis	NOUN
dpc-3767	163	4	and	and	CCONJ
dpc-3767	163	5	meta	meta	NOUN
dpc-3767	163	6	-	-	PUNCT
dpc-3767	163	7	analysis	analysis	NOUN
dpc-3767	163	8	in	in	ADP
dpc-3767	163	9	this	this	DET
dpc-3767	163	10	study	study	NOUN
dpc-3767	163	11	were	be	AUX
dpc-3767	163	12	limited	limit	VERB
dpc-3767	163	13	because	because	SCONJ
dpc-3767	163	14	of	of	ADP
dpc-3767	163	15	the	the	DET
dpc-3767	163	16	limited	limited	ADJ
dpc-3767	163	17	number	number	NOUN
dpc-3767	163	18	of	of	ADP
dpc-3767	163	19	patients	patient	NOUN
dpc-3767	163	20	.	.	PUNCT
dpc-3767	164	1	heterogeneity	heterogeneity	NOUN
dpc-3767	164	2	of	of	ADP
dpc-3767	164	3	the	the	DET
dpc-3767	164	4	dosage	dosage	NOUN
dpc-3767	164	5	,	,	PUNCT
dpc-3767	164	6	technique	technique	NOUN
dpc-3767	164	7	procedure	procedure	NOUN
dpc-3767	164	8	,	,	PUNCT
dpc-3767	164	9	and	and	CCONJ
dpc-3767	164	10	frequency	frequency	NOUN
dpc-3767	164	11	of	of	ADP
dpc-3767	164	12	the	the	DET
dpc-3767	164	13	therapy	therapy	NOUN
dpc-3767	164	14	that	that	PRON
dpc-3767	164	15	had	have	AUX
dpc-3767	164	16	not	not	PART
dpc-3767	164	17	been	be	AUX
dpc-3767	164	18	standardized	standardize	VERB
dpc-3767	164	19	also	also	ADV
dpc-3767	164	20	affected	affect	VERB
dpc-3767	164	21	the	the	DET
dpc-3767	164	22	results	result	NOUN
dpc-3767	164	23	of	of	ADP
dpc-3767	164	24	this	this	DET
dpc-3767	164	25	study	study	NOUN
dpc-3767	164	26	.	.	PUNCT
dpc-3767	165	1	however	however	ADV
dpc-3767	165	2	,	,	PUNCT
dpc-3767	165	3	this	this	DET
dpc-3767	165	4	study	study	NOUN
dpc-3767	165	5	has	have	VERB
dpc-3767	165	6	some	some	DET
dpc-3767	165	7	limitations	limitation	NOUN
dpc-3767	165	8	,	,	PUNCT
dpc-3767	165	9	including	include	VERB
dpc-3767	165	10	the	the	DET
dpc-3767	165	11	limited	limited	ADJ
dpc-3767	165	12	number	number	NOUN
dpc-3767	165	13	of	of	ADP
dpc-3767	165	14	rcts	rct	NOUN
dpc-3767	165	15	evaluating	evaluate	VERB
dpc-3767	165	16	the	the	DET
dpc-3767	165	17	administration	administration	NOUN
dpc-3767	165	18	of	of	ADP
dpc-3767	165	19	mtx	mtx	PROPN
dpc-3767	165	20	and	and	CCONJ
dpc-3767	165	21	prp	prp	NOUN
dpc-3767	165	22	injection	injection	NOUN
dpc-3767	165	23	in	in	ADP
dpc-3767	165	24	nail	nail	NOUN
dpc-3767	165	25	psoriasis	psoriasis	NOUN
dpc-3767	165	26	,	,	PUNCT
dpc-3767	165	27	thus	thus	ADV
dpc-3767	165	28	affecting	affect	VERB
dpc-3767	165	29	the	the	PRON
dpc-3767	165	30	in	in	ADP
dpc-3767	165	31	the	the	DET
dpc-3767	165	32	effectiveness	effectiveness	NOUN
dpc-3767	165	33	of	of	ADP
dpc-3767	165	34	intralesional	intralesional	ADJ
dpc-3767	165	35	mtx	mtx	NOUN
dpc-3767	165	36	injection	injection	NOUN
dpc-3767	165	37	compared	compare	VERB
dpc-3767	165	38	to	to	ADP
dpc-3767	165	39	ta	ta	PROPN
dpc-3767	165	40	in	in	ADP
dpc-3767	165	41	the	the	DET
dpc-3767	165	42	management	management	NOUN
dpc-3767	165	43	of	of	ADP
dpc-3767	165	44	nail	nail	NOUN
dpc-3767	165	45	psoriasis	psoriasis	NOUN
dpc-3767	165	46	.	.	PUNCT
dpc-3767	166	1	risk	risk	NOUN
dpc-3767	166	2	of	of	ADP
dpc-3767	166	3	bias	bias	NOUN
dpc-3767	166	4	in	in	ADP
dpc-3767	166	5	included	include	VERB
dpc-3767	166	6	studies	study	NOUN
dpc-3767	166	7	the	the	DET
dpc-3767	166	8	quality	quality	NOUN
dpc-3767	166	9	of	of	ADP
dpc-3767	166	10	evidence	evidence	NOUN
dpc-3767	166	11	was	be	AUX
dpc-3767	166	12	assessed	assess	VERB
dpc-3767	166	13	using	use	VERB
dpc-3767	166	14	the	the	DET
dpc-3767	166	15	grading	grading	NOUN
dpc-3767	166	16	of	of	ADP
dpc-3767	166	17	recommendations	recommendation	NOUN
dpc-3767	166	18	,	,	PUNCT
dpc-3767	166	19	assessment	assessment	NOUN
dpc-3767	166	20	,	,	PUNCT
dpc-3767	166	21	development	development	NOUN
dpc-3767	166	22	and	and	CCONJ
dpc-3767	166	23	evaluations	evaluation	NOUN
dpc-3767	166	24	(	(	PUNCT
dpc-3767	166	25	grade	grade	NOUN
dpc-3767	166	26	)	)	PUNCT
dpc-3767	166	27	system	system	NOUN
dpc-3767	166	28	.	.	PUNCT
dpc-3767	167	1	the	the	DET
dpc-3767	167	2	studies	study	NOUN
dpc-3767	167	3	by	by	ADP
dpc-3767	167	4	starace	starace	NOUN
dpc-3767	167	5	et	et	PROPN
dpc-3767	167	6	al	al	PROPN
dpc-3767	167	7	.	.	PROPN
dpc-3767	167	8	and	and	CCONJ
dpc-3767	167	9	by	by	ADP
dpc-3767	167	10	mitral	mitral	NOUN
dpc-3767	167	11	et	et	PROPN
dpc-3767	167	12	al	al	PROPN
dpc-3767	167	13	.	.	PROPN
dpc-3767	167	14	showed	show	VERB
dpc-3767	167	15	the	the	DET
dpc-3767	167	16	possibility	possibility	NOUN
dpc-3767	167	17	of	of	ADP
dpc-3767	167	18	risk	risk	NOUN
dpc-3767	167	19	of	of	ADP
dpc-3767	167	20	bias	bias	NOUN
dpc-3767	167	21	,	,	PUNCT
dpc-3767	167	22	while	while	SCONJ
dpc-3767	167	23	the	the	DET
dpc-3767	167	24	study	study	NOUN
dpc-3767	167	25	by	by	ADP
dpc-3767	167	26	adelmeniem	adelmeniem	PROPN
dpc-3767	167	27	et	et	PROPN
dpc-3767	167	28	al	al	PROPN
dpc-3767	167	29	.	.	PROPN
dpc-3767	167	30	showed	show	VERB
dpc-3767	167	31	a	a	DET
dpc-3767	167	32	low	low	ADJ
dpc-3767	167	33	risk	risk	NOUN
dpc-3767	167	34	of	of	ADP
dpc-3767	167	35	bias	bias	NOUN
dpc-3767	167	36	.	.	PUNCT
dpc-3767	168	1	overall	overall	ADV
dpc-3767	168	2	,	,	PUNCT
dpc-3767	168	3	the	the	DET
dpc-3767	168	4	result	result	NOUN
dpc-3767	168	5	of	of	ADP
dpc-3767	168	6	the	the	DET
dpc-3767	168	7	meta	meta	ADJ
dpc-3767	168	8	-	-	PUNCT
dpc-3767	168	9	analysis	analysis	NOUN
dpc-3767	168	10	evaluating	evaluate	VERB
dpc-3767	168	11	the	the	DET
dpc-3767	168	12	efficacy	efficacy	NOUN
dpc-3767	168	13	of	of	ADP
dpc-3767	168	14	mtx	mtx	NOUN
dpc-3767	168	15	versus	versus	X
dpc-3767	168	16	ta	ta	ADP
dpc-3767	168	17	injection	injection	NOUN
dpc-3767	168	18	in	in	ADP
dpc-3767	168	19	nail	nail	NOUN
dpc-3767	168	20	psoriasis	psoriasis	NOUN
dpc-3767	168	21	treatment	treatment	NOUN
dpc-3767	168	22	was	be	AUX
dpc-3767	168	23	considered	consider	VERB
dpc-3767	168	24	to	to	PART
dpc-3767	168	25	be	be	AUX
dpc-3767	168	26	of	of	ADP
dpc-3767	168	27	moderate	moderate	ADJ
dpc-3767	168	28	-	-	PUNCT
dpc-3767	168	29	quality	quality	NOUN
dpc-3767	168	30	(	(	PUNCT
dpc-3767	168	31	⊕⊕⊕⊝	⊕⊕⊕⊝	NOUN
dpc-3767	168	32	)	)	PUNCT
dpc-3767	168	33	.	.	PUNCT
dpc-3767	169	1	moderate	moderate	ADJ
dpc-3767	169	2	-	-	PUNCT
dpc-3767	169	3	quality	quality	NOUN
dpc-3767	169	4	evidence	evidence	NOUN
dpc-3767	169	5	indicated	indicate	VERB
dpc-3767	169	6	that	that	SCONJ
dpc-3767	169	7	there	there	PRON
dpc-3767	169	8	was	be	VERB
dpc-3767	169	9	a	a	DET
dpc-3767	169	10	moderate	moderate	ADJ
dpc-3767	169	11	level	level	NOUN
dpc-3767	169	12	of	of	ADP
dpc-3767	169	13	confidence	confidence	NOUN
dpc-3767	169	14	in	in	ADP
dpc-3767	169	15	the	the	DET
dpc-3767	169	16	estimated	estimate	VERB
dpc-3767	169	17	effect	effect	NOUN
dpc-3767	169	18	size	size	NOUN
dpc-3767	169	19	from	from	ADP
dpc-3767	169	20	the	the	DET
dpc-3767	169	21	meta	meta	ADJ
dpc-3767	169	22	-	-	PUNCT
dpc-3767	169	23	analysis	analysis	NOUN
dpc-3767	169	24	,	,	PUNCT
dpc-3767	169	25	where	where	SCONJ
dpc-3767	169	26	the	the	DET
dpc-3767	169	27	actual	actual	ADJ
dpc-3767	169	28	effect	effect	NOUN
dpc-3767	169	29	size	size	NOUN
dpc-3767	169	30	was	be	AUX
dpc-3767	169	31	likely	likely	ADJ
dpc-3767	169	32	to	to	PART
dpc-3767	169	33	be	be	AUX
dpc-3767	169	34	close	close	ADJ
dpc-3767	169	35	to	to	ADP
dpc-3767	169	36	the	the	DET
dpc-3767	169	37	estimated	estimate	VERB
dpc-3767	169	38	value	value	NOUN
dpc-3767	169	39	,	,	PUNCT
dpc-3767	169	40	although	although	SCONJ
dpc-3767	169	41	there	there	PRON
dpc-3767	169	42	was	be	VERB
dpc-3767	169	43	a	a	DET
dpc-3767	169	44	possibility	possibility	NOUN
dpc-3767	169	45	that	that	SCONJ
dpc-3767	169	46	the	the	DET
dpc-3767	169	47	actual	actual	ADJ
dpc-3767	169	48	effect	effect	NOUN
dpc-3767	169	49	size	size	NOUN
dpc-3767	169	50	was	be	AUX
dpc-3767	169	51	substantially	substantially	ADV
dpc-3767	169	52	different	different	ADJ
dpc-3767	169	53	.	.	PUNCT
dpc-3767	170	1	further	further	ADJ
dpc-3767	170	2	studies	study	NOUN
dpc-3767	170	3	are	be	AUX
dpc-3767	170	4	likely	likely	ADJ
dpc-3767	170	5	to	to	PART
dpc-3767	170	6	have	have	VERB
dpc-3767	170	7	an	an	DET
dpc-3767	170	8	important	important	ADJ
dpc-3767	170	9	impact	impact	NOUN
dpc-3767	170	10	on	on	ADP
dpc-3767	170	11	the	the	DET
dpc-3767	170	12	estimated	estimate	VERB
dpc-3767	170	13	effect	effect	NOUN
dpc-3767	170	14	size	size	NOUN
dpc-3767	170	15	and	and	CCONJ
dpc-3767	170	16	the	the	DET
dpc-3767	170	17	level	level	NOUN
dpc-3767	170	18	of	of	ADP
dpc-3767	170	19	confidence	confidence	NOUN
dpc-3767	170	20	in	in	ADP
dpc-3767	170	21	the	the	DET
dpc-3767	170	22	estimated	estimate	VERB
dpc-3767	170	23	effect	effect	NOUN
dpc-3767	170	24	size	size	NOUN
dpc-3767	170	25	.	.	PUNCT
dpc-3767	171	1	discussion	discussion	NOUN
dpc-3767	171	2	this	this	PRON
dpc-3767	171	3	was	be	AUX
dpc-3767	171	4	a	a	DET
dpc-3767	171	5	systematic	systematic	ADJ
dpc-3767	171	6	review	review	NOUN
dpc-3767	171	7	and	and	CCONJ
dpc-3767	171	8	meta	meta	ADJ
dpc-3767	171	9	-	-	PUNCT
dpc-3767	171	10	analysis	analysis	NOUN
dpc-3767	171	11	evaluating	evaluate	VERB
dpc-3767	171	12	the	the	DET
dpc-3767	171	13	efficacy	efficacy	NOUN
dpc-3767	171	14	of	of	ADP
dpc-3767	171	15	mtx	mtx	NOUN
dpc-3767	171	16	versus	versus	X
dpc-3767	171	17	ta	ta	ADP
dpc-3767	171	18	intralesional	intralesional	ADJ
dpc-3767	171	19	injection	injection	NOUN
dpc-3767	171	20	in	in	ADP
dpc-3767	171	21	treating	treat	VERB
dpc-3767	171	22	nail	nail	NOUN
dpc-3767	171	23	psoriasis	psoriasis	NOUN
dpc-3767	171	24	.	.	PUNCT
dpc-3767	172	1	three	three	NUM
dpc-3767	172	2	studies	study	NOUN
dpc-3767	172	3	were	be	AUX
dpc-3767	172	4	included	include	VERB
dpc-3767	172	5	in	in	ADP
dpc-3767	172	6	the	the	DET
dpc-3767	172	7	qualitative	qualitative	ADJ
dpc-3767	172	8	review	review	NOUN
dpc-3767	172	9	(	(	PUNCT
dpc-3767	172	10	systematic	systematic	ADJ
dpc-3767	172	11	review	review	NOUN
dpc-3767	172	12	)	)	PUNCT
dpc-3767	172	13	,	,	PUNCT
dpc-3767	172	14	and	and	CCONJ
dpc-3767	172	15	all	all	DET
dpc-3767	172	16	three	three	NUM
dpc-3767	172	17	could	could	AUX
dpc-3767	172	18	be	be	AUX
dpc-3767	172	19	reviewed	review	VERB
dpc-3767	172	20	quantitatively	quantitatively	ADV
dpc-3767	172	21	(	(	PUNCT
dpc-3767	172	22	meta	meta	VERB
dpc-3767	172	23	-	-	PUNCT
dpc-3767	172	24	analysis	analysis	NOUN
dpc-3767	172	25	)	)	PUNCT
dpc-3767	172	26	to	to	PART
dpc-3767	172	27	determine	determine	VERB
dpc-3767	172	28	the	the	DET
dpc-3767	172	29	efficacy	efficacy	NOUN
dpc-3767	172	30	of	of	ADP
dpc-3767	172	31	mtx	mtx	NOUN
dpc-3767	172	32	and	and	CCONJ
dpc-3767	172	33	ta	ta	ADP
dpc-3767	172	34	intralesional	intralesional	ADJ
dpc-3767	172	35	injection	injection	NOUN
dpc-3767	172	36	in	in	ADP
dpc-3767	172	37	nail	nail	NOUN
dpc-3767	172	38	psoriasis	psoriasis	NOUN
dpc-3767	172	39	treatment	treatment	NOUN
dpc-3767	172	40	based	base	VERB
dpc-3767	172	41	on	on	ADP
dpc-3767	172	42	the	the	DET
dpc-3767	172	43	changes	change	NOUN
dpc-3767	172	44	in	in	ADP
dpc-3767	172	45	the	the	DET
dpc-3767	172	46	napsi	napsi	NOUN
dpc-3767	172	47	score	score	NOUN
dpc-3767	172	48	.	.	PUNCT
dpc-3767	173	1	methotrexate	methotrexate	NOUN
dpc-3767	173	2	(	(	PUNCT
dpc-3767	173	3	mtx	mtx	NOUN
dpc-3767	173	4	)	)	PUNCT
dpc-3767	173	5	has	have	AUX
dpc-3767	173	6	been	be	AUX
dpc-3767	173	7	shown	show	VERB
dpc-3767	173	8	to	to	PART
dpc-3767	173	9	improve	improve	VERB
dpc-3767	173	10	napsi	napsi	ADJ
dpc-3767	173	11	score	score	NOUN
dpc-3767	173	12	in	in	ADP
dpc-3767	173	13	several	several	ADJ
dpc-3767	173	14	studies	study	NOUN
dpc-3767	173	15	.	.	PUNCT
dpc-3767	174	1	mtx	mtx	NOUN
dpc-3767	174	2	is	be	AUX
dpc-3767	174	3	a	a	DET
dpc-3767	174	4	folic	folic	ADJ
dpc-3767	174	5	acid	acid	NOUN
dpc-3767	174	6	analog	analog	NOUN
dpc-3767	174	7	that	that	PRON
dpc-3767	174	8	irreversibly	irreversibly	ADV
dpc-3767	174	9	binds	bind	VERB
dpc-3767	174	10	to	to	PART
dpc-3767	174	11	dihydrofolate	dihydrofolate	NOUN
dpc-3767	174	12	reductase	reductase	NOUN
dpc-3767	174	13	and	and	CCONJ
dpc-3767	174	14	blocks	block	VERB
dpc-3767	174	15	deoxyribonucleic	deoxyribonucleic	ADJ
dpc-3767	174	16	acid	acid	NOUN
dpc-3767	174	17	synthesis	synthesis	NOUN
dpc-3767	174	18	.	.	PUNCT
dpc-3767	175	1	mtx	mtx	NOUN
dpc-3767	175	2	acts	act	NOUN
dpc-3767	175	3	as	as	ADP
dpc-3767	175	4	the	the	DET
dpc-3767	175	5	anti	anti	ADJ
dpc-3767	175	6	-	-	ADJ
dpc-3767	175	7	inflammatory	inflammatory	ADJ
dpc-3767	175	8	,	,	PUNCT
dpc-3767	175	9	anti	anti	ADJ
dpc-3767	175	10	-	-	ADJ
dpc-3767	175	11	proliferative	proliferative	ADJ
dpc-3767	175	12	,	,	PUNCT
dpc-3767	175	13	and	and	CCONJ
dpc-3767	175	14	immunosuppressant	immunosuppressant	ADJ
dpc-3767	175	15	agent	agent	NOUN
dpc-3767	175	16	[	[	X
dpc-3767	175	17	11	11	NUM
dpc-3767	175	18	]	]	PUNCT
dpc-3767	175	19	.	.	PUNCT
dpc-3767	176	1	it	it	PRON
dpc-3767	176	2	is	be	AUX
dpc-3767	176	3	usually	usually	ADV
dpc-3767	176	4	taken	take	VERB
dpc-3767	176	5	orally	orally	ADV
dpc-3767	176	6	or	or	CCONJ
dpc-3767	176	7	administered	administer	VERB
dpc-3767	176	8	by	by	ADP
dpc-3767	176	9	injection	injection	NOUN
dpc-3767	176	10	(	(	PUNCT
dpc-3767	176	11	intramuscular	intramuscular	ADJ
dpc-3767	176	12	,	,	PUNCT
dpc-3767	176	13	intravenous	intravenous	ADJ
dpc-3767	176	14	,	,	PUNCT
dpc-3767	176	15	subcutaneous	subcutaneous	ADJ
dpc-3767	176	16	)	)	PUNCT
dpc-3767	176	17	and	and	CCONJ
dpc-3767	176	18	has	have	VERB
dpc-3767	176	19	several	several	ADJ
dpc-3767	176	20	indications	indication	NOUN
dpc-3767	176	21	,	,	PUNCT
dpc-3767	176	22	including	include	VERB
dpc-3767	176	23	nail	nail	NOUN
dpc-3767	176	24	psoriasis	psoriasis	NOUN
dpc-3767	176	25	.	.	PUNCT
dpc-3767	177	1	current	current	ADJ
dpc-3767	177	2	studies	study	NOUN
dpc-3767	177	3	suggest	suggest	VERB
dpc-3767	177	4	injections	injection	NOUN
dpc-3767	177	5	of	of	ADP
dpc-3767	177	6	mtx	mtx	NOUN
dpc-3767	177	7	(	(	PUNCT
dpc-3767	177	8	10–25	10–25	NUM
dpc-3767	177	9	mg	mg	NUM
dpc-3767	177	10	/	/	SYM
dpc-3767	177	11	ml	ml	NOUN
dpc-3767	177	12	)	)	PUNCT
dpc-3767	177	13	be	be	AUX
dpc-3767	177	14	administered	administer	VERB
dpc-3767	177	15	every	every	DET
dpc-3767	177	16	4–8	4–8	NUM
dpc-3767	177	17	weeks	week	NOUN
dpc-3767	178	1	[	[	X
dpc-3767	178	2	11	11	NUM
dpc-3767	178	3	,	,	PUNCT
dpc-3767	178	4	12	12	NUM
dpc-3767	178	5	]	]	PUNCT
dpc-3767	178	6	.	.	PUNCT
dpc-3767	179	1	triamcinolone	triamcinolone	PROPN
dpc-3767	179	2	acetonide	acetonide	NOUN
dpc-3767	179	3	(	(	PUNCT
dpc-3767	179	4	ta	ta	NOUN
dpc-3767	179	5	)	)	PUNCT
dpc-3767	179	6	is	be	AUX
dpc-3767	179	7	a	a	DET
dpc-3767	179	8	synthetic	synthetic	ADJ
dpc-3767	179	9	corticosteroid	corticosteroid	NOUN
dpc-3767	179	10	[	[	X
dpc-3767	179	11	13	13	NUM
dpc-3767	179	12	]	]	PUNCT
dpc-3767	179	13	.	.	PUNCT
dpc-3767	180	1	the	the	DET
dpc-3767	180	2	existing	exist	VERB
dpc-3767	180	3	evidence	evidence	NOUN
dpc-3767	180	4	suggests	suggest	VERB
dpc-3767	180	5	that	that	SCONJ
dpc-3767	180	6	ta	ta	PART
dpc-3767	180	7	intralesional	intralesional	ADJ
dpc-3767	180	8	injections	injection	NOUN
dpc-3767	180	9	into	into	ADP
dpc-3767	180	10	the	the	DET
dpc-3767	180	11	nail	nail	NOUN
dpc-3767	180	12	bed	bed	NOUN
dpc-3767	180	13	and	and	CCONJ
dpc-3767	180	14	matrix	matrix	NOUN
dpc-3767	180	15	are	be	AUX
dpc-3767	180	16	particularly	particularly	ADV
dpc-3767	180	17	effective	effective	ADJ
dpc-3767	180	18	for	for	ADP
dpc-3767	180	19	alleviating	alleviate	VERB
dpc-3767	180	20	lesions	lesion	NOUN
dpc-3767	180	21	caused	cause	VERB
dpc-3767	180	22	by	by	ADP
dpc-3767	180	23	psoriasis	psoriasis	NOUN
dpc-3767	180	24	of	of	ADP
dpc-3767	180	25	the	the	DET
dpc-3767	180	26	nail	nail	NOUN
dpc-3767	180	27	matrix	matrix	NOUN
dpc-3767	180	28	,	,	PUNCT
dpc-3767	180	29	and	and	CCONJ
dpc-3767	180	30	they	they	PRON
dpc-3767	180	31	also	also	ADV
dpc-3767	180	32	have	have	VERB
dpc-3767	180	33	moderate	moderate	ADJ
dpc-3767	180	34	effects	effect	NOUN
dpc-3767	180	35	on	on	ADP
dpc-3767	180	36	nail	nail	NOUN
dpc-3767	180	37	bed	bed	NOUN
dpc-3767	180	38	signs	sign	NOUN
dpc-3767	180	39	[	[	X
dpc-3767	180	40	14	14	NUM
dpc-3767	180	41	,	,	PUNCT
dpc-3767	180	42	15	15	NUM
dpc-3767	180	43	]	]	PUNCT
dpc-3767	180	44	.	.	PUNCT
dpc-3767	181	1	ta	ta	X
dpc-3767	181	2	acts	act	VERB
dpc-3767	181	3	as	as	ADP
dpc-3767	181	4	the	the	DET
dpc-3767	181	5	anti	anti	ADJ
dpc-3767	181	6	-	-	ADJ
dpc-3767	181	7	inflammatory	inflammatory	ADJ
dpc-3767	181	8	,	,	PUNCT
dpc-3767	181	9	anti	anti	ADJ
dpc-3767	181	10	-	-	ADJ
dpc-3767	181	11	proliferative	proliferative	ADJ
dpc-3767	181	12	,	,	PUNCT
dpc-3767	181	13	and	and	CCONJ
dpc-3767	181	14	immunosuppressant	immunosuppressant	ADJ
dpc-3767	181	15	agent	agent	NOUN
dpc-3767	181	16	.	.	PUNCT
dpc-3767	182	1	current	current	ADJ
dpc-3767	182	2	studies	study	NOUN
dpc-3767	182	3	suggest	suggest	VERB
dpc-3767	182	4	injections	injection	NOUN
dpc-3767	182	5	of	of	ADP
dpc-3767	182	6	triamcinolone	triamcinolone	NOUN
dpc-3767	182	7	acetonide	acetonide	NOUN
dpc-3767	182	8	(	(	PUNCT
dpc-3767	182	9	5–10	5–10	ADJ
dpc-3767	182	10	mg	mg	PROPN
dpc-3767	182	11	/	/	SYM
dpc-3767	182	12	ml	ml	AUX
dpc-3767	182	13	)	)	PUNCT
dpc-3767	182	14	be	be	AUX
dpc-3767	182	15	administered	administer	VERB
dpc-3767	182	16	every	every	DET
dpc-3767	182	17	4–8	4–8	NUM
dpc-3767	182	18	weeks	week	NOUN
dpc-3767	182	19	.	.	PUNCT
dpc-3767	183	1	side	side	NOUN
dpc-3767	183	2	effects	effect	NOUN
dpc-3767	183	3	after	after	ADP
dpc-3767	183	4	these	these	DET
dpc-3767	183	5	procedures	procedure	NOUN
dpc-3767	183	6	are	be	AUX
dpc-3767	183	7	well	well	ADV
dpc-3767	183	8	known	known	ADJ
dpc-3767	183	9	[	[	PUNCT
dpc-3767	183	10	16	16	NUM
dpc-3767	183	11	]	]	PUNCT
dpc-3767	183	12	.	.	PUNCT
dpc-3767	184	1	local	local	ADJ
dpc-3767	184	2	side	side	NOUN
dpc-3767	184	3	effects	effect	NOUN
dpc-3767	184	4	include	include	VERB
dpc-3767	184	5	telangiectasia	telangiectasia	NOUN
dpc-3767	184	6	,	,	PUNCT
dpc-3767	184	7	skin	skin	NOUN
dpc-3767	184	8	atrophy	atrophy	NOUN
dpc-3767	184	9	,	,	PUNCT
dpc-3767	184	10	subungual	subungual	ADJ
dpc-3767	184	11	drug	drug	NOUN
dpc-3767	184	12	deposition	deposition	NOUN
dpc-3767	184	13	,	,	PUNCT
dpc-3767	184	14	subungual	subungual	ADJ
dpc-3767	184	15	or	or	CCONJ
dpc-3767	184	16	review	review	VERB
dpc-3767	184	17	|	|	ADV
dpc-3767	184	18	dermatol	dermatol	ADJ
dpc-3767	184	19	pract	pract	NOUN
dpc-3767	184	20	concept	concept	NOUN
dpc-3767	184	21	.	.	PUNCT
dpc-3767	185	1	2024;14(2):e2024109	2024;14(2):e2024109	NUM
dpc-3767	185	2	7	7	NUM
dpc-3767	185	3	5	5	NUM
dpc-3767	185	4	.	.	PUNCT
dpc-3767	186	1	ventura	ventura	PROPN
dpc-3767	186	2	a	a	PROPN
dpc-3767	186	3	,	,	PUNCT
dpc-3767	186	4	mazzeo	mazzeo	NOUN
dpc-3767	186	5	m	m	PROPN
dpc-3767	186	6	,	,	PUNCT
dpc-3767	186	7	gaziano	gaziano	PROPN
dpc-3767	186	8	r	r	PROPN
dpc-3767	186	9	,	,	PUNCT
dpc-3767	186	10	galluzzo	galluzzo	NOUN
dpc-3767	186	11	m	m	PROPN
dpc-3767	186	12	,	,	PUNCT
dpc-3767	186	13	bianchi	bianchi	PROPN
dpc-3767	186	14	l	l	PROPN
dpc-3767	186	15	,	,	PUNCT
dpc-3767	186	16	campione	campione	PROPN
dpc-3767	186	17	e.	e.	PROPN
dpc-3767	186	18	new	new	PROPN
dpc-3767	186	19	insight	insight	NOUN
dpc-3767	186	20	into	into	ADP
dpc-3767	186	21	the	the	DET
dpc-3767	186	22	pathogenesis	pathogenesis	NOUN
dpc-3767	186	23	of	of	ADP
dpc-3767	186	24	nail	nail	NOUN
dpc-3767	186	25	psoriasis	psoriasis	NOUN
dpc-3767	186	26	and	and	CCONJ
dpc-3767	186	27	overview	overview	NOUN
dpc-3767	186	28	of	of	ADP
dpc-3767	186	29	treatment	treatment	NOUN
dpc-3767	186	30	strategies	strategy	NOUN
dpc-3767	186	31	.	.	PUNCT
dpc-3767	187	1	drug	drug	NOUN
dpc-3767	187	2	des	des	PROPN
dpc-3767	187	3	devel	devel	NOUN
dpc-3767	187	4	ther	ther	ADV
dpc-3767	187	5	.	.	PUNCT
dpc-3767	188	1	2017;2527–35	2017;2527–35	NUM
dpc-3767	188	2	.	.	NOUN
dpc-3767	188	3	6	6	NUM
dpc-3767	188	4	.	.	PUNCT
dpc-3767	188	5	lawry	lawry	PROPN
dpc-3767	188	6	m.	m.	PROPN
dpc-3767	188	7	biological	biological	PROPN
dpc-3767	188	8	therapy	therapy	NOUN
dpc-3767	188	9	and	and	CCONJ
dpc-3767	188	10	nail	nail	NOUN
dpc-3767	188	11	psoriasis	psoriasis	NOUN
dpc-3767	188	12	.	.	PUNCT
dpc-3767	189	1	dermatol	dermatol	NOUN
dpc-3767	189	2	ther	ther	ADV
dpc-3767	189	3	.	.	PUNCT
dpc-3767	190	1	2007;20(1):60–7	2007;20(1):60–7	X
dpc-3767	190	2	.	.	PUNCT
dpc-3767	191	1	7	7	NUM
dpc-3767	191	2	.	.	NUM
dpc-3767	191	3	mittal	mittal	PROPN
dpc-3767	191	4	j	j	PROPN
dpc-3767	191	5	,	,	PUNCT
dpc-3767	191	6	mahajan	mahajan	PROPN
dpc-3767	191	7	bb	bb	PROPN
dpc-3767	191	8	.	.	PUNCT
dpc-3767	192	1	intramatricial	intramatricial	ADJ
dpc-3767	192	2	injections	injection	NOUN
dpc-3767	192	3	for	for	ADP
dpc-3767	192	4	nail	nail	NOUN
dpc-3767	192	5	psoriasis	psoriasis	NOUN
dpc-3767	192	6	:	:	PUNCT
dpc-3767	192	7	an	an	DET
dpc-3767	192	8	open	open	ADJ
dpc-3767	192	9	-	-	PUNCT
dpc-3767	192	10	label	label	NOUN
dpc-3767	192	11	comparative	comparative	ADJ
dpc-3767	192	12	study	study	NOUN
dpc-3767	192	13	of	of	ADP
dpc-3767	192	14	triamcinolone	triamcinolone	NOUN
dpc-3767	192	15	,	,	PUNCT
dpc-3767	192	16	methotrexate	methotrexate	NOUN
dpc-3767	192	17	,	,	PUNCT
dpc-3767	192	18	and	and	CCONJ
dpc-3767	192	19	cyclosporine	cyclosporine	NOUN
dpc-3767	192	20	.	.	PUNCT
dpc-3767	193	1	indian	indian	PROPN
dpc-3767	193	2	j	j	PROPN
dpc-3767	193	3	dermatol	dermatol	PROPN
dpc-3767	193	4	venereol	venereol	ADJ
dpc-3767	193	5	leprol	leprol	NOUN
dpc-3767	193	6	.	.	PUNCT
dpc-3767	194	1	2018;84(4):419–23	2018;84(4):419–23	NUM
dpc-3767	194	2	.	.	NOUN
dpc-3767	194	3	8	8	NUM
dpc-3767	194	4	.	.	PUNCT
dpc-3767	195	1	moher	moher	PROPN
dpc-3767	195	2	d	d	PROPN
dpc-3767	195	3	,	,	PUNCT
dpc-3767	195	4	liberati	liberati	PROPN
dpc-3767	195	5	a	a	PRON
dpc-3767	195	6	,	,	PUNCT
dpc-3767	195	7	tetzlaff	tetzlaff	PROPN
dpc-3767	195	8	j	j	PROPN
dpc-3767	195	9	,	,	PUNCT
dpc-3767	195	10	altman	altman	PROPN
dpc-3767	195	11	dg	dg	PROPN
dpc-3767	195	12	,	,	PUNCT
dpc-3767	195	13	altman	altman	PROPN
dpc-3767	195	14	d	d	PROPN
dpc-3767	195	15	,	,	PUNCT
dpc-3767	195	16	antes	ante	VERB
dpc-3767	195	17	g	g	PROPN
dpc-3767	195	18	,	,	PUNCT
dpc-3767	195	19	et	et	PROPN
dpc-3767	195	20	al	al	PROPN
dpc-3767	195	21	.	.	PROPN
dpc-3767	196	1	preferred	preferred	ADJ
dpc-3767	196	2	reporting	reporting	NOUN
dpc-3767	196	3	items	item	NOUN
dpc-3767	196	4	for	for	ADP
dpc-3767	196	5	systematic	systematic	ADJ
dpc-3767	196	6	reviews	review	NOUN
dpc-3767	196	7	and	and	CCONJ
dpc-3767	196	8	meta	meta	NOUN
dpc-3767	196	9	-	-	PUNCT
dpc-3767	196	10	analyses	analysis	NOUN
dpc-3767	196	11	:	:	PUNCT
dpc-3767	196	12	the	the	DET
dpc-3767	196	13	prisma	prisma	PROPN
dpc-3767	196	14	statement	statement	NOUN
dpc-3767	196	15	.	.	PUNCT
dpc-3767	197	1	plos	plos	PROPN
dpc-3767	197	2	med	med	PROPN
dpc-3767	197	3	.	.	PUNCT
dpc-3767	197	4	2009;6(7	2009;6(7	NUM
dpc-3767	197	5	)	)	PUNCT
dpc-3767	197	6	.	.	PUNCT
dpc-3767	198	1	9	9	X
dpc-3767	198	2	.	.	X
dpc-3767	198	3	abdelmeniem	abdelmeniem	PROPN
dpc-3767	199	1	i	i	PRON
dpc-3767	199	2	m	m	VERB
dpc-3767	199	3	,	,	PUNCT
dpc-3767	199	4	eryan	eryan	VERB
dpc-3767	199	5	i	i	PROPN
dpc-3767	199	6	m	m	PROPN
dpc-3767	199	7	el	el	PROPN
dpc-3767	199	8	,	,	PUNCT
dpc-3767	199	9	nofal	nofal	ADV
dpc-3767	199	10	a	a	X
dpc-3767	199	11	,	,	PUNCT
dpc-3767	199	12	fouda	fouda	NOUN
dpc-3767	199	13	if	if	SCONJ
dpc-3767	199	14	,	,	PUNCT
dpc-3767	199	15	omar	omar	PROPN
dpc-3767	199	16	ss	ss	PROPN
dpc-3767	199	17	.	.	PUNCT
dpc-3767	200	1	topical	topical	ADJ
dpc-3767	200	2	calcipotriol	calcipotriol	NOUN
dpc-3767	200	3	combined	combine	VERB
dpc-3767	200	4	with	with	ADP
dpc-3767	200	5	urea	urea	NOUN
dpc-3767	200	6	20	20	NUM
dpc-3767	200	7	%	%	NOUN
dpc-3767	200	8	versus	versus	ADP
dpc-3767	200	9	intralesional	intralesional	ADJ
dpc-3767	200	10	injection	injection	NOUN
dpc-3767	200	11	of	of	ADP
dpc-3767	200	12	triamcinolone	triamcinolone	PROPN
dpc-3767	200	13	acetonide	acetonide	NOUN
dpc-3767	200	14	,	,	PUNCT
dpc-3767	200	15	5‐fluorouracil	5‐fluorouracil	ADV
dpc-3767	200	16	,	,	PUNCT
dpc-3767	200	17	and	and	CCONJ
dpc-3767	200	18	methotrexate	methotrexate	VERB
dpc-3767	200	19	in	in	ADP
dpc-3767	200	20	the	the	DET
dpc-3767	200	21	treatment	treatment	NOUN
dpc-3767	200	22	of	of	ADP
dpc-3767	200	23	nail	nail	NOUN
dpc-3767	200	24	psoriasis	psoriasis	NOUN
dpc-3767	200	25	:	:	PUNCT
dpc-3767	200	26	a	a	DET
dpc-3767	200	27	comparative	comparative	ADJ
dpc-3767	200	28	study	study	NOUN
dpc-3767	200	29	.	.	PUNCT
dpc-3767	201	1	dermatol	dermatol	NOUN
dpc-3767	201	2	ther	ther	ADV
dpc-3767	201	3	.	.	PUNCT
dpc-3767	202	1	2022;1–26	2022;1–26	NUM
dpc-3767	202	2	.	.	PUNCT
dpc-3767	203	1	10	10	NUM
dpc-3767	203	2	.	.	PUNCT
dpc-3767	203	3	starace	starace	PROPN
dpc-3767	203	4	m	m	PROPN
dpc-3767	203	5	,	,	PUNCT
dpc-3767	203	6	alessandrini	alessandrini	PROPN
dpc-3767	203	7	a	a	PRON
dpc-3767	203	8	,	,	PUNCT
dpc-3767	203	9	iorizzo	iorizzo	VERB
dpc-3767	203	10	m	m	PROPN
dpc-3767	203	11	,	,	PUNCT
dpc-3767	203	12	d’altobrando	d’altobrando	PROPN
dpc-3767	203	13	a	a	PROPN
dpc-3767	203	14	,	,	PUNCT
dpc-3767	203	15	ferrari	ferrari	PROPN
dpc-3767	203	16	t	t	PROPN
dpc-3767	203	17	,	,	PUNCT
dpc-3767	203	18	bruni	bruni	PROPN
dpc-3767	203	19	f	f	PROPN
dpc-3767	203	20	,	,	PUNCT
dpc-3767	203	21	et	et	PROPN
dpc-3767	203	22	al	al	PROPN
dpc-3767	203	23	.	.	PUNCT
dpc-3767	204	1	a	a	DET
dpc-3767	204	2	pilot	pilot	NOUN
dpc-3767	204	3	study	study	NOUN
dpc-3767	204	4	of	of	ADP
dpc-3767	204	5	intralesional	intralesional	ADJ
dpc-3767	204	6	methotrexate	methotrexate	NOUN
dpc-3767	204	7	injections	injection	NOUN
dpc-3767	204	8	versus	versus	ADP
dpc-3767	204	9	triamcinolone	triamcinolone	PROPN
dpc-3767	204	10	acetonide	acetonide	NOUN
dpc-3767	204	11	in	in	ADP
dpc-3767	204	12	patients	patient	NOUN
dpc-3767	204	13	affected	affect	VERB
dpc-3767	204	14	by	by	ADP
dpc-3767	204	15	nail	nail	NOUN
dpc-3767	204	16	matrix	matrix	NOUN
dpc-3767	204	17	psoriasis	psoriasis	NOUN
dpc-3767	204	18	.	.	PUNCT
dpc-3767	205	1	clin	clin	PROPN
dpc-3767	205	2	exp	exp	NOUN
dpc-3767	205	3	dermatol	dermatol	NOUN
dpc-3767	205	4	.	.	PUNCT
dpc-3767	206	1	2022;47(6):1165–8	2022;47(6):1165–8	X
dpc-3767	206	2	.	.	PROPN
dpc-3767	207	1	11	11	NUM
dpc-3767	207	2	.	.	PUNCT
dpc-3767	208	1	carretero	carretero	PROPN
dpc-3767	208	2	g	g	PROPN
dpc-3767	208	3	,	,	PUNCT
dpc-3767	208	4	puig	puig	X
dpc-3767	208	5	l	l	NOUN
dpc-3767	208	6	,	,	PUNCT
dpc-3767	208	7	dehesa	dehesa	PROPN
dpc-3767	208	8	l	l	PROPN
dpc-3767	208	9	,	,	PUNCT
dpc-3767	208	10	carrascosa	carrascosa	PROPN
dpc-3767	208	11	jm	jm	PROPN
dpc-3767	208	12	,	,	PUNCT
dpc-3767	208	13	ribera	ribera	PROPN
dpc-3767	208	14	m	m	PROPN
dpc-3767	208	15	,	,	PUNCT
dpc-3767	208	16	sánchez	sánchez	NOUN
dpc-3767	208	17	-	-	PUNCT
dpc-3767	208	18	regaña	regaña	PROPN
dpc-3767	208	19	m	m	PROPN
dpc-3767	208	20	,	,	PUNCT
dpc-3767	208	21	et	et	PROPN
dpc-3767	208	22	al	al	PROPN
dpc-3767	208	23	.	.	PUNCT
dpc-3767	208	24	guidelines	guideline	NOUN
dpc-3767	208	25	on	on	ADP
dpc-3767	208	26	the	the	DET
dpc-3767	208	27	use	use	NOUN
dpc-3767	208	28	of	of	ADP
dpc-3767	208	29	methotrexate	methotrexate	NOUN
dpc-3767	208	30	in	in	ADP
dpc-3767	208	31	psoriasis	psoriasis	NOUN
dpc-3767	208	32	.	.	PUNCT
dpc-3767	209	1	actas	actas	NOUN
dpc-3767	209	2	dermosifiliogr	dermosifiliogr	NOUN
dpc-3767	209	3	[	[	X
dpc-3767	209	4	internet	internet	NOUN
dpc-3767	209	5	]	]	PUNCT
dpc-3767	209	6	.	.	PUNCT
dpc-3767	210	1	2010;101(7):600–13	2010;101(7):600–13	NUM
dpc-3767	210	2	.	.	PUNCT
dpc-3767	210	3	available	available	ADJ
dpc-3767	210	4	from	from	ADP
dpc-3767	210	5	:	:	PUNCT
dpc-3767	210	6	http://dx.doi.org/10.1016/s15782190(10	http://dx.doi.org/10.1016/s15782190(10	NOUN
dpc-3767	210	7	)	)	PUNCT
dpc-3767	210	8	70682	70682	NUM
dpc-3767	210	9	-	-	SYM
dpc-3767	210	10	x	x	SYM
dpc-3767	210	11	12	12	NUM
dpc-3767	210	12	.	.	PUNCT
dpc-3767	211	1	abdelmeniem	abdelmeniem	INTJ
dpc-3767	212	1	i	i	PRON
dpc-3767	212	2	m	m	VERB
dpc-3767	212	3	,	,	PUNCT
dpc-3767	212	4	eryan	eryan	VERB
dpc-3767	212	5	i	i	PROPN
dpc-3767	212	6	m	m	PROPN
dpc-3767	212	7	el	el	PROPN
dpc-3767	212	8	,	,	PUNCT
dpc-3767	212	9	nofal	nofal	ADV
dpc-3767	212	10	a	a	X
dpc-3767	212	11	,	,	PUNCT
dpc-3767	212	12	fouda	fouda	NOUN
dpc-3767	212	13	if	if	SCONJ
dpc-3767	212	14	,	,	PUNCT
dpc-3767	212	15	omar	omar	PROPN
dpc-3767	212	16	ss	ss	PROPN
dpc-3767	212	17	.	.	PUNCT
dpc-3767	213	1	topical	topical	ADJ
dpc-3767	213	2	calcipotriol	calcipotriol	NOUN
dpc-3767	213	3	combined	combine	VERB
dpc-3767	213	4	with	with	ADP
dpc-3767	213	5	urea	urea	NOUN
dpc-3767	213	6	20	20	NUM
dpc-3767	213	7	%	%	NOUN
dpc-3767	213	8	versus	versus	ADP
dpc-3767	213	9	intralesional	intralesional	ADJ
dpc-3767	213	10	injection	injection	NOUN
dpc-3767	213	11	of	of	ADP
dpc-3767	213	12	triamcinolone	triamcinolone	PROPN
dpc-3767	213	13	acetonide	acetonide	NOUN
dpc-3767	213	14	,	,	PUNCT
dpc-3767	213	15	5‐fluorouracil	5‐fluorouracil	ADV
dpc-3767	213	16	,	,	PUNCT
dpc-3767	213	17	and	and	CCONJ
dpc-3767	213	18	methotrexate	methotrexate	VERB
dpc-3767	213	19	in	in	ADP
dpc-3767	213	20	the	the	DET
dpc-3767	213	21	treatment	treatment	NOUN
dpc-3767	213	22	of	of	ADP
dpc-3767	213	23	nail	nail	NOUN
dpc-3767	213	24	psoriasis	psoriasis	NOUN
dpc-3767	213	25	:	:	PUNCT
dpc-3767	213	26	a	a	DET
dpc-3767	213	27	comparative	comparative	ADJ
dpc-3767	213	28	study	study	NOUN
dpc-3767	213	29	.	.	PUNCT
dpc-3767	214	1	dermatol	dermatol	NOUN
dpc-3767	214	2	ther	ther	ADV
dpc-3767	214	3	.	.	PUNCT
dpc-3767	215	1	2022;1–26	2022;1–26	NUM
dpc-3767	215	2	.	.	PUNCT
dpc-3767	216	1	13	13	NUM
dpc-3767	216	2	.	.	PUNCT
dpc-3767	217	1	haneke	haneke	PROPN
dpc-3767	217	2	e.	e.	PROPN
dpc-3767	217	3	nail	nail	PROPN
dpc-3767	217	4	psoriasis	psoriasis	NOUN
dpc-3767	217	5	:	:	PUNCT
dpc-3767	217	6	clinical	clinical	ADJ
dpc-3767	217	7	features	feature	NOUN
dpc-3767	217	8	,	,	PUNCT
dpc-3767	217	9	pathogenesis	pathogenesis	NOUN
dpc-3767	217	10	,	,	PUNCT
dpc-3767	217	11	differential	differential	NOUN
dpc-3767	217	12	diagnoses	diagnosis	NOUN
dpc-3767	217	13	,	,	PUNCT
dpc-3767	217	14	and	and	CCONJ
dpc-3767	217	15	108	108	NUM
dpc-3767	217	16	management	management	NOUN
dpc-3767	217	17	.	.	PUNCT
dpc-3767	218	1	psoriasis	psoriasis	NOUN
dpc-3767	218	2	targets	target	NOUN
dpc-3767	218	3	ther	ther	ADV
dpc-3767	218	4	.	.	PUNCT
dpc-3767	219	1	2017;volume	2017;volume	PROPN
dpc-3767	220	1	7:51–63	7:51–63	NUM
dpc-3767	220	2	.	.	PUNCT
dpc-3767	221	1	14	14	NUM
dpc-3767	221	2	.	.	PUNCT
dpc-3767	222	1	saricaoglu	saricaoglu	PROPN
dpc-3767	222	2	h	h	PROPN
dpc-3767	222	3	,	,	PUNCT
dpc-3767	222	4	oz	oz	X
dpc-3767	222	5	a	a	PRON
dpc-3767	222	6	,	,	PUNCT
dpc-3767	222	7	turan	turan	PROPN
dpc-3767	222	8	h.	h.	PROPN
dpc-3767	222	9	nail	nail	NOUN
dpc-3767	222	10	psoriasis	psoriasis	NOUN
dpc-3767	222	11	successfully	successfully	ADV
dpc-3767	222	12	treated	treat	VERB
dpc-3767	222	13	with	with	ADP
dpc-3767	222	14	intralesional	intralesional	ADJ
dpc-3767	222	15	methotrexate	methotrexate	NOUN
dpc-3767	222	16	:	:	PUNCT
dpc-3767	222	17	case	case	NOUN
dpc-3767	222	18	report	report	NOUN
dpc-3767	222	19	.	.	PUNCT
dpc-3767	223	1	dermatology	dermatology	NOUN
dpc-3767	223	2	.	.	PUNCT
dpc-3767	224	1	2011;222(1):5–7	2011;222(1):5–7	NUM
dpc-3767	224	2	.	.	PUNCT
dpc-3767	225	1	15	15	NUM
dpc-3767	225	2	.	.	PUNCT
dpc-3767	225	3	srisinlapakig	srisinlapakig	PROPN
dpc-3767	225	4	s	s	PROPN
dpc-3767	225	5	,	,	PUNCT
dpc-3767	225	6	juntongjin	juntongjin	PROPN
dpc-3767	225	7	p.	p.	PROPN
dpc-3767	225	8	intralesional	intralesional	PROPN
dpc-3767	226	1	triamcinolone	triamcinolone	PROPN
dpc-3767	226	2	acetonide	acetonide	ADJ
dpc-3767	226	3	injection	injection	NOUN
dpc-3767	226	4	and	and	CCONJ
dpc-3767	226	5	topical	topical	ADJ
dpc-3767	226	6	betamethasone	betamethasone	NOUN
dpc-3767	226	7	/	/	SYM
dpc-3767	226	8	calcipotriol	calcipotriol	PROPN
dpc-3767	226	9	treatment	treatment	NOUN
dpc-3767	226	10	in	in	ADP
dpc-3767	226	11	nail	nail	NOUN
dpc-3767	226	12	psoriasis	psoriasis	NOUN
dpc-3767	226	13	.	.	PUNCT
dpc-3767	227	1	rsu	rsu	PROPN
dpc-3767	227	2	international	international	PROPN
dpc-3767	227	3	research	research	PROPN
dpc-3767	227	4	conference	conference	NOUN
dpc-3767	227	5	2022	2022	NUM
dpc-3767	227	6	https://rsucon.rsu.ac.th/proceedings	https://rsucon.rsu.ac.th/proceeding	NOUN
dpc-3767	227	7	29	29	NUM
dpc-3767	227	8	april	april	PROPN
dpc-3767	227	9	2022	2022	NUM
dpc-3767	227	10	.	.	PUNCT
dpc-3767	228	1	2022	2022	NUM
dpc-3767	228	2	;	;	PUNCT
dpc-3767	228	3	(	(	PUNCT
dpc-3767	228	4	april):1–7	april):1–7	NOUN
dpc-3767	228	5	.	.	PUNCT
dpc-3767	229	1	16	16	NUM
dpc-3767	229	2	.	.	X
dpc-3767	229	3	de	de	PROPN
dpc-3767	229	4	berker	berker	PROPN
dpc-3767	229	5	dar	dar	PROPN
dpc-3767	229	6	,	,	PUNCT
dpc-3767	229	7	lawrence	lawrence	PROPN
dpc-3767	229	8	cm	cm	PROPN
dpc-3767	229	9	.	.	PUNCT
dpc-3767	230	1	a	a	DET
dpc-3767	230	2	simplified	simplified	ADJ
dpc-3767	230	3	protocol	protocol	NOUN
dpc-3767	230	4	of	of	ADP
dpc-3767	230	5	steroid	steroid	NOUN
dpc-3767	230	6	injection	injection	NOUN
dpc-3767	230	7	for	for	ADP
dpc-3767	230	8	psoriatic	psoriatic	ADJ
dpc-3767	230	9	nail	nail	NOUN
dpc-3767	230	10	dystrophy	dystrophy	NOUN
dpc-3767	230	11	.	.	PUNCT
dpc-3767	231	1	br	br	PROPN
dpc-3767	231	2	j	j	PROPN
dpc-3767	231	3	dermatol	dermatol	NOUN
dpc-3767	231	4	.	.	PUNCT
dpc-3767	232	1	1998	1998	NUM
dpc-3767	232	2	;	;	PUNCT
dpc-3767	232	3	138(1):90–5	138(1):90–5	NUM
dpc-3767	232	4	.	.	PUNCT
dpc-3767	233	1	limited	limited	ADJ
dpc-3767	233	2	number	number	NOUN
dpc-3767	233	3	of	of	ADP
dpc-3767	233	4	participants	participant	NOUN
dpc-3767	233	5	in	in	ADP
dpc-3767	233	6	this	this	DET
dpc-3767	233	7	study	study	NOUN
dpc-3767	233	8	,	,	PUNCT
dpc-3767	233	9	and	and	CCONJ
dpc-3767	233	10	that	that	SCONJ
dpc-3767	233	11	some	some	DET
dpc-3767	233	12	studies	study	NOUN
dpc-3767	233	13	only	only	ADV
dpc-3767	233	14	presented	present	VERB
dpc-3767	233	15	their	their	PRON
dpc-3767	233	16	results	result	NOUN
dpc-3767	233	17	in	in	ADP
dpc-3767	233	18	the	the	DET
dpc-3767	233	19	form	form	NOUN
dpc-3767	233	20	of	of	ADP
dpc-3767	233	21	boxplot	boxplot	NOUN
dpc-3767	233	22	graph	graph	NOUN
dpc-3767	233	23	without	without	ADP
dpc-3767	233	24	specifying	specify	VERB
dpc-3767	233	25	the	the	DET
dpc-3767	233	26	numerical	numerical	ADJ
dpc-3767	233	27	value	value	NOUN
dpc-3767	233	28	or	or	CCONJ
dpc-3767	233	29	assessed	assess	VERB
dpc-3767	233	30	the	the	DET
dpc-3767	233	31	treatment	treatment	NOUN
dpc-3767	233	32	response	response	NOUN
dpc-3767	233	33	using	use	VERB
dpc-3767	233	34	different	different	ADJ
dpc-3767	233	35	scores	score	NOUN
dpc-3767	233	36	,	,	PUNCT
dpc-3767	233	37	thus	thus	ADV
dpc-3767	233	38	disqualifying	disqualify	VERB
dpc-3767	233	39	that	that	DET
dpc-3767	233	40	study	study	NOUN
dpc-3767	233	41	from	from	ADP
dpc-3767	233	42	being	be	AUX
dpc-3767	233	43	included	include	VERB
dpc-3767	233	44	in	in	ADP
dpc-3767	233	45	the	the	DET
dpc-3767	233	46	meta	meta	ADJ
dpc-3767	233	47	-	-	PUNCT
dpc-3767	233	48	analysis	analysis	NOUN
dpc-3767	233	49	.	.	PUNCT
dpc-3767	234	1	conclusion	conclusion	NOUN
dpc-3767	234	2	both	both	PRON
dpc-3767	234	3	methotrexate	methotrexate	VERB
dpc-3767	234	4	and	and	CCONJ
dpc-3767	234	5	triamcinolone	triamcinolone	NOUN
dpc-3767	234	6	acetonide	acetonide	NOUN
dpc-3767	234	7	are	be	AUX
dpc-3767	234	8	effective	effective	ADJ
dpc-3767	234	9	in	in	ADP
dpc-3767	234	10	treating	treat	VERB
dpc-3767	234	11	nail	nail	NOUN
dpc-3767	234	12	psoriasis	psoriasis	NOUN
dpc-3767	234	13	based	base	VERB
dpc-3767	234	14	on	on	ADP
dpc-3767	234	15	the	the	DET
dpc-3767	234	16	reduction	reduction	NOUN
dpc-3767	234	17	in	in	ADP
dpc-3767	234	18	napsi	napsi	ADJ
dpc-3767	234	19	score	score	NOUN
dpc-3767	234	20	.	.	PUNCT
dpc-3767	235	1	however	however	ADV
dpc-3767	235	2	,	,	PUNCT
dpc-3767	235	3	larger	large	ADJ
dpc-3767	235	4	studies	study	NOUN
dpc-3767	235	5	with	with	ADP
dpc-3767	235	6	more	more	ADJ
dpc-3767	235	7	participants	participant	NOUN
dpc-3767	235	8	are	be	AUX
dpc-3767	235	9	necessary	necessary	ADJ
dpc-3767	235	10	to	to	PART
dpc-3767	235	11	establish	establish	VERB
dpc-3767	235	12	the	the	DET
dpc-3767	235	13	optimal	optimal	ADJ
dpc-3767	235	14	dosage	dosage	NOUN
dpc-3767	235	15	,	,	PUNCT
dpc-3767	235	16	number	number	NOUN
dpc-3767	235	17	and	and	CCONJ
dpc-3767	235	18	frequency	frequency	NOUN
dpc-3767	235	19	of	of	ADP
dpc-3767	235	20	injections	injection	NOUN
dpc-3767	235	21	,	,	PUNCT
dpc-3767	235	22	and	and	CCONJ
dpc-3767	235	23	technique	technique	NOUN
dpc-3767	235	24	of	of	ADP
dpc-3767	235	25	injection	injection	NOUN
dpc-3767	235	26	.	.	PUNCT
dpc-3767	236	1	a	a	DET
dpc-3767	236	2	standardized	standardized	ADJ
dpc-3767	236	3	assessment	assessment	NOUN
dpc-3767	236	4	score	score	NOUN
dpc-3767	236	5	is	be	AUX
dpc-3767	236	6	also	also	ADV
dpc-3767	236	7	needed	need	VERB
dpc-3767	236	8	to	to	PART
dpc-3767	236	9	obtain	obtain	VERB
dpc-3767	236	10	more	more	ADV
dpc-3767	236	11	accurate	accurate	ADJ
dpc-3767	236	12	results	result	NOUN
dpc-3767	236	13	.	.	PUNCT
dpc-3767	237	1	abbreviations	abbreviation	NOUN
dpc-3767	237	2	:	:	PUNCT
dpc-3767	237	3	mtx	mtx	NOUN
dpc-3767	237	4	:	:	PUNCT
dpc-3767	237	5	methotrexate	methotrexate	NOUN
dpc-3767	237	6	ta	ta	PROPN
dpc-3767	238	1	:	:	PUNCT
dpc-3767	239	1	triamcinolone	triamcinolone	PROPN
dpc-3767	239	2	acetonide	acetonide	PROPN
dpc-3767	239	3	napsi	napsi	PROPN
dpc-3767	239	4	:	:	PUNCT
dpc-3767	239	5	nail	nail	NOUN
dpc-3767	239	6	psoriasis	psoriasis	NOUN
dpc-3767	239	7	severity	severity	NOUN
dpc-3767	239	8	index	index	NOUN
dpc-3767	239	9	prisma	prisma	NOUN
dpc-3767	239	10	:	:	PUNCT
dpc-3767	239	11	preferred	prefer	VERB
dpc-3767	239	12	reporting	reporting	NOUN
dpc-3767	239	13	items	item	NOUN
dpc-3767	239	14	for	for	ADP
dpc-3767	239	15	systematic	systematic	ADJ
dpc-3767	239	16	review	review	NOUN
dpc-3767	239	17	and	and	CCONJ
dpc-3767	239	18	meta	meta	VERB
dpc-3767	239	19	analysis	analysis	NOUN
dpc-3767	239	20	references	reference	NOUN
dpc-3767	239	21	1	1	NUM
dpc-3767	239	22	.	.	PUNCT
dpc-3767	240	1	christophers	christopher	NOUN
dpc-3767	240	2	e.	e.	PROPN
dpc-3767	240	3	psoriasis	psoriasis	PROPN
dpc-3767	240	4	epidemiology	epidemiology	NOUN
dpc-3767	240	5	and	and	CCONJ
dpc-3767	240	6	clinical	clinical	ADJ
dpc-3767	240	7	spectrum	spectrum	NOUN
dpc-3767	240	8	.	.	PUNCT
dpc-3767	241	1	clin	clin	PROPN
dpc-3767	241	2	exp	exp	NOUN
dpc-3767	241	3	dermatol	dermatol	NOUN
dpc-3767	241	4	.	.	PUNCT
dpc-3767	242	1	2001;26:314–20	2001;26:314–20	X
dpc-3767	242	2	.	.	PROPN
dpc-3767	242	3	2	2	NUM
dpc-3767	242	4	.	.	X
dpc-3767	242	5	de	de	PROPN
dpc-3767	242	6	jong	jong	PROPN
dpc-3767	242	7	emgj	emgj	PROPN
dpc-3767	242	8	,	,	PUNCT
dpc-3767	242	9	seegers	seeger	NOUN
dpc-3767	242	10	bampa	bampa	VERB
dpc-3767	242	11	,	,	PUNCT
dpc-3767	242	12	gulinck	gulinck	NOUN
dpc-3767	242	13	mk	mk	NOUN
dpc-3767	242	14	,	,	PUNCT
dpc-3767	242	15	boezeman	boezeman	PROPN
dpc-3767	242	16	jbm	jbm	PROPN
dpc-3767	242	17	,	,	PUNCT
dpc-3767	242	18	van	van	PROPN
dpc-3767	242	19	de	de	X
dpc-3767	242	20	kerkhof	kerkhof	PROPN
dpc-3767	242	21	pcm	pcm	ADJ
dpc-3767	242	22	.	.	PUNCT
dpc-3767	243	1	psoriasis	psoriasis	NOUN
dpc-3767	243	2	of	of	ADP
dpc-3767	243	3	the	the	DET
dpc-3767	243	4	nails	nail	NOUN
dpc-3767	243	5	associated	associate	VERB
dpc-3767	243	6	with	with	ADP
dpc-3767	243	7	disability	disability	NOUN
dpc-3767	243	8	in	in	ADP
dpc-3767	243	9	a	a	DET
dpc-3767	243	10	large	large	ADJ
dpc-3767	243	11	number	number	NOUN
dpc-3767	243	12	of	of	ADP
dpc-3767	243	13	patients	patient	NOUN
dpc-3767	243	14	:	:	PUNCT
dpc-3767	243	15	results	result	NOUN
dpc-3767	243	16	of	of	ADP
dpc-3767	243	17	a	a	DET
dpc-3767	243	18	recent	recent	ADJ
dpc-3767	243	19	interview	interview	NOUN
dpc-3767	243	20	with	with	ADP
dpc-3767	243	21	1,728	1,728	NUM
dpc-3767	243	22	patients	patient	NOUN
dpc-3767	243	23	.	.	PUNCT
dpc-3767	244	1	vol	vol	NOUN
dpc-3767	244	2	.	.	NOUN
dpc-3767	244	3	193	193	NUM
dpc-3767	244	4	,	,	PUNCT
dpc-3767	244	5	dermatology	dermatology	NOUN
dpc-3767	244	6	.	.	PUNCT
dpc-3767	245	1	1996	1996	NUM
dpc-3767	245	2	.	.	PUNCT
dpc-3767	246	1	p.	p.	NOUN
dpc-3767	246	2	300	300	NUM
dpc-3767	246	3	.	.	PUNCT
dpc-3767	247	1	3	3	X
dpc-3767	247	2	.	.	PUNCT
dpc-3767	247	3	lawry	lawry	PROPN
dpc-3767	247	4	m.	m.	PROPN
dpc-3767	247	5	biological	biological	PROPN
dpc-3767	247	6	therapy	therapy	NOUN
dpc-3767	247	7	and	and	CCONJ
dpc-3767	247	8	nail	nail	NOUN
dpc-3767	247	9	psoriasis	psoriasis	NOUN
dpc-3767	247	10	.	.	PUNCT
dpc-3767	248	1	dermatol	dermatol	NOUN
dpc-3767	248	2	ther	ther	ADV
dpc-3767	248	3	.	.	PUNCT
dpc-3767	249	1	2007;20(1):60–7	2007;20(1):60–7	X
dpc-3767	249	2	.	.	PUNCT
dpc-3767	250	1	4	4	X
dpc-3767	250	2	.	.	X
dpc-3767	250	3	klaassen	klaassen	PROPN
dpc-3767	250	4	kmg	kmg	PROPN
dpc-3767	250	5	,	,	PUNCT
dpc-3767	250	6	van	van	PROPN
dpc-3767	250	7	de	de	X
dpc-3767	250	8	kerkhof	kerkhof	PROPN
dpc-3767	250	9	pcm	pcm	PROPN
dpc-3767	250	10	,	,	PUNCT
dpc-3767	250	11	bastiaens	bastiaens	PROPN
dpc-3767	250	12	mt	mt	PROPN
dpc-3767	250	13	,	,	PUNCT
dpc-3767	250	14	plusjé	plusjé	NOUN
dpc-3767	250	15	lgjm	lgjm	NOUN
dpc-3767	250	16	,	,	PUNCT
dpc-3767	250	17	baran	baran	PROPN
dpc-3767	250	18	rl	rl	PROPN
dpc-3767	250	19	,	,	PUNCT
dpc-3767	250	20	pasch	pasch	PROPN
dpc-3767	250	21	mc	mc	PROPN
dpc-3767	250	22	.	.	PROPN
dpc-3767	250	23	scoring	score	VERB
dpc-3767	250	24	nail	nail	NOUN
dpc-3767	250	25	psoriasis	psoriasis	NOUN
dpc-3767	250	26	.	.	PUNCT
dpc-3767	251	1	j	j	PROPN
dpc-3767	251	2	am	be	AUX
dpc-3767	251	3	acad	acad	ADJ
dpc-3767	251	4	dermatol	dermatol	NOUN
dpc-3767	251	5	.	.	PUNCT
dpc-3767	252	1	2014;70(6):1061–6	2014;70(6):1061–6	NUM
dpc-3767	252	2	.	.	PUNCT